id	sid	tid	token	lemma	pos
dpc-1965	1	1	dermatology	dermatology	NOUN
dpc-1965	1	2	:	:	PUNCT
dpc-1965	1	3	practical	practical	ADJ
dpc-1965	1	4	and	and	CCONJ
dpc-1965	1	5	conceptual	conceptual	ADJ
dpc-1965	1	6	original	original	ADJ
dpc-1965	1	7	article	article	NOUN
dpc-1965	1	8	|	|	ADV
dpc-1965	1	9	dermatol	dermatol	ADJ
dpc-1965	1	10	pract	pract	NOUN
dpc-1965	1	11	concept	concept	NOUN
dpc-1965	1	12	.	.	PUNCT
dpc-1965	2	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	2	2	1	1	NUM
dpc-1965	2	3	dermatology	dermatology	NOUN
dpc-1965	2	4	practical	practical	ADJ
dpc-1965	2	5	&	&	CCONJ
dpc-1965	2	6	conceptual	conceptual	ADJ
dpc-1965	2	7	elevated	elevated	ADJ
dpc-1965	2	8	serum	serum	NOUN
dpc-1965	2	9	levels	level	NOUN
dpc-1965	2	10	of	of	ADP
dpc-1965	2	11	interleukin-15	interleukin-15	PROPN
dpc-1965	2	12	in	in	ADP
dpc-1965	2	13	pemphigus	pemphigus	NOUN
dpc-1965	2	14	vulgaris	vulgaris	NOUN
dpc-1965	2	15	patients	patient	NOUN
dpc-1965	2	16	:	:	PUNCT
dpc-1965	2	17	a	a	DET
dpc-1965	2	18	potential	potential	ADJ
dpc-1965	2	19	therapeutic	therapeutic	ADJ
dpc-1965	2	20	target	target	NOUN
dpc-1965	2	21	maedeh	maedeh	NOUN
dpc-1965	2	22	kheirodin1	kheirodin1	NOUN
dpc-1965	2	23	,	,	PUNCT
dpc-1965	2	24	zohreh	zohreh	PROPN
dpc-1965	2	25	tehranchinia2,yasaman	tehranchinia2,yasaman	NOUN
dpc-1965	2	26	ketabi2	ketabi2	PROPN
dpc-1965	2	27	,	,	PUNCT
dpc-1965	2	28	soheil	soheil	PROPN
dpc-1965	2	29	tavakolpour2	tavakolpour2	NOUN
dpc-1965	2	30	,	,	PUNCT
dpc-1965	2	31	sahar	sahar	PROPN
dpc-1965	2	32	dadkhahfar2	dadkhahfar2	PROPN
dpc-1965	2	33	,	,	PUNCT
dpc-1965	2	34	masoomeh	masoomeh	PROPN
dpc-1965	2	35	faghankhani3	faghankhani3	PROPN
dpc-1965	2	36	,	,	PUNCT
dpc-1965	2	37	hassan	hassan	PROPN
dpc-1965	2	38	vahidnezhad3	vahidnezhad3	PROPN
dpc-1965	2	39	,	,	PUNCT
dpc-1965	2	40	nikoo	nikoo	NOUN
dpc-1965	2	41	mozafari2,4	mozafari2,4	PROPN
dpc-1965	2	42	1	1	NUM
dpc-1965	2	43	school	school	NOUN
dpc-1965	2	44	of	of	ADP
dpc-1965	2	45	medicine	medicine	NOUN
dpc-1965	2	46	,	,	PUNCT
dpc-1965	2	47	shahid	shahid	PROPN
dpc-1965	2	48	beheshti	beheshti	VERB
dpc-1965	2	49	university	university	PROPN
dpc-1965	2	50	of	of	ADP
dpc-1965	2	51	medical	medical	ADJ
dpc-1965	2	52	sciences	sciences	PROPN
dpc-1965	2	53	,	,	PUNCT
dpc-1965	2	54	tehran	tehran	PROPN
dpc-1965	2	55	,	,	PUNCT
dpc-1965	2	56	iran	iran	PROPN
dpc-1965	2	57	2	2	NUM
dpc-1965	2	58	skin	skin	NOUN
dpc-1965	2	59	research	research	NOUN
dpc-1965	2	60	center	center	NOUN
dpc-1965	2	61	,	,	PUNCT
dpc-1965	2	62	shahid	shahid	PROPN
dpc-1965	2	63	beheshti	beheshti	VERB
dpc-1965	2	64	university	university	PROPN
dpc-1965	2	65	of	of	ADP
dpc-1965	2	66	medical	medical	ADJ
dpc-1965	2	67	sciences	sciences	PROPN
dpc-1965	2	68	,	,	PUNCT
dpc-1965	2	69	tehran	tehran	PROPN
dpc-1965	2	70	,	,	PUNCT
dpc-1965	2	71	iran	iran	PROPN
dpc-1965	2	72	3	3	NUM
dpc-1965	2	73	department	department	NOUN
dpc-1965	2	74	of	of	ADP
dpc-1965	2	75	dermatology	dermatology	NOUN
dpc-1965	2	76	and	and	CCONJ
dpc-1965	2	77	cutaneous	cutaneous	ADJ
dpc-1965	2	78	biology	biology	NOUN
dpc-1965	2	79	,	,	PUNCT
dpc-1965	2	80	sidney	sidney	PROPN
dpc-1965	2	81	kimmel	kimmel	PROPN
dpc-1965	2	82	medical	medical	PROPN
dpc-1965	2	83	college	college	PROPN
dpc-1965	2	84	,	,	PUNCT
dpc-1965	2	85	thomas	thomas	PROPN
dpc-1965	2	86	jefferson	jefferson	PROPN
dpc-1965	2	87	university	university	PROPN
dpc-1965	2	88	,	,	PUNCT
dpc-1965	2	89	philadelphia	philadelphia	PROPN
dpc-1965	2	90	,	,	PUNCT
dpc-1965	2	91	pa	pa	PROPN
dpc-1965	2	92	,	,	PUNCT
dpc-1965	2	93	united	united	PROPN
dpc-1965	2	94	states	states	PROPN
dpc-1965	2	95	4	4	NUM
dpc-1965	2	96	department	department	NOUN
dpc-1965	2	97	of	of	ADP
dpc-1965	2	98	dermatology	dermatology	NOUN
dpc-1965	2	99	,	,	PUNCT
dpc-1965	2	100	loghman	loghman	PROPN
dpc-1965	2	101	hakim	hakim	PROPN
dpc-1965	2	102	hospital	hospital	PROPN
dpc-1965	2	103	,	,	PUNCT
dpc-1965	2	104	shahid	shahid	PROPN
dpc-1965	2	105	beheshti	beheshti	VERB
dpc-1965	2	106	university	university	PROPN
dpc-1965	2	107	of	of	ADP
dpc-1965	2	108	medical	medical	ADJ
dpc-1965	2	109	sciences	sciences	PROPN
dpc-1965	2	110	,	,	PUNCT
dpc-1965	2	111	tehran	tehran	PROPN
dpc-1965	2	112	,	,	PUNCT
dpc-1965	2	113	iran	iran	PROPN
dpc-1965	2	114	key	key	ADJ
dpc-1965	2	115	words	word	NOUN
dpc-1965	2	116	:	:	PUNCT
dpc-1965	2	117	pemphigus	pemphigus	NOUN
dpc-1965	2	118	vulgaris	vulgaris	NOUN
dpc-1965	2	119	,	,	PUNCT
dpc-1965	2	120	interleukin-15	interleukin-15	PROPN
dpc-1965	2	121	,	,	PUNCT
dpc-1965	2	122	anti	anti	ADJ
dpc-1965	2	123	-	-	ADJ
dpc-1965	2	124	desmoglein	desmoglein	ADJ
dpc-1965	2	125	,	,	PUNCT
dpc-1965	2	126	il-15	il-15	PRON
dpc-1965	2	127	,	,	PUNCT
dpc-1965	2	128	absis	absis	PRON
dpc-1965	2	129	citation	citation	NOUN
dpc-1965	2	130	:	:	PUNCT
dpc-1965	2	131	kheirodin	kheirodin	VERB
dpc-1965	2	132	m	m	PROPN
dpc-1965	2	133	,	,	PUNCT
dpc-1965	2	134	tehranchinia	tehranchinia	PROPN
dpc-1965	2	135	z	z	PROPN
dpc-1965	2	136	,	,	PUNCT
dpc-1965	2	137	ketabi	ketabi	PROPN
dpc-1965	2	138	y	y	PROPN
dpc-1965	2	139	,	,	PUNCT
dpc-1965	2	140	et	et	PROPN
dpc-1965	2	141	al	al	PROPN
dpc-1965	2	142	.	.	PROPN
dpc-1965	2	143	elevated	elevate	VERB
dpc-1965	2	144	serum	serum	NOUN
dpc-1965	2	145	levels	level	NOUN
dpc-1965	2	146	of	of	ADP
dpc-1965	2	147	interleukin-15	interleukin-15	PROPN
dpc-1965	2	148	in	in	ADP
dpc-1965	2	149	pemphigus	pemphigus	NOUN
dpc-1965	2	150	vulgaris	vulgaris	NOUN
dpc-1965	2	151	patients	patient	NOUN
dpc-1965	2	152	:	:	PUNCT
dpc-1965	2	153	a	a	DET
dpc-1965	2	154	potential	potential	ADJ
dpc-1965	2	155	therapeutic	therapeutic	ADJ
dpc-1965	2	156	target	target	NOUN
dpc-1965	2	157	.	.	PUNCT
dpc-1965	3	1	dermatol	dermatol	NOUN
dpc-1965	3	2	pract	pract	PROPN
dpc-1965	3	3	concept	concept	NOUN
dpc-1965	3	4	.	.	PUNCT
dpc-1965	4	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	4	2	.	.	PUNCT
dpc-1965	4	3	doi	doi	PROPN
dpc-1965	4	4	:	:	PUNCT
dpc-1965	4	5	https://doi.org/10.5826/dpc.1203a118	https://doi.org/10.5826/dpc.1203a118	PROPN
dpc-1965	4	6	accepted	accept	VERB
dpc-1965	4	7	:	:	PUNCT
dpc-1965	4	8	november	november	PROPN
dpc-1965	4	9	13	13	NUM
dpc-1965	4	10	,	,	PUNCT
dpc-1965	4	11	2021	2021	NUM
dpc-1965	4	12	;	;	PUNCT
dpc-1965	4	13	published	publish	VERB
dpc-1965	4	14	:	:	PUNCT
dpc-1965	5	1	july	july	PROPN
dpc-1965	5	2	2022	2022	NUM
dpc-1965	5	3	copyright	copyright	NOUN
dpc-1965	5	4	:	:	PUNCT
dpc-1965	5	5	©	©	PROPN
dpc-1965	5	6	2022	2022	NUM
dpc-1965	5	7	kheirodin	kheirodin	VERB
dpc-1965	5	8	et	et	PROPN
dpc-1965	5	9	al	al	PROPN
dpc-1965	5	10	.	.	PUNCT
dpc-1965	6	1	this	this	PRON
dpc-1965	6	2	is	be	AUX
dpc-1965	6	3	an	an	DET
dpc-1965	6	4	open	open	ADJ
dpc-1965	6	5	-	-	PUNCT
dpc-1965	6	6	access	access	NOUN
dpc-1965	6	7	article	article	NOUN
dpc-1965	6	8	distributed	distribute	VERB
dpc-1965	6	9	under	under	ADP
dpc-1965	6	10	the	the	DET
dpc-1965	6	11	terms	term	NOUN
dpc-1965	6	12	of	of	ADP
dpc-1965	6	13	the	the	DET
dpc-1965	6	14	creative	creative	ADJ
dpc-1965	6	15	commons	common	NOUN
dpc-1965	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-1965	6	17	license	license	NOUN
dpc-1965	6	18	(	(	PUNCT
dpc-1965	6	19	by	by	ADP
dpc-1965	6	20	-	-	PUNCT
dpc-1965	6	21	nc-4.0	nc-4.0	NOUN
dpc-1965	6	22	)	)	PUNCT
dpc-1965	6	23	,	,	PUNCT
dpc-1965	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1965	6	25	,	,	PUNCT
dpc-1965	6	26	which	which	PRON
dpc-1965	6	27	permits	permit	VERB
dpc-1965	6	28	unrestricted	unrestricted	ADJ
dpc-1965	6	29	noncommercial	noncommercial	ADJ
dpc-1965	6	30	use	use	NOUN
dpc-1965	6	31	,	,	PUNCT
dpc-1965	6	32	distribution	distribution	NOUN
dpc-1965	6	33	,	,	PUNCT
dpc-1965	6	34	and	and	CCONJ
dpc-1965	6	35	reproduction	reproduction	NOUN
dpc-1965	6	36	in	in	ADP
dpc-1965	6	37	any	any	DET
dpc-1965	6	38	medium	medium	NOUN
dpc-1965	6	39	,	,	PUNCT
dpc-1965	6	40	provided	provide	VERB
dpc-1965	6	41	the	the	DET
dpc-1965	6	42	original	original	ADJ
dpc-1965	6	43	authors	author	NOUN
dpc-1965	6	44	and	and	CCONJ
dpc-1965	6	45	source	source	NOUN
dpc-1965	6	46	are	be	AUX
dpc-1965	6	47	credited	credit	VERB
dpc-1965	6	48	.	.	PUNCT
dpc-1965	7	1	funding	funding	NOUN
dpc-1965	7	2	:	:	PUNCT
dpc-1965	7	3	the	the	DET
dpc-1965	7	4	present	present	ADJ
dpc-1965	7	5	study	study	NOUN
dpc-1965	7	6	was	be	AUX
dpc-1965	7	7	founded	found	VERB
dpc-1965	7	8	by	by	ADP
dpc-1965	7	9	skin	skin	NOUN
dpc-1965	7	10	research	research	NOUN
dpc-1965	7	11	center	center	NOUN
dpc-1965	7	12	,	,	PUNCT
dpc-1965	7	13	shahid	shahid	PROPN
dpc-1965	7	14	beheshti	beheshti	VERB
dpc-1965	7	15	university	university	PROPN
dpc-1965	7	16	of	of	ADP
dpc-1965	7	17	medical	medical	ADJ
dpc-1965	7	18	sciences	science	NOUN
dpc-1965	7	19	.	.	PUNCT
dpc-1965	8	1	competing	compete	VERB
dpc-1965	8	2	interests	interest	NOUN
dpc-1965	8	3	:	:	PUNCT
dpc-1965	8	4	none	none	NOUN
dpc-1965	8	5	.	.	PUNCT
dpc-1965	9	1	authorship	authorship	NOUN
dpc-1965	9	2	:	:	PUNCT
dpc-1965	9	3	all	all	DET
dpc-1965	9	4	authors	author	NOUN
dpc-1965	9	5	have	have	AUX
dpc-1965	9	6	contributed	contribute	VERB
dpc-1965	9	7	significantly	significantly	ADV
dpc-1965	9	8	to	to	ADP
dpc-1965	9	9	this	this	DET
dpc-1965	9	10	publication	publication	NOUN
dpc-1965	9	11	.	.	PUNCT
dpc-1965	10	1	corresponding	correspond	VERB
dpc-1965	10	2	author	author	NOUN
dpc-1965	10	3	:	:	PUNCT
dpc-1965	10	4	nikoo	nikoo	NOUN
dpc-1965	10	5	mozafari	mozafari	PROPN
dpc-1965	10	6	,	,	PUNCT
dpc-1965	10	7	md	md	PROPN
dpc-1965	10	8	,	,	PUNCT
dpc-1965	10	9	shahrdari	shahrdari	PROPN
dpc-1965	10	10	st	st	PROPN
dpc-1965	10	11	,	,	PUNCT
dpc-1965	10	12	tajrish	tajrish	ADJ
dpc-1965	10	13	sq	sq	NOUN
dpc-1965	10	14	,	,	PUNCT
dpc-1965	10	15	skin	skin	NOUN
dpc-1965	10	16	research	research	NOUN
dpc-1965	10	17	center	center	NOUN
dpc-1965	10	18	,	,	PUNCT
dpc-1965	10	19	shohada	shohada	NOUN
dpc-1965	10	20	-	-	PUNCT
dpc-1965	10	21	e	e	NOUN
dpc-1965	10	22	-	-	ADJ
dpc-1965	10	23	tajrish	tajrish	ADJ
dpc-1965	10	24	,	,	PUNCT
dpc-1965	10	25	hospital	hospital	NOUN
dpc-1965	10	26	,	,	PUNCT
dpc-1965	10	27	tehran	tehran	PROPN
dpc-1965	10	28	,	,	PUNCT
dpc-1965	10	29	iran	iran	PROPN
dpc-1965	10	30	tel	tel	PROPN
dpc-1965	10	31	number	number	NOUN
dpc-1965	10	32	:	:	PUNCT
dpc-1965	10	33	(	(	PUNCT
dpc-1965	10	34	98	98	NUM
dpc-1965	10	35	)	)	SYM
dpc-1965	10	36	21	21	NUM
dpc-1965	10	37	-	-	SYM
dpc-1965	10	38	22741507	22741507	NUM
dpc-1965	10	39	,	,	PUNCT
dpc-1965	10	40	fax	fax	NOUN
dpc-1965	10	41	:	:	PUNCT
dpc-1965	10	42	(	(	PUNCT
dpc-1965	10	43	98	98	NUM
dpc-1965	10	44	)	)	SYM
dpc-1965	10	45	21	21	NUM
dpc-1965	10	46	-	-	SYM
dpc-1965	10	47	22741508	22741508	NUM
dpc-1965	10	48	e	e	NOUN
dpc-1965	10	49	-	-	NOUN
dpc-1965	10	50	mail	mail	NOUN
dpc-1965	10	51	:	:	PUNCT
dpc-1965	10	52	nikoo_md@yahoo.com	nikoo_md@yahoo.com	PROPN
dpc-1965	10	53	introduction	introduction	NOUN
dpc-1965	10	54	:	:	PUNCT
dpc-1965	11	1	pemphigus	pemphigus	NOUN
dpc-1965	11	2	vulgaris	vulgaris	NOUN
dpc-1965	11	3	(	(	PUNCT
dpc-1965	11	4	pv	pv	NOUN
dpc-1965	11	5	)	)	PUNCT
dpc-1965	11	6	is	be	AUX
dpc-1965	11	7	a	a	DET
dpc-1965	11	8	rare	rare	ADJ
dpc-1965	11	9	autoimmune	autoimmune	ADJ
dpc-1965	11	10	disease	disease	NOUN
dpc-1965	11	11	that	that	PRON
dpc-1965	11	12	causes	cause	VERB
dpc-1965	11	13	painful	painful	ADJ
dpc-1965	11	14	blistering	blistering	NOUN
dpc-1965	11	15	.	.	PUNCT
dpc-1965	12	1	interleukin-15	interleukin-15	PROPN
dpc-1965	12	2	(	(	PUNCT
dpc-1965	12	3	il-15	il-15	NOUN
dpc-1965	12	4	)	)	PUNCT
dpc-1965	12	5	as	as	ADP
dpc-1965	12	6	a	a	DET
dpc-1965	12	7	member	member	NOUN
dpc-1965	12	8	of	of	ADP
dpc-1965	12	9	the	the	DET
dpc-1965	12	10	immunoregulatory	immunoregulatory	ADJ
dpc-1965	12	11	cytokines	cytokine	NOUN
dpc-1965	12	12	family	family	NOUN
dpc-1965	12	13	is	be	AUX
dpc-1965	12	14	associated	associate	VERB
dpc-1965	12	15	with	with	ADP
dpc-1965	12	16	the	the	DET
dpc-1965	12	17	development	development	NOUN
dpc-1965	12	18	of	of	ADP
dpc-1965	12	19	the	the	DET
dpc-1965	12	20	chronic	chronic	ADJ
dpc-1965	12	21	inflammatory	inflammatory	ADJ
dpc-1965	12	22	or	or	CCONJ
dpc-1965	12	23	autoimmune	autoimmune	ADJ
dpc-1965	12	24	disease	disease	NOUN
dpc-1965	12	25	.	.	PUNCT
dpc-1965	13	1	there	there	PRON
dpc-1965	13	2	is	be	VERB
dpc-1965	13	3	not	not	PART
dpc-1965	13	4	much	much	ADJ
dpc-1965	13	5	information	information	NOUN
dpc-1965	13	6	available	available	ADJ
dpc-1965	13	7	in	in	ADP
dpc-1965	13	8	the	the	DET
dpc-1965	13	9	literature	literature	NOUN
dpc-1965	13	10	on	on	ADP
dpc-1965	13	11	the	the	DET
dpc-1965	13	12	exact	exact	ADJ
dpc-1965	13	13	role	role	NOUN
dpc-1965	13	14	il-15	il-15	NOUN
dpc-1965	13	15	plays	play	VERB
dpc-1965	13	16	in	in	ADP
dpc-1965	13	17	pv	pv	NOUN
dpc-1965	13	18	.	.	PUNCT
dpc-1965	14	1	objectives	objective	NOUN
dpc-1965	14	2	:	:	PUNCT
dpc-1965	14	3	the	the	DET
dpc-1965	14	4	goal	goal	NOUN
dpc-1965	14	5	of	of	ADP
dpc-1965	14	6	this	this	DET
dpc-1965	14	7	study	study	NOUN
dpc-1965	14	8	was	be	AUX
dpc-1965	14	9	to	to	PART
dpc-1965	14	10	evaluate	evaluate	VERB
dpc-1965	14	11	the	the	DET
dpc-1965	14	12	serum	serum	NOUN
dpc-1965	14	13	levels	level	NOUN
dpc-1965	14	14	of	of	ADP
dpc-1965	14	15	il-15	il-15	NOUN
dpc-1965	14	16	in	in	ADP
dpc-1965	14	17	patients	patient	NOUN
dpc-1965	14	18	with	with	ADP
dpc-1965	14	19	pv	pv	NOUN
dpc-1965	14	20	and	and	CCONJ
dpc-1965	14	21	assess	assess	VERB
dpc-1965	14	22	the	the	DET
dpc-1965	14	23	association	association	NOUN
dpc-1965	14	24	of	of	ADP
dpc-1965	14	25	il-15	il-15	NOUN
dpc-1965	14	26	with	with	ADP
dpc-1965	14	27	anti	anti	ADJ
dpc-1965	14	28	-	-	ADJ
dpc-1965	14	29	desmoglein	desmoglein	ADJ
dpc-1965	14	30	antibodies	antibody	NOUN
dpc-1965	14	31	and	and	CCONJ
dpc-1965	14	32	the	the	DET
dpc-1965	14	33	severity	severity	NOUN
dpc-1965	14	34	of	of	ADP
dpc-1965	14	35	the	the	DET
dpc-1965	14	36	disease	disease	NOUN
dpc-1965	14	37	.	.	PUNCT
dpc-1965	15	1	methods	method	NOUN
dpc-1965	15	2	:	:	PUNCT
dpc-1965	15	3	fifty	fifty	NUM
dpc-1965	15	4	-	-	PUNCT
dpc-1965	15	5	three	three	NUM
dpc-1965	15	6	individuals	individual	NOUN
dpc-1965	15	7	affected	affect	VERB
dpc-1965	15	8	with	with	ADP
dpc-1965	15	9	active	active	ADJ
dpc-1965	15	10	pv	pv	NOUN
dpc-1965	15	11	and	and	CCONJ
dpc-1965	15	12	38	38	NUM
dpc-1965	15	13	ageand	ageand	NOUN
dpc-1965	15	14	gender	gender	NOUN
dpc-1965	15	15	-	-	PUNCT
dpc-1965	15	16	matched	match	VERB
dpc-1965	15	17	healthy	healthy	ADJ
dpc-1965	15	18	controls	control	NOUN
dpc-1965	15	19	were	be	AUX
dpc-1965	15	20	participated	participate	VERB
dpc-1965	15	21	in	in	ADP
dpc-1965	15	22	this	this	DET
dpc-1965	15	23	study	study	NOUN
dpc-1965	15	24	.	.	PUNCT
dpc-1965	16	1	disease	disease	NOUN
dpc-1965	16	2	severity	severity	NOUN
dpc-1965	16	3	was	be	AUX
dpc-1965	16	4	assessed	assess	VERB
dpc-1965	16	5	 	 	SPACE
dpc-1965	16	6	using	use	VERB
dpc-1965	16	7	autoimmune	autoimmune	ADJ
dpc-1965	16	8	bullous	bullous	ADJ
dpc-1965	16	9	skin	skin	NOUN
dpc-1965	16	10	disorder	disorder	NOUN
dpc-1965	16	11	intensity	intensity	NOUN
dpc-1965	16	12	score	score	NOUN
dpc-1965	16	13	(	(	PUNCT
dpc-1965	16	14	absis	absis	NOUN
dpc-1965	16	15	)	)	PUNCT
dpc-1965	16	16	.	.	PUNCT
dpc-1965	17	1	serum	serum	NOUN
dpc-1965	17	2	levels	level	NOUN
dpc-1965	17	3	of	of	ADP
dpc-1965	17	4	il-15	il-15	NOUN
dpc-1965	17	5	(	(	PUNCT
dpc-1965	17	6	pg	pg	NOUN
dpc-1965	17	7	/	/	SYM
dpc-1965	17	8	ml	ml	NOUN
dpc-1965	17	9	)	)	PUNCT
dpc-1965	17	10	and	and	CCONJ
dpc-1965	17	11	anti	anti	ADJ
dpc-1965	17	12	-	-	ADJ
dpc-1965	17	13	desmoglein	desmoglein	ADJ
dpc-1965	17	14	antibodies	antibody	NOUN
dpc-1965	17	15	(	(	PUNCT
dpc-1965	17	16	dsg1	dsg1	NOUN
dpc-1965	17	17	,	,	PUNCT
dpc-1965	17	18	3	3	X
dpc-1965	17	19	)	)	PUNCT
dpc-1965	17	20	were	be	AUX
dpc-1965	17	21	determined	determine	VERB
dpc-1965	17	22	.	.	PUNCT
dpc-1965	18	1	results	result	NOUN
dpc-1965	18	2	:	:	PUNCT
dpc-1965	18	3	in	in	ADP
dpc-1965	18	4	the	the	DET
dpc-1965	18	5	patient	patient	NOUN
dpc-1965	18	6	group	group	NOUN
dpc-1965	18	7	,	,	PUNCT
dpc-1965	18	8	il-15	il-15	NOUN
dpc-1965	18	9	serum	serum	NOUN
dpc-1965	18	10	levels	level	NOUN
dpc-1965	18	11	were	be	AUX
dpc-1965	18	12	statistically	statistically	ADV
dpc-1965	18	13	higher	high	ADJ
dpc-1965	18	14	than	than	ADP
dpc-1965	18	15	those	those	PRON
dpc-1965	18	16	in	in	ADP
dpc-1965	18	17	the	the	DET
dpc-1965	18	18	control	control	NOUN
dpc-1965	18	19	group	group	NOUN
dpc-1965	18	20	(	(	PUNCT
dpc-1965	18	21	3.71	3.71	NUM
dpc-1965	18	22	±	±	NUM
dpc-1965	18	23	1.5	1.5	NUM
dpc-1965	18	24	vs.	vs.	ADP
dpc-1965	18	25	0.79	0.79	NUM
dpc-1965	18	26	±	±	NUM
dpc-1965	18	27	1.03	1.03	NUM
dpc-1965	18	28	,	,	PUNCT
dpc-1965	18	29	p	p	X
dpc-1965	18	30	<	<	X
dpc-1965	18	31	0.001	0.001	NUM
dpc-1965	18	32	)	)	PUNCT
dpc-1965	18	33	.	.	PUNCT
dpc-1965	19	1	a	a	DET
dpc-1965	19	2	positive	positive	ADJ
dpc-1965	19	3	correlation	correlation	NOUN
dpc-1965	19	4	was	be	AUX
dpc-1965	19	5	found	find	VERB
dpc-1965	19	6	between	between	ADP
dpc-1965	19	7	serum	serum	NOUN
dpc-1965	19	8	levels	level	NOUN
dpc-1965	19	9	of	of	ADP
dpc-1965	19	10	il-15	il-15	NOUN
dpc-1965	19	11	and	and	CCONJ
dpc-1965	19	12	absis	absis	NOUN
dpc-1965	19	13	(	(	PUNCT
dpc-1965	19	14	r	r	NOUN
dpc-1965	19	15	=	=	SYM
dpc-1965	19	16	0.5	0.5	NUM
dpc-1965	19	17	,	,	PUNCT
dpc-1965	19	18	p	p	NOUN
dpc-1965	19	19	=	=	NOUN
dpc-1965	19	20	0.04	0.04	NUM
dpc-1965	19	21	)	)	PUNCT
dpc-1965	19	22	.	.	PUNCT
dpc-1965	20	1	we	we	PRON
dpc-1965	20	2	 	 	SPACE
dpc-1965	20	3	found	find	VERB
dpc-1965	20	4	 	 	SPACE
dpc-1965	20	5	no	no	DET
dpc-1965	20	6	significant	significant	ADJ
dpc-1965	20	7	correlation	correlation	NOUN
dpc-1965	20	8	 	 	SPACE
dpc-1965	20	9	between	between	ADP
dpc-1965	20	10	 	 	SPACE
dpc-1965	20	11	serum	serum	NOUN
dpc-1965	20	12	 	 	SPACE
dpc-1965	20	13	concentrations	concentration	NOUN
dpc-1965	20	14	 	 	SPACE
dpc-1965	20	15	of	of	ADP
dpc-1965	20	16	il-15	il-15	NOUN
dpc-1965	20	17	and	and	CCONJ
dpc-1965	20	18	antidesmoglein	antidesmoglein	ADJ
dpc-1965	20	19	antibodies	antibody	NOUN
dpc-1965	20	20	(	(	PUNCT
dpc-1965	20	21	dsg1	dsg1	NOUN
dpc-1965	20	22	or	or	CCONJ
dpc-1965	20	23	dsg3	dsg3	PROPN
dpc-1965	20	24	)	)	PUNCT
dpc-1965	20	25	.	.	PUNCT
dpc-1965	21	1	conclusions	conclusion	NOUN
dpc-1965	21	2	:	:	PUNCT
dpc-1965	21	3	an	an	DET
dpc-1965	21	4	increase	increase	NOUN
dpc-1965	21	5	in	in	ADP
dpc-1965	21	6	serum	serum	NOUN
dpc-1965	21	7	level	level	NOUN
dpc-1965	21	8	of	of	ADP
dpc-1965	21	9	il-15	il-15	NOUN
dpc-1965	21	10	in	in	ADP
dpc-1965	21	11	patients	patient	NOUN
dpc-1965	21	12	with	with	ADP
dpc-1965	21	13	pv	pv	NOUN
dpc-1965	21	14	and	and	CCONJ
dpc-1965	21	15	its	its	PRON
dpc-1965	21	16	relationship	relationship	NOUN
dpc-1965	21	17	with	with	ADP
dpc-1965	21	18	disease	disease	NOUN
dpc-1965	21	19	severity	severity	NOUN
dpc-1965	21	20	suggest	suggest	VERB
dpc-1965	21	21	that	that	SCONJ
dpc-1965	21	22	this	this	DET
dpc-1965	21	23	cytokine	cytokine	NOUN
dpc-1965	21	24	possibly	possibly	ADV
dpc-1965	21	25	contributes	contribute	VERB
dpc-1965	21	26	to	to	ADP
dpc-1965	21	27	the	the	DET
dpc-1965	21	28	pathogenesis	pathogenesis	NOUN
dpc-1965	21	29	of	of	ADP
dpc-1965	21	30	the	the	DET
dpc-1965	21	31	disease	disease	NOUN
dpc-1965	21	32	and	and	CCONJ
dpc-1965	21	33	targeting	target	VERB
dpc-1965	21	34	il-15	il-15	NOUN
dpc-1965	21	35	will	will	AUX
dpc-1965	21	36	likely	likely	ADV
dpc-1965	21	37	provide	provide	VERB
dpc-1965	21	38	a	a	DET
dpc-1965	21	39	new	new	ADJ
dpc-1965	21	40	insight	insight	NOUN
dpc-1965	21	41	into	into	ADP
dpc-1965	21	42	the	the	DET
dpc-1965	21	43	treatment	treatment	NOUN
dpc-1965	21	44	of	of	ADP
dpc-1965	21	45	this	this	DET
dpc-1965	21	46	disease	disease	NOUN
dpc-1965	21	47	.	.	PUNCT
dpc-1965	22	1	abstract	abstract	ADJ
dpc-1965	22	2	2	2	NUM
dpc-1965	22	3	original	original	ADJ
dpc-1965	22	4	article	article	NOUN
dpc-1965	22	5	|	|	ADV
dpc-1965	22	6	dermatol	dermatol	ADJ
dpc-1965	22	7	pract	pract	NOUN
dpc-1965	22	8	concept	concept	NOUN
dpc-1965	22	9	.	.	PUNCT
dpc-1965	23	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	23	2	introduction	introduction	NOUN
dpc-1965	23	3	pemphigus	pemphigus	NOUN
dpc-1965	23	4	vulgaris	vulgaris	NOUN
dpc-1965	23	5	(	(	PUNCT
dpc-1965	23	6	pv	pv	NOUN
dpc-1965	23	7	)	)	PUNCT
dpc-1965	23	8	is	be	AUX
dpc-1965	23	9	a	a	DET
dpc-1965	23	10	rare	rare	ADJ
dpc-1965	23	11	autoimmune	autoimmune	ADJ
dpc-1965	23	12	disorder	disorder	NOUN
dpc-1965	23	13	that	that	PRON
dpc-1965	23	14	causes	cause	VERB
dpc-1965	23	15	painful	painful	ADJ
dpc-1965	23	16	blisters	blister	NOUN
dpc-1965	23	17	and	and	CCONJ
dpc-1965	23	18	erosions	erosion	NOUN
dpc-1965	23	19	on	on	ADP
dpc-1965	23	20	the	the	DET
dpc-1965	23	21	skin	skin	NOUN
dpc-1965	23	22	and	and	CCONJ
dpc-1965	23	23	mucosa	mucosa	NOUN
dpc-1965	24	1	[	[	X
dpc-1965	24	2	1	1	NUM
dpc-1965	24	3	]	]	PUNCT
dpc-1965	24	4	.	.	PUNCT
dpc-1965	25	1	pv	pv	PROPN
dpc-1965	25	2	is	be	AUX
dpc-1965	25	3	caused	cause	VERB
dpc-1965	25	4	by	by	ADP
dpc-1965	25	5	environmental	environmental	ADJ
dpc-1965	25	6	and	and	CCONJ
dpc-1965	25	7	genetic	genetic	ADJ
dpc-1965	25	8	factors	factor	NOUN
dpc-1965	25	9	that	that	PRON
dpc-1965	25	10	lead	lead	VERB
dpc-1965	25	11	to	to	ADP
dpc-1965	25	12	immunological	immunological	ADJ
dpc-1965	25	13	impairments	impairment	NOUN
dpc-1965	25	14	.	.	PUNCT
dpc-1965	26	1	auto	auto	NOUN
dpc-1965	26	2	-	-	PUNCT
dpc-1965	26	3	antibodies	antibody	NOUN
dpc-1965	26	4	against	against	ADP
dpc-1965	26	5	the	the	DET
dpc-1965	26	6	desmosomal	desmosomal	ADJ
dpc-1965	26	7	adhesion	adhesion	NOUN
dpc-1965	26	8	proteins	protein	NOUN
dpc-1965	26	9	of	of	ADP
dpc-1965	26	10	epidermal	epidermal	ADJ
dpc-1965	26	11	keratinocytes	keratinocyte	NOUN
dpc-1965	26	12	,	,	PUNCT
dpc-1965	26	13	desmoglein3	desmoglein3	NOUN
dpc-1965	26	14	and/or	and/or	CCONJ
dpc-1965	26	15	desmoglein	desmoglein	PROPN
dpc-1965	26	16	1	1	NUM
dpc-1965	26	17	,	,	PUNCT
dpc-1965	26	18	lead	lead	VERB
dpc-1965	26	19	to	to	ADP
dpc-1965	26	20	the	the	DET
dpc-1965	26	21	loss	loss	NOUN
dpc-1965	26	22	of	of	ADP
dpc-1965	26	23	epidermal	epidermal	ADJ
dpc-1965	26	24	cell	cell	NOUN
dpc-1965	26	25	adhesion	adhesion	NOUN
dpc-1965	26	26	and	and	CCONJ
dpc-1965	26	27	development	development	NOUN
dpc-1965	26	28	of	of	ADP
dpc-1965	26	29	erosive	erosive	ADJ
dpc-1965	26	30	lesions	lesion	NOUN
dpc-1965	26	31	[	[	X
dpc-1965	26	32	1,2	1,2	NUM
dpc-1965	26	33	]	]	PUNCT
dpc-1965	26	34	.	.	PUNCT
dpc-1965	27	1	to	to	ADP
dpc-1965	27	2	date	date	NOUN
dpc-1965	27	3	,	,	PUNCT
dpc-1965	27	4	different	different	ADJ
dpc-1965	27	5	cytokines	cytokine	NOUN
dpc-1965	27	6	,	,	PUNCT
dpc-1965	27	7	such	such	ADJ
dpc-1965	27	8	as	as	ADP
dpc-1965	27	9	osteopontin	osteopontin	ADJ
dpc-1965	27	10	,	,	PUNCT
dpc-1965	27	11	interleukin	interleukin	NOUN
dpc-1965	27	12	(	(	PUNCT
dpc-1965	27	13	il)-4	il)-4	NOUN
dpc-1965	27	14	and	and	CCONJ
dpc-1965	27	15	il-21	il-21	NOUN
dpc-1965	27	16	have	have	AUX
dpc-1965	27	17	been	be	AUX
dpc-1965	27	18	suggested	suggest	VERB
dpc-1965	27	19	to	to	PART
dpc-1965	27	20	be	be	AUX
dpc-1965	27	21	associated	associate	VERB
dpc-1965	27	22	with	with	ADP
dpc-1965	27	23	disease	disease	NOUN
dpc-1965	27	24	pathogenesis	pathogenesis	NOUN
dpc-1965	27	25	and	and	CCONJ
dpc-1965	27	26	severity	severity	NOUN
dpc-1965	28	1	[	[	X
dpc-1965	28	2	3	3	NUM
dpc-1965	28	3	-	-	SYM
dpc-1965	28	4	5	5	NUM
dpc-1965	28	5	]	]	PUNCT
dpc-1965	28	6	.	.	PUNCT
dpc-1965	29	1	these	these	DET
dpc-1965	29	2	cytokines	cytokine	NOUN
dpc-1965	29	3	contribute	contribute	VERB
dpc-1965	29	4	to	to	ADP
dpc-1965	29	5	rising	rise	VERB
dpc-1965	29	6	proinflammatory	proinflammatory	ADJ
dpc-1965	29	7	responses	response	NOUN
dpc-1965	29	8	and	and	CCONJ
dpc-1965	29	9	production	production	NOUN
dpc-1965	29	10	of	of	ADP
dpc-1965	29	11	autoantibodies	autoantibody	NOUN
dpc-1965	29	12	through	through	ADP
dpc-1965	29	13	differentiation	differentiation	NOUN
dpc-1965	29	14	of	of	ADP
dpc-1965	29	15	naïve	naïve	ADJ
dpc-1965	29	16	t	t	PROPN
dpc-1965	29	17	-	-	PUNCT
dpc-1965	29	18	cells	cell	NOUN
dpc-1965	29	19	into	into	ADP
dpc-1965	29	20	effector	effector	NOUN
dpc-1965	29	21	t	t	PROPN
dpc-1965	29	22	-ells	-ell	NOUN
dpc-1965	29	23	,	,	PUNCT
dpc-1965	29	24	increased	increase	VERB
dpc-1965	29	25	b	b	NUM
dpc-1965	29	26	-	-	PUNCT
dpc-1965	29	27	cell	cell	NOUN
dpc-1965	29	28	responses	response	NOUN
dpc-1965	29	29	,	,	PUNCT
dpc-1965	29	30	and	and	CCONJ
dpc-1965	29	31	favors	favor	VERB
dpc-1965	29	32	a	a	DET
dpc-1965	29	33	class	class	NOUN
dpc-1965	29	34	switch	switch	NOUN
dpc-1965	29	35	to	to	AUX
dpc-1965	29	36	igg4	igg4	PROPN
dpc-1965	29	37	.	.	PUNCT
dpc-1965	30	1	interfering	interfere	VERB
dpc-1965	30	2	with	with	ADP
dpc-1965	30	3	the	the	DET
dpc-1965	30	4	function	function	NOUN
dpc-1965	30	5	of	of	ADP
dpc-1965	30	6	them	they	PRON
dpc-1965	30	7	using	use	VERB
dpc-1965	30	8	monoclonal	monoclonal	NOUN
dpc-1965	30	9	antibodies	antibody	NOUN
dpc-1965	30	10	,	,	PUNCT
dpc-1965	30	11	such	such	ADJ
dpc-1965	30	12	as	as	ADP
dpc-1965	30	13	dupilumab	dupilumab	NOUN
dpc-1965	30	14	for	for	ADP
dpc-1965	30	15	il-4/	il-4/	NOUN
dpc-1965	30	16	il-4	il-4	PART
dpc-1965	30	17	receptor	receptor	NOUN
dpc-1965	30	18	could	could	AUX
dpc-1965	30	19	be	be	AUX
dpc-1965	30	20	probably	probably	ADV
dpc-1965	30	21	effective	effective	ADJ
dpc-1965	30	22	in	in	ADP
dpc-1965	30	23	treating	treat	VERB
dpc-1965	30	24	some	some	DET
dpc-1965	30	25	pv	pv	NOUN
dpc-1965	30	26	patients	patient	NOUN
dpc-1965	30	27	[	[	X
dpc-1965	30	28	6,7	6,7	NUM
dpc-1965	30	29	]	]	PUNCT
dpc-1965	30	30	.	.	PUNCT
dpc-1965	31	1	in	in	ADP
dpc-1965	31	2	contrast	contrast	NOUN
dpc-1965	31	3	,	,	PUNCT
dpc-1965	31	4	regulatory	regulatory	ADJ
dpc-1965	31	5	cytokines	cytokine	NOUN
dpc-1965	31	6	,	,	PUNCT
dpc-1965	31	7	such	such	ADJ
dpc-1965	31	8	as	as	ADP
dpc-1965	31	9	tgf	tgf	PROPN
dpc-1965	31	10	-	-	PUNCT
dpc-1965	31	11	β	β	PROPN
dpc-1965	31	12	and	and	CCONJ
dpc-1965	31	13	il-35	il-35	ADP
dpc-1965	31	14	-	-	PUNCT
dpc-1965	31	15	dependent	dependent	ADJ
dpc-1965	31	16	mechanisms	mechanism	NOUN
dpc-1965	31	17	could	could	AUX
dpc-1965	31	18	mediate	mediate	VERB
dpc-1965	31	19	restoration	restoration	NOUN
dpc-1965	31	20	of	of	ADP
dpc-1965	31	21	self	self	NOUN
dpc-1965	31	22	-	-	PUNCT
dpc-1965	31	23	tolerance	tolerance	NOUN
dpc-1965	31	24	,	,	PUNCT
dpc-1965	31	25	which	which	PRON
dpc-1965	31	26	had	have	AUX
dpc-1965	31	27	been	be	AUX
dpc-1965	31	28	broken	break	VERB
dpc-1965	31	29	in	in	ADP
dpc-1965	31	30	patients	patient	NOUN
dpc-1965	31	31	with	with	ADP
dpc-1965	31	32	autoimmune	autoimmune	ADJ
dpc-1965	31	33	diseases	disease	NOUN
dpc-1965	31	34	[	[	X
dpc-1965	31	35	8,9	8,9	NUM
dpc-1965	31	36	]	]	PUNCT
dpc-1965	31	37	.	.	PUNCT
dpc-1965	32	1	however	however	ADV
dpc-1965	32	2	,	,	PUNCT
dpc-1965	32	3	the	the	DET
dpc-1965	32	4	role	role	NOUN
dpc-1965	32	5	of	of	ADP
dpc-1965	32	6	some	some	DET
dpc-1965	32	7	less	less	ADV
dpc-1965	32	8	studied	studied	ADJ
dpc-1965	32	9	cytokines	cytokine	NOUN
dpc-1965	32	10	,	,	PUNCT
dpc-1965	32	11	such	such	ADJ
dpc-1965	32	12	as	as	ADP
dpc-1965	32	13	il-15	il-15	PUNCT
dpc-1965	32	14	has	have	AUX
dpc-1965	32	15	remained	remain	VERB
dpc-1965	32	16	controversial	controversial	ADJ
dpc-1965	32	17	.	.	PUNCT
dpc-1965	33	1	to	to	ADP
dpc-1965	33	2	our	our	PRON
dpc-1965	33	3	best	good	ADJ
dpc-1965	33	4	knowledge	knowledge	NOUN
dpc-1965	33	5	,	,	PUNCT
dpc-1965	33	6	3	3	NUM
dpc-1965	33	7	studies	study	NOUN
dpc-1965	33	8	have	have	AUX
dpc-1965	33	9	assessed	assess	VERB
dpc-1965	33	10	the	the	DET
dpc-1965	33	11	serum	serum	NOUN
dpc-1965	33	12	levels	level	NOUN
dpc-1965	33	13	of	of	ADP
dpc-1965	33	14	il-15	il-15	NOUN
dpc-1965	33	15	in	in	ADP
dpc-1965	33	16	pv	pv	PROPN
dpc-1965	33	17	patients	patient	NOUN
dpc-1965	33	18	.	.	PUNCT
dpc-1965	34	1	two	two	NUM
dpc-1965	34	2	have	have	AUX
dpc-1965	34	3	reported	report	VERB
dpc-1965	34	4	increased	increase	VERB
dpc-1965	34	5	serum	serum	NOUN
dpc-1965	34	6	levels	level	NOUN
dpc-1965	34	7	of	of	ADP
dpc-1965	34	8	il-15	il-15	NOUN
dpc-1965	34	9	and	and	CCONJ
dpc-1965	34	10	one	one	NUM
dpc-1965	34	11	suggested	suggest	VERB
dpc-1965	34	12	suppressed	suppress	VERB
dpc-1965	34	13	production	production	NOUN
dpc-1965	34	14	of	of	ADP
dpc-1965	34	15	il-15	il-15	NOUN
dpc-1965	34	16	as	as	SCONJ
dpc-1965	34	17	compared	compare	VERB
dpc-1965	34	18	to	to	ADP
dpc-1965	34	19	the	the	DET
dpc-1965	34	20	healthy	healthy	ADJ
dpc-1965	34	21	controls	control	NOUN
dpc-1965	34	22	[	[	X
dpc-1965	34	23	10	10	NUM
dpc-1965	34	24	-	-	SYM
dpc-1965	34	25	12	12	NUM
dpc-1965	34	26	]	]	PUNCT
dpc-1965	34	27	.	.	PUNCT
dpc-1965	35	1	il-15	il-15	PUNCT
dpc-1965	35	2	is	be	AUX
dpc-1965	35	3	a	a	DET
dpc-1965	35	4	glycoprotein	glycoprotein	NOUN
dpc-1965	35	5	cytokine	cytokine	NOUN
dpc-1965	35	6	produced	produce	VERB
dpc-1965	35	7	by	by	ADP
dpc-1965	35	8	multiple	multiple	ADJ
dpc-1965	35	9	cell	cell	NOUN
dpc-1965	35	10	types	type	NOUN
dpc-1965	35	11	including	include	VERB
dpc-1965	35	12	monocytes	monocyte	NOUN
dpc-1965	35	13	,	,	PUNCT
dpc-1965	35	14	macrophages	macrophage	NOUN
dpc-1965	35	15	,	,	PUNCT
dpc-1965	35	16	dendritic	dendritic	ADJ
dpc-1965	35	17	cells	cell	NOUN
dpc-1965	35	18	,	,	PUNCT
dpc-1965	35	19	fibroblasts	fibroblast	NOUN
dpc-1965	35	20	,	,	PUNCT
dpc-1965	35	21	and	and	CCONJ
dpc-1965	35	22	epithelial	epithelial	ADJ
dpc-1965	35	23	cells	cell	NOUN
dpc-1965	35	24	.	.	PUNCT
dpc-1965	36	1	it	it	PRON
dpc-1965	36	2	is	be	AUX
dpc-1965	36	3	well	well	ADV
dpc-1965	36	4	known	know	VERB
dpc-1965	36	5	that	that	SCONJ
dpc-1965	36	6	il-15	il-15	NOUN
dpc-1965	36	7	contributes	contribute	VERB
dpc-1965	36	8	to	to	ADP
dpc-1965	36	9	the	the	DET
dpc-1965	36	10	survival	survival	NOUN
dpc-1965	36	11	and	and	CCONJ
dpc-1965	36	12	proliferation	proliferation	NOUN
dpc-1965	36	13	of	of	ADP
dpc-1965	36	14	 	 	SPACE
dpc-1965	36	15	t	t	NOUN
dpc-1965	36	16	-	-	PUNCT
dpc-1965	36	17	cell	cell	NOUN
dpc-1965	37	1	[	[	X
dpc-1965	37	2	13	13	NUM
dpc-1965	37	3	]	]	PUNCT
dpc-1965	37	4	.	.	PUNCT
dpc-1965	38	1	it	it	PRON
dpc-1965	38	2	also	also	ADV
dpc-1965	38	3	increases	increase	VERB
dpc-1965	38	4	the	the	DET
dpc-1965	38	5	proliferation	proliferation	NOUN
dpc-1965	38	6	of	of	ADP
dpc-1965	38	7	b	b	NOUN
dpc-1965	38	8	lymphocytes	lymphocyte	NOUN
dpc-1965	38	9	and	and	CCONJ
dpc-1965	38	10	promotes	promote	VERB
dpc-1965	38	11	their	their	PRON
dpc-1965	38	12	differentiation	differentiation	NOUN
dpc-1965	38	13	into	into	ADP
dpc-1965	38	14	the	the	DET
dpc-1965	38	15	plasma	plasma	NOUN
dpc-1965	38	16	cells	cell	NOUN
dpc-1965	38	17	[	[	X
dpc-1965	38	18	13,14	13,14	NUM
dpc-1965	38	19	]	]	PUNCT
dpc-1965	38	20	.	.	PUNCT
dpc-1965	39	1	recent	recent	ADJ
dpc-1965	39	2	studies	study	NOUN
dpc-1965	39	3	have	have	AUX
dpc-1965	39	4	indicated	indicate	VERB
dpc-1965	39	5	that	that	SCONJ
dpc-1965	39	6	inhibiting	inhibit	VERB
dpc-1965	39	7	il-15	il-15	NOUN
dpc-1965	39	8	with	with	ADP
dpc-1965	39	9	various	various	ADJ
dpc-1965	39	10	methods	method	NOUN
dpc-1965	39	11	may	may	AUX
dpc-1965	39	12	be	be	AUX
dpc-1965	39	13	the	the	DET
dpc-1965	39	14	goal	goal	NOUN
dpc-1965	39	15	of	of	ADP
dpc-1965	39	16	appropriate	appropriate	ADJ
dpc-1965	39	17	treatment	treatment	NOUN
dpc-1965	39	18	to	to	PART
dpc-1965	39	19	reduce	reduce	VERB
dpc-1965	39	20	inflammation	inflammation	NOUN
dpc-1965	39	21	[	[	X
dpc-1965	39	22	14	14	NUM
dpc-1965	39	23	]	]	PUNCT
dpc-1965	39	24	.	.	PUNCT
dpc-1965	40	1	objectives	objective	NOUN
dpc-1965	40	2	il-15	il-15	VERB
dpc-1965	40	3	is	be	AUX
dpc-1965	40	4	involved	involve	VERB
dpc-1965	40	5	in	in	ADP
dpc-1965	40	6	the	the	DET
dpc-1965	40	7	pathogenesis	pathogenesis	NOUN
dpc-1965	40	8	of	of	ADP
dpc-1965	40	9	a	a	DET
dpc-1965	40	10	variety	variety	NOUN
dpc-1965	40	11	of	of	ADP
dpc-1965	40	12	autoimmune	autoimmune	ADJ
dpc-1965	40	13	diseases	disease	NOUN
dpc-1965	40	14	such	such	ADJ
dpc-1965	40	15	as	as	ADP
dpc-1965	40	16	sjogren	sjogren	NOUN
dpc-1965	40	17	disease	disease	NOUN
dpc-1965	40	18	,	,	PUNCT
dpc-1965	40	19	behcet	behcet	NOUN
dpc-1965	40	20	disease	disease	NOUN
dpc-1965	40	21	,	,	PUNCT
dpc-1965	40	22	systemic	systemic	ADJ
dpc-1965	40	23	lupus	lupus	PROPN
dpc-1965	40	24	erythematous	erythematous	ADJ
dpc-1965	40	25	(	(	PUNCT
dpc-1965	40	26	sle	sle	PROPN
dpc-1965	40	27	)	)	PUNCT
dpc-1965	40	28	and	and	CCONJ
dpc-1965	40	29	rheumatoid	rheumatoid	VERB
dpc-1965	40	30	arthritis	arthritis	NOUN
dpc-1965	40	31	(	(	PUNCT
dpc-1965	40	32	ra	ra	NOUN
dpc-1965	40	33	)	)	PUNCT
dpc-1965	41	1	[	[	X
dpc-1965	41	2	3,15]_enref_14	3,15]_enref_14	X
dpc-1965	41	3	.	.	PUNCT
dpc-1965	41	4	there	there	PRON
dpc-1965	41	5	has	have	AUX
dpc-1965	41	6	been	be	AUX
dpc-1965	41	7	little	little	ADJ
dpc-1965	41	8	information	information	NOUN
dpc-1965	41	9	about	about	ADP
dpc-1965	41	10	the	the	DET
dpc-1965	41	11	exact	exact	ADJ
dpc-1965	41	12	role	role	NOUN
dpc-1965	41	13	of	of	ADP
dpc-1965	41	14	il-15	il-15	NOUN
dpc-1965	41	15	in	in	ADP
dpc-1965	41	16	pemphigus	pemphigus	NOUN
dpc-1965	41	17	pathogenesis	pathogenesis	NOUN
dpc-1965	41	18	or	or	CCONJ
dpc-1965	41	19	how	how	SCONJ
dpc-1965	41	20	il-15	il-15	DET
dpc-1965	41	21	production	production	NOUN
dpc-1965	41	22	relates	relate	VERB
dpc-1965	41	23	to	to	ADP
dpc-1965	41	24	the	the	DET
dpc-1965	41	25	severity	severity	NOUN
dpc-1965	41	26	of	of	ADP
dpc-1965	41	27	pemphigus	pemphigus	PROPN
dpc-1965	41	28	.	.	PUNCT
dpc-1965	42	1	in	in	ADP
dpc-1965	42	2	this	this	DET
dpc-1965	42	3	regard	regard	NOUN
dpc-1965	42	4	,	,	PUNCT
dpc-1965	42	5	the	the	DET
dpc-1965	42	6	goal	goal	NOUN
dpc-1965	42	7	of	of	ADP
dpc-1965	42	8	this	this	DET
dpc-1965	42	9	study	study	NOUN
dpc-1965	42	10	was	be	AUX
dpc-1965	42	11	to	to	PART
dpc-1965	42	12	assess	assess	VERB
dpc-1965	42	13	the	the	DET
dpc-1965	42	14	serum	serum	NOUN
dpc-1965	42	15	levels	level	NOUN
dpc-1965	42	16	of	of	ADP
dpc-1965	42	17	il-15	il-15	NOUN
dpc-1965	42	18	in	in	ADP
dpc-1965	42	19	patients	patient	NOUN
dpc-1965	42	20	with	with	ADP
dpc-1965	42	21	pv	pv	NOUN
dpc-1965	42	22	and	and	CCONJ
dpc-1965	42	23	to	to	PART
dpc-1965	42	24	find	find	VERB
dpc-1965	42	25	out	out	ADP
dpc-1965	42	26	whether	whether	SCONJ
dpc-1965	42	27	il-15	il-15	ADJ
dpc-1965	42	28	levels	level	NOUN
dpc-1965	42	29	were	be	AUX
dpc-1965	42	30	associated	associate	VERB
dpc-1965	42	31	with	with	ADP
dpc-1965	42	32	severity	severity	NOUN
dpc-1965	42	33	of	of	ADP
dpc-1965	42	34	their	their	PRON
dpc-1965	42	35	disease	disease	NOUN
dpc-1965	42	36	.	.	PUNCT
dpc-1965	43	1	methods	method	NOUN
dpc-1965	43	2	patients	patient	NOUN
dpc-1965	43	3	to	to	PART
dpc-1965	43	4	evaluate	evaluate	VERB
dpc-1965	43	5	the	the	DET
dpc-1965	43	6	serum	serum	NOUN
dpc-1965	43	7	levels	level	NOUN
dpc-1965	43	8	of	of	ADP
dpc-1965	43	9	il-15	il-15	NOUN
dpc-1965	43	10	,	,	PUNCT
dpc-1965	43	11	53	53	NUM
dpc-1965	43	12	individuals	individual	NOUN
dpc-1965	43	13	with	with	ADP
dpc-1965	43	14	active	active	ADJ
dpc-1965	43	15	pv	pv	NOUN
dpc-1965	43	16	and	and	CCONJ
dpc-1965	43	17	38	38	NUM
dpc-1965	43	18	healthy	healthy	ADJ
dpc-1965	43	19	individuals	individual	NOUN
dpc-1965	43	20	were	be	AUX
dpc-1965	43	21	enrolled	enrol	VERB
dpc-1965	43	22	in	in	ADP
dpc-1965	43	23	this	this	DET
dpc-1965	43	24	study	study	NOUN
dpc-1965	43	25	.	.	PUNCT
dpc-1965	44	1	among	among	ADP
dpc-1965	44	2	53	53	NUM
dpc-1965	44	3	patients	patient	NOUN
dpc-1965	44	4	,	,	PUNCT
dpc-1965	44	5	37	37	NUM
dpc-1965	44	6	cases	case	NOUN
dpc-1965	44	7	were	be	AUX
dpc-1965	44	8	newly	newly	ADV
dpc-1965	44	9	diagnosed	diagnose	VERB
dpc-1965	44	10	while	while	SCONJ
dpc-1965	44	11	16	16	NUM
dpc-1965	44	12	cases	case	NOUN
dpc-1965	44	13	were	be	AUX
dpc-1965	44	14	presented	present	VERB
dpc-1965	44	15	with	with	ADP
dpc-1965	44	16	relapse	relapse	NOUN
dpc-1965	44	17	during	during	ADP
dpc-1965	44	18	minimal	minimal	ADJ
dpc-1965	44	19	therapy	therapy	NOUN
dpc-1965	44	20	(	(	PUNCT
dpc-1965	44	21	5	5	NUM
dpc-1965	44	22	-	-	SYM
dpc-1965	44	23	10	10	NUM
dpc-1965	44	24	mg	mg	NOUN
dpc-1965	44	25	prednisolone	prednisolone	PROPN
dpc-1965	44	26	per	per	ADP
dpc-1965	44	27	day	day	NOUN
dpc-1965	44	28	)	)	PUNCT
dpc-1965	44	29	.	.	PUNCT
dpc-1965	45	1	pv	pv	PROPN
dpc-1965	45	2	was	be	AUX
dpc-1965	45	3	diagnosed	diagnose	VERB
dpc-1965	45	4	based	base	VERB
dpc-1965	45	5	on	on	ADP
dpc-1965	45	6	clinical	clinical	ADJ
dpc-1965	45	7	evidence	evidence	NOUN
dpc-1965	45	8	,	,	PUNCT
dpc-1965	45	9	histopathologic	histopathologic	NOUN
dpc-1965	45	10	findings	finding	NOUN
dpc-1965	45	11	,	,	PUNCT
dpc-1965	45	12	direct	direct	ADJ
dpc-1965	45	13	immune	immune	NOUN
dpc-1965	45	14	-	-	PUNCT
dpc-1965	45	15	fluorescence	fluorescence	NOUN
dpc-1965	45	16	examination	examination	NOUN
dpc-1965	45	17	and	and	CCONJ
dpc-1965	45	18	the	the	DET
dpc-1965	45	19	detection	detection	NOUN
dpc-1965	45	20	of	of	ADP
dpc-1965	45	21	serum	serum	NOUN
dpc-1965	45	22	autoantibodies	autoantibody	NOUN
dpc-1965	45	23	by	by	ADP
dpc-1965	45	24	elisa	elisa	NOUN
dpc-1965	45	25	.	.	PUNCT
dpc-1965	46	1	participants	participant	NOUN
dpc-1965	46	2	with	with	ADP
dpc-1965	46	3	any	any	DET
dpc-1965	46	4	history	history	NOUN
dpc-1965	46	5	of	of	ADP
dpc-1965	46	6	inflammatory	inflammatory	ADJ
dpc-1965	46	7	/	/	SYM
dpc-1965	46	8	autoimmune	autoimmune	ADJ
dpc-1965	46	9	diseases	disease	NOUN
dpc-1965	46	10	,	,	PUNCT
dpc-1965	46	11	hematologic	hematologic	NOUN
dpc-1965	46	12	and	and	CCONJ
dpc-1965	46	13	solid	solid	ADJ
dpc-1965	46	14	malignancies	malignancy	NOUN
dpc-1965	46	15	,	,	PUNCT
dpc-1965	46	16	viral	viral	ADJ
dpc-1965	46	17	hepatitis	hepatitis	NOUN
dpc-1965	46	18	,	,	PUNCT
dpc-1965	46	19	and	and	CCONJ
dpc-1965	46	20	hiv	hiv	PROPN
dpc-1965	46	21	were	be	AUX
dpc-1965	46	22	excluded	exclude	VERB
dpc-1965	46	23	.	.	PUNCT
dpc-1965	47	1	this	this	DET
dpc-1965	47	2	study	study	NOUN
dpc-1965	47	3	was	be	AUX
dpc-1965	47	4	approved	approve	VERB
dpc-1965	47	5	by	by	ADP
dpc-1965	47	6	the	the	DET
dpc-1965	47	7	ethical	ethical	ADJ
dpc-1965	47	8	committee	committee	NOUN
dpc-1965	47	9	of	of	ADP
dpc-1965	47	10	our	our	PRON
dpc-1965	47	11	skin	skin	NOUN
dpc-1965	47	12	research	research	NOUN
dpc-1965	47	13	center	center	NOUN
dpc-1965	47	14	(	(	PUNCT
dpc-1965	47	15	ethical	ethical	PROPN
dpc-1965	47	16	code	code	NOUN
dpc-1965	47	17	:	:	PUNCT
dpc-1965	47	18	ir.sbmu.src.rec.1395.41	ir.sbmu.src.rec.1395.41	PROPN
dpc-1965	47	19	)	)	PUNCT
dpc-1965	47	20	.	.	PUNCT
dpc-1965	48	1	prior	prior	ADV
dpc-1965	48	2	to	to	ADP
dpc-1965	48	3	enrollment	enrollment	NOUN
dpc-1965	48	4	in	in	ADP
dpc-1965	48	5	the	the	DET
dpc-1965	48	6	study	study	NOUN
dpc-1965	48	7	,	,	PUNCT
dpc-1965	48	8	all	all	DET
dpc-1965	48	9	participants	participant	NOUN
dpc-1965	48	10	provided	provide	VERB
dpc-1965	48	11	written	write	VERB
dpc-1965	48	12	informed	inform	VERB
dpc-1965	48	13	consent	consent	NOUN
dpc-1965	48	14	.	.	PUNCT
dpc-1965	49	1	clinical	clinical	ADJ
dpc-1965	49	2	and	and	CCONJ
dpc-1965	49	3	laboratory	laboratory	NOUN
dpc-1965	49	4	data	datum	NOUN
dpc-1965	49	5	all	all	DET
dpc-1965	49	6	the	the	DET
dpc-1965	49	7	patients	patient	NOUN
dpc-1965	49	8	enrolled	enrol	VERB
dpc-1965	49	9	in	in	ADP
dpc-1965	49	10	the	the	DET
dpc-1965	49	11	study	study	NOUN
dpc-1965	49	12	had	have	VERB
dpc-1965	49	13	an	an	DET
dpc-1965	49	14	active	active	ADJ
dpc-1965	49	15	disease	disease	NOUN
dpc-1965	49	16	,	,	PUNCT
dpc-1965	49	17	defined	define	VERB
dpc-1965	49	18	as	as	ADP
dpc-1965	49	19	the	the	DET
dpc-1965	49	20	development	development	NOUN
dpc-1965	49	21	of	of	ADP
dpc-1965	49	22	at	at	ADV
dpc-1965	49	23	least	least	ADV
dpc-1965	49	24	3	3	NUM
dpc-1965	49	25	de	de	X
dpc-1965	49	26	novo	novo	NOUN
dpc-1965	49	27	blisters/	blisters/	NUM
dpc-1965	49	28	erosions	erosion	NOUN
dpc-1965	49	29	,	,	PUNCT
dpc-1965	49	30	which	which	PRON
dpc-1965	49	31	do	do	AUX
dpc-1965	49	32	not	not	PART
dpc-1965	49	33	heal	heal	VERB
dpc-1965	49	34	spontaneously	spontaneously	ADV
dpc-1965	49	35	within	within	ADP
dpc-1965	49	36	one	one	NUM
dpc-1965	49	37	week	week	NOUN
dpc-1965	49	38	.	.	PUNCT
dpc-1965	50	1	the	the	DET
dpc-1965	50	2	autoimmune	autoimmune	ADJ
dpc-1965	50	3	bullous	bullous	ADJ
dpc-1965	50	4	skin	skin	NOUN
dpc-1965	50	5	disorder	disorder	NOUN
dpc-1965	50	6	intensity	intensity	NOUN
dpc-1965	50	7	score	score	NOUN
dpc-1965	50	8	(	(	PUNCT
dpc-1965	50	9	absis	absis	NOUN
dpc-1965	50	10	)	)	PUNCT
dpc-1965	50	11	was	be	AUX
dpc-1965	50	12	used	use	VERB
dpc-1965	50	13	to	to	PART
dpc-1965	50	14	assess	assess	VERB
dpc-1965	50	15	the	the	DET
dpc-1965	50	16	severity	severity	NOUN
dpc-1965	50	17	of	of	ADP
dpc-1965	50	18	the	the	DET
dpc-1965	50	19	disease	disease	NOUN
dpc-1965	50	20	.	.	PUNCT
dpc-1965	51	1	the	the	DET
dpc-1965	51	2	absis	absis	NOUN
dpc-1965	51	3	provides	provide	VERB
dpc-1965	51	4	a	a	DET
dpc-1965	51	5	maximum	maximum	ADJ
dpc-1965	51	6	score	score	NOUN
dpc-1965	51	7	of	of	ADP
dpc-1965	51	8	206	206	NUM
dpc-1965	51	9	(	(	PUNCT
dpc-1965	51	10	150	150	NUM
dpc-1965	51	11	points	point	NOUN
dpc-1965	51	12	for	for	ADP
dpc-1965	51	13	skin	skin	NOUN
dpc-1965	51	14	involvement	involvement	NOUN
dpc-1965	51	15	,	,	PUNCT
dpc-1965	51	16	11	11	NUM
dpc-1965	51	17	points	point	NOUN
dpc-1965	51	18	for	for	ADP
dpc-1965	51	19	oral	oral	ADJ
dpc-1965	51	20	involvement	involvement	NOUN
dpc-1965	51	21	,	,	PUNCT
dpc-1965	51	22	and	and	CCONJ
dpc-1965	51	23	45	45	NUM
dpc-1965	51	24	points	point	NOUN
dpc-1965	51	25	for	for	ADP
dpc-1965	51	26	subjective	subjective	ADJ
dpc-1965	51	27	oral	oral	ADJ
dpc-1965	51	28	discomfort	discomfort	NOUN
dpc-1965	51	29	)	)	PUNCT
dpc-1965	52	1	[	[	X
dpc-1965	52	2	16	16	NUM
dpc-1965	52	3	]	]	PUNCT
dpc-1965	52	4	.	.	PUNCT
dpc-1965	53	1	the	the	DET
dpc-1965	53	2	score	score	NOUN
dpc-1965	53	3	is	be	AUX
dpc-1965	53	4	determined	determine	VERB
dpc-1965	53	5	by	by	ADP
dpc-1965	53	6	calculating	calculate	VERB
dpc-1965	53	7	the	the	DET
dpc-1965	53	8	percentage	percentage	NOUN
dpc-1965	53	9	of	of	ADP
dpc-1965	53	10	blisters	blister	NOUN
dpc-1965	53	11	involvement	involvement	NOUN
dpc-1965	53	12	and	and	CCONJ
dpc-1965	53	13	erosions	erosion	NOUN
dpc-1965	53	14	on	on	ADP
dpc-1965	53	15	the	the	DET
dpc-1965	53	16	skin	skin	NOUN
dpc-1965	53	17	,	,	PUNCT
dpc-1965	53	18	along	along	ADP
dpc-1965	53	19	with	with	ADP
dpc-1965	53	20	weighting	weight	VERB
dpc-1965	53	21	factors	factor	NOUN
dpc-1965	53	22	at	at	ADP
dpc-1965	53	23	the	the	DET
dpc-1965	53	24	stage	stage	NOUN
dpc-1965	53	25	of	of	ADP
dpc-1965	53	26	the	the	DET
dpc-1965	53	27	blistering	blister	VERB
dpc-1965	53	28	and	and	CCONJ
dpc-1965	53	29	erosions	erosion	NOUN
dpc-1965	53	30	,	,	PUNCT
dpc-1965	53	31	respectively	respectively	ADV
dpc-1965	53	32	.	.	PUNCT
dpc-1965	54	1	discomfort	discomfort	NOUN
dpc-1965	54	2	during	during	ADP
dpc-1965	54	3	eating	eat	VERB
dpc-1965	54	4	and	and	CCONJ
dpc-1965	54	5	drinking	drinking	NOUN
dpc-1965	54	6	is	be	AUX
dpc-1965	54	7	also	also	ADV
dpc-1965	54	8	considered	consider	VERB
dpc-1965	54	9	[	[	PUNCT
dpc-1965	54	10	16]._enref_16	16]._enref_16	NUM
dpc-1965	54	11	cytokine	cytokine	ADJ
dpc-1965	54	12	measurements	measurement	NOUN
dpc-1965	54	13	for	for	ADP
dpc-1965	54	14	evaluating	evaluate	VERB
dpc-1965	54	15	the	the	DET
dpc-1965	54	16	level	level	NOUN
dpc-1965	54	17	of	of	ADP
dpc-1965	54	18	il-15	il-15	NOUN
dpc-1965	54	19	and	and	CCONJ
dpc-1965	54	20	anti	anti	NOUN
dpc-1965	54	21	-	-	NOUN
dpc-1965	54	22	desmogleins	desmoglein	NOUN
dpc-1965	54	23	(	(	PUNCT
dpc-1965	54	24	dsg	dsg	PROPN
dpc-1965	54	25	)	)	PUNCT
dpc-1965	54	26	,	,	PUNCT
dpc-1965	54	27	10	10	NUM
dpc-1965	54	28	ccs	ccs	PROPN
dpc-1965	54	29	venous	venous	ADJ
dpc-1965	54	30	blood	blood	NOUN
dpc-1965	54	31	of	of	ADP
dpc-1965	54	32	each	each	DET
dpc-1965	54	33	participant	participant	NOUN
dpc-1965	54	34	was	be	AUX
dpc-1965	54	35	collected	collect	VERB
dpc-1965	54	36	.	.	PUNCT
dpc-1965	55	1	the	the	DET
dpc-1965	55	2	blood	blood	NOUN
dpc-1965	55	3	samples	sample	NOUN
dpc-1965	55	4	were	be	AUX
dpc-1965	55	5	centrifuged	centrifuge	VERB
dpc-1965	55	6	to	to	PART
dpc-1965	55	7	gather	gather	VERB
dpc-1965	55	8	the	the	DET
dpc-1965	55	9	serums	serum	NOUN
dpc-1965	55	10	.	.	PUNCT
dpc-1965	56	1	then	then	ADV
dpc-1965	56	2	,	,	PUNCT
dpc-1965	56	3	the	the	DET
dpc-1965	56	4	serums	serum	NOUN
dpc-1965	56	5	were	be	AUX
dpc-1965	56	6	frozen	freeze	VERB
dpc-1965	56	7	at	at	ADP
dpc-1965	56	8	–	–	PUNCT
dpc-1965	56	9	80	80	NUM
dpc-1965	56	10	°	°	NOUN
dpc-1965	56	11	c	c	NOUN
dpc-1965	56	12	.	.	PUNCT
dpc-1965	57	1	after	after	ADP
dpc-1965	57	2	gathering	gather	VERB
dpc-1965	57	3	all	all	DET
dpc-1965	57	4	the	the	DET
dpc-1965	57	5	samples	sample	NOUN
dpc-1965	57	6	,	,	PUNCT
dpc-1965	57	7	levels	level	NOUN
dpc-1965	57	8	of	of	ADP
dpc-1965	57	9	il-15	il-15	PUNCT
dpc-1965	57	10	were	be	AUX
dpc-1965	57	11	measured	measure	VERB
dpc-1965	57	12	by	by	ADP
dpc-1965	57	13	an	an	DET
dpc-1965	57	14	elisa	elisa	NOUN
dpc-1965	57	15	kit	kit	NOUN
dpc-1965	57	16	(	(	PUNCT
dpc-1965	57	17	diaclone	diaclone	PROPN
dpc-1965	57	18	,	,	PUNCT
dpc-1965	57	19	france	france	PROPN
dpc-1965	57	20	)	)	PUNCT
dpc-1965	57	21	,	,	PUNCT
dpc-1965	57	22	according	accord	VERB
dpc-1965	57	23	to	to	ADP
dpc-1965	57	24	the	the	DET
dpc-1965	57	25	manufacturer	manufacturer	NOUN
dpc-1965	57	26	’s	’s	PART
dpc-1965	57	27	instructions	instruction	NOUN
dpc-1965	57	28	.	.	PUNCT
dpc-1965	58	1	using	use	VERB
dpc-1965	58	2	the	the	DET
dpc-1965	58	3	elisa	elisa	NOUN
dpc-1965	58	4	method	method	NOUN
dpc-1965	58	5	(	(	PUNCT
dpc-1965	58	6	euroimmun	euroimmun	PROPN
dpc-1965	58	7	ag	ag	PROPN
dpc-1965	58	8	)	)	PUNCT
dpc-1965	58	9	anti	anti	ADJ
dpc-1965	58	10	-	-	ADJ
dpc-1965	58	11	dsg	dsg	ADJ
dpc-1965	58	12	1	1	NUM
dpc-1965	58	13	and	and	CCONJ
dpc-1965	58	14	3	3	NUM
dpc-1965	58	15	antibodies	antibody	NOUN
dpc-1965	58	16	were	be	AUX
dpc-1965	58	17	measured	measure	VERB
dpc-1965	58	18	in	in	ADP
dpc-1965	58	19	patients	patient	NOUN
dpc-1965	58	20	.	.	PUNCT
dpc-1965	59	1	values	value	NOUN
dpc-1965	59	2	≥	≥	NUM
dpc-1965	59	3	20	20	NUM
dpc-1965	59	4	of	of	ADP
dpc-1965	59	5	relative	relative	ADJ
dpc-1965	59	6	units	unit	NOUN
dpc-1965	59	7	per	per	ADP
dpc-1965	59	8	milliliter	milliliter	NOUN
dpc-1965	59	9	(	(	PUNCT
dpc-1965	59	10	ru	ru	NOUN
dpc-1965	59	11	/	/	SYM
dpc-1965	59	12	ml	ml	NOUN
dpc-1965	59	13	)	)	PUNCT
dpc-1965	59	14	were	be	AUX
dpc-1965	59	15	considered	consider	VERB
dpc-1965	59	16	positive	positive	ADJ
dpc-1965	59	17	.	.	PUNCT
dpc-1965	60	1	statistical	statistical	ADJ
dpc-1965	60	2	analysis	analysis	NOUN
dpc-1965	60	3	findings	finding	NOUN
dpc-1965	60	4	were	be	AUX
dpc-1965	60	5	respectively	respectively	ADV
dpc-1965	60	6	expressed	express	VERB
dpc-1965	60	7	as	as	ADP
dpc-1965	60	8	mean	mean	NOUN
dpc-1965	60	9	±	±	NUM
dpc-1965	60	10	standard	standard	ADJ
dpc-1965	60	11	deviation	deviation	NOUN
dpc-1965	60	12	or	or	CCONJ
dpc-1965	60	13	as	as	ADP
dpc-1965	60	14	number	number	NOUN
dpc-1965	60	15	(	(	PUNCT
dpc-1965	60	16	percentage	percentage	NOUN
dpc-1965	60	17	)	)	PUNCT
dpc-1965	60	18	for	for	ADP
dpc-1965	60	19	continuous	continuous	ADJ
dpc-1965	60	20	variables	variable	NOUN
dpc-1965	60	21	and	and	CCONJ
dpc-1965	60	22	categorical	categorical	ADJ
dpc-1965	60	23	data	datum	NOUN
dpc-1965	60	24	,	,	PUNCT
dpc-1965	60	25	respectively	respectively	ADV
dpc-1965	60	26	.	.	PUNCT
dpc-1965	61	1	independent	independent	ADJ
dpc-1965	61	2	samples	sample	NOUN
dpc-1965	61	3	t	t	NOUN
dpc-1965	61	4	test	test	NOUN
dpc-1965	61	5	and	and	CCONJ
dpc-1965	61	6	non	non	ADJ
dpc-1965	61	7	-	-	ADJ
dpc-1965	61	8	parametric	parametric	ADJ
dpc-1965	61	9	mann	mann	PROPN
dpc-1965	61	10	–	–	PUNCT
dpc-1965	61	11	whitney	whitney	PROPN
dpc-1965	61	12	u	u	PROPN
dpc-1965	61	13	test	test	NOUN
dpc-1965	61	14	were	be	AUX
dpc-1965	61	15	applied	apply	VERB
dpc-1965	61	16	to	to	PART
dpc-1965	61	17	compare	compare	VERB
dpc-1965	61	18	the	the	DET
dpc-1965	61	19	means	mean	NOUN
dpc-1965	61	20	of	of	ADP
dpc-1965	61	21	continuous	continuous	ADJ
dpc-1965	61	22	variables	variable	NOUN
dpc-1965	61	23	and	and	CCONJ
dpc-1965	61	24	chi	chi	ADJ
dpc-1965	61	25	squared	squared	ADJ
dpc-1965	61	26	test	test	NOUN
dpc-1965	61	27	was	be	AUX
dpc-1965	61	28	used	use	VERB
dpc-1965	61	29	for	for	ADP
dpc-1965	61	30	categorical	categorical	ADJ
dpc-1965	61	31	variables	variable	NOUN
dpc-1965	61	32	.	.	PUNCT
dpc-1965	62	1	analysis	analysis	NOUN
dpc-1965	62	2	of	of	ADP
dpc-1965	62	3	variance	variance	NOUN
dpc-1965	62	4	(	(	PUNCT
dpc-1965	62	5	anova	anova	X
dpc-1965	62	6	test	test	NOUN
dpc-1965	62	7	)	)	PUNCT
dpc-1965	62	8	was	be	AUX
dpc-1965	62	9	used	use	VERB
dpc-1965	62	10	for	for	ADP
dpc-1965	62	11	comparing	compare	VERB
dpc-1965	62	12	means	mean	NOUN
dpc-1965	62	13	between	between	ADP
dpc-1965	62	14	variables	variable	NOUN
dpc-1965	62	15	.	.	PUNCT
dpc-1965	63	1	to	to	PART
dpc-1965	63	2	determine	determine	VERB
dpc-1965	63	3	if	if	SCONJ
dpc-1965	63	4	there	there	PRON
dpc-1965	63	5	was	be	VERB
dpc-1965	63	6	a	a	DET
dpc-1965	63	7	linear	linear	ADJ
dpc-1965	63	8	relationship	relationship	NOUN
dpc-1965	63	9	between	between	ADP
dpc-1965	63	10	variables	variable	NOUN
dpc-1965	63	11	,	,	PUNCT
dpc-1965	63	12	pearson	pearson	NOUN
dpc-1965	63	13	correlation	correlation	NOUN
dpc-1965	63	14	testing	testing	NOUN
dpc-1965	63	15	was	be	AUX
dpc-1965	63	16	performed	perform	VERB
dpc-1965	63	17	.	.	PUNCT
dpc-1965	64	1	we	we	PRON
dpc-1965	64	2	used	use	VERB
dpc-1965	64	3	the	the	DET
dpc-1965	64	4	statistical	statistical	ADJ
dpc-1965	64	5	package	package	NOUN
dpc-1965	64	6	of	of	ADP
dpc-1965	64	7	spss	spss	PROPN
dpc-1965	64	8	version	version	PROPN
dpc-1965	64	9	16.0.0	16.0.0	NOUN
dpc-1965	64	10	.	.	PUNCT
dpc-1965	65	1	(	(	PUNCT
dpc-1965	65	2	spss	spss	PROPN
dpc-1965	65	3	inc	inc	PROPN
dpc-1965	65	4	.	.	PROPN
dpc-1965	65	5	)	)	PUNCT
dpc-1965	66	1	to	to	PART
dpc-1965	66	2	analyze	analyze	VERB
dpc-1965	66	3	the	the	DET
dpc-1965	66	4	data	datum	NOUN
dpc-1965	66	5	.	.	PUNCT
dpc-1965	67	1	the	the	DET
dpc-1965	67	2	level	level	NOUN
dpc-1965	67	3	of	of	ADP
dpc-1965	67	4	significance	significance	NOUN
dpc-1965	67	5	was	be	AUX
dpc-1965	67	6	considered	consider	VERB
dpc-1965	67	7	as	as	ADP
dpc-1965	67	8	p	p	NOUN
dpc-1965	67	9	values	value	NOUN
dpc-1965	67	10	less	less	ADJ
dpc-1965	67	11	than	than	ADP
dpc-1965	67	12	0.05	0.05	NUM
dpc-1965	67	13	.	.	PUNCT
dpc-1965	68	1	original	original	ADJ
dpc-1965	68	2	article	article	NOUN
dpc-1965	68	3	|	|	ADV
dpc-1965	68	4	dermatol	dermatol	ADJ
dpc-1965	68	5	pract	pract	NOUN
dpc-1965	68	6	concept	concept	NOUN
dpc-1965	68	7	.	.	PUNCT
dpc-1965	69	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	69	2	3	3	NUM
dpc-1965	69	3	results	result	VERB
dpc-1965	69	4	patient	patient	ADJ
dpc-1965	69	5	characteristics	characteristic	NOUN
dpc-1965	69	6	fifty	fifty	NUM
dpc-1965	69	7	-	-	PUNCT
dpc-1965	69	8	three	three	NUM
dpc-1965	69	9	patients	patient	NOUN
dpc-1965	69	10	with	with	ADP
dpc-1965	69	11	pv	pv	PROPN
dpc-1965	69	12	(	(	PUNCT
dpc-1965	69	13	35	35	NUM
dpc-1965	69	14	females	female	NOUN
dpc-1965	69	15	and	and	CCONJ
dpc-1965	69	16	18	18	NUM
dpc-1965	69	17	males	male	NOUN
dpc-1965	69	18	)	)	PUNCT
dpc-1965	69	19	and	and	CCONJ
dpc-1965	69	20	38	38	NUM
dpc-1965	69	21	healthy	healthy	ADJ
dpc-1965	69	22	individuals	individual	NOUN
dpc-1965	69	23	(	(	PUNCT
dpc-1965	69	24	24	24	NUM
dpc-1965	69	25	women	woman	NOUN
dpc-1965	69	26	and	and	CCONJ
dpc-1965	69	27	14	14	NUM
dpc-1965	69	28	men	man	NOUN
dpc-1965	69	29	)	)	PUNCT
dpc-1965	69	30	were	be	AUX
dpc-1965	69	31	enrolled	enrol	VERB
dpc-1965	69	32	in	in	ADP
dpc-1965	69	33	the	the	DET
dpc-1965	69	34	study	study	NOUN
dpc-1965	69	35	.	.	PUNCT
dpc-1965	70	1	the	the	DET
dpc-1965	70	2	control	control	NOUN
dpc-1965	70	3	group	group	NOUN
dpc-1965	70	4	was	be	AUX
dpc-1965	70	5	frequency	frequency	NOUN
dpc-1965	70	6	-	-	PUNCT
dpc-1965	70	7	matched	match	VERB
dpc-1965	70	8	to	to	ADP
dpc-1965	70	9	cases	case	NOUN
dpc-1965	70	10	by	by	ADP
dpc-1965	70	11	gender	gender	NOUN
dpc-1965	70	12	and	and	CCONJ
dpc-1965	70	13	age	age	NOUN
dpc-1965	70	14	.	.	PUNCT
dpc-1965	71	1	the	the	DET
dpc-1965	71	2	mean	mean	ADJ
dpc-1965	71	3	ages	age	NOUN
dpc-1965	71	4	of	of	ADP
dpc-1965	71	5	patients	patient	NOUN
dpc-1965	71	6	and	and	CCONJ
dpc-1965	71	7	control	control	NOUN
dpc-1965	71	8	subjects	subject	NOUN
dpc-1965	71	9	were	be	AUX
dpc-1965	71	10	equal	equal	ADJ
dpc-1965	71	11	to	to	ADP
dpc-1965	71	12	45.62	45.62	NUM
dpc-1965	71	13	±	±	NUM
dpc-1965	71	14	12.27	12.27	NUM
dpc-1965	71	15	and	and	CCONJ
dpc-1965	71	16	44.21	44.21	NUM
dpc-1965	71	17	±	±	NUM
dpc-1965	71	18	13.15	13.15	NUM
dpc-1965	71	19	,	,	PUNCT
dpc-1965	71	20	respectively	respectively	ADV
dpc-1965	71	21	.	.	PUNCT
dpc-1965	72	1	the	the	DET
dpc-1965	72	2	baseline	baseline	ADJ
dpc-1965	72	3	demographics	demographic	NOUN
dpc-1965	72	4	and	and	CCONJ
dpc-1965	72	5	clinical	clinical	ADJ
dpc-1965	72	6	characteristics	characteristic	NOUN
dpc-1965	72	7	of	of	ADP
dpc-1965	72	8	the	the	DET
dpc-1965	72	9	participants	participant	NOUN
dpc-1965	72	10	have	have	AUX
dpc-1965	72	11	been	be	AUX
dpc-1965	72	12	presented	present	VERB
dpc-1965	72	13	in	in	ADP
dpc-1965	72	14	table	table	NOUN
dpc-1965	72	15	1	1	NUM
dpc-1965	72	16	.	.	PUNCT
dpc-1965	73	1	the	the	DET
dpc-1965	73	2	two	two	NUM
dpc-1965	73	3	groups	group	NOUN
dpc-1965	73	4	were	be	AUX
dpc-1965	73	5	comparable	comparable	ADJ
dpc-1965	73	6	in	in	ADP
dpc-1965	73	7	age	age	NOUN
dpc-1965	73	8	,	,	PUNCT
dpc-1965	73	9	gender	gender	NOUN
dpc-1965	73	10	,	,	PUNCT
dpc-1965	73	11	and	and	CCONJ
dpc-1965	73	12	comorbidities	comorbiditie	NOUN
dpc-1965	73	13	(	(	PUNCT
dpc-1965	73	14	table	table	NOUN
dpc-1965	73	15	1	1	NUM
dpc-1965	73	16	)	)	PUNCT
dpc-1965	73	17	.	.	PUNCT
dpc-1965	74	1	serum	serum	NOUN
dpc-1965	74	2	levels	level	NOUN
dpc-1965	74	3	of	of	ADP
dpc-1965	74	4	il-15	il-15	NOUN
dpc-1965	74	5	pv	pv	PROPN
dpc-1965	74	6	patients	patient	NOUN
dpc-1965	74	7	had	have	VERB
dpc-1965	74	8	significantly	significantly	ADV
dpc-1965	74	9	higher	high	ADJ
dpc-1965	74	10	levels	level	NOUN
dpc-1965	74	11	of	of	ADP
dpc-1965	74	12	il-15	il-15	NOUN
dpc-1965	74	13	than	than	ADP
dpc-1965	74	14	controls	control	NOUN
dpc-1965	74	15	.	.	PUNCT
dpc-1965	75	1	the	the	DET
dpc-1965	75	2	mean	mean	ADJ
dpc-1965	75	3	serum	serum	NOUN
dpc-1965	75	4	levels	level	NOUN
dpc-1965	75	5	of	of	ADP
dpc-1965	75	6	il-15	il-15	NOUN
dpc-1965	75	7	±	±	NUM
dpc-1965	75	8	sd	sd	NOUN
dpc-1965	75	9	in	in	ADP
dpc-1965	75	10	pv	pv	PROPN
dpc-1965	75	11	patients	patient	NOUN
dpc-1965	75	12	were	be	AUX
dpc-1965	75	13	3.71	3.71	NUM
dpc-1965	75	14	±	±	NUM
dpc-1965	75	15	1.5	1.5	NUM
dpc-1965	75	16	pg	pg	NOUN
dpc-1965	75	17	/	/	SYM
dpc-1965	75	18	ml	ml	NOUN
dpc-1965	75	19	,	,	PUNCT
dpc-1965	75	20	while	while	SCONJ
dpc-1965	75	21	for	for	ADP
dpc-1965	75	22	healthy	healthy	ADJ
dpc-1965	75	23	controls	control	NOUN
dpc-1965	75	24	were	be	AUX
dpc-1965	75	25	0.79	0.79	NUM
dpc-1965	75	26	±	±	NUM
dpc-1965	75	27	1.03	1.03	NUM
dpc-1965	75	28	pg	pg	NOUN
dpc-1965	75	29	/	/	SYM
dpc-1965	75	30	ml	ml	NOUN
dpc-1965	75	31	,	,	PUNCT
dpc-1965	75	32	which	which	PRON
dpc-1965	75	33	was	be	AUX
dpc-1965	75	34	statistically	statistically	ADV
dpc-1965	75	35	different	different	ADJ
dpc-1965	75	36	(	(	PUNCT
dpc-1965	75	37	p	p	X
dpc-1965	75	38	<	<	X
dpc-1965	75	39	0.001	0.001	NUM
dpc-1965	75	40	)	)	PUNCT
dpc-1965	75	41	.	.	PUNCT
dpc-1965	76	1	figure	figure	NOUN
dpc-1965	76	2	1	1	NUM
dpc-1965	76	3	demonstrates	demonstrate	VERB
dpc-1965	76	4	the	the	DET
dpc-1965	76	5	il-15	il-15	ADJ
dpc-1965	76	6	levels	level	NOUN
dpc-1965	76	7	in	in	ADP
dpc-1965	76	8	these	these	DET
dpc-1965	76	9	two	two	NUM
dpc-1965	76	10	groups	group	NOUN
dpc-1965	76	11	.	.	PUNCT
dpc-1965	77	1	in	in	ADP
dpc-1965	77	2	patients	patient	NOUN
dpc-1965	77	3	with	with	ADP
dpc-1965	77	4	pv	pv	INTJ
dpc-1965	77	5	,	,	PUNCT
dpc-1965	77	6	no	no	DET
dpc-1965	77	7	significant	significant	ADJ
dpc-1965	77	8	correlations	correlation	NOUN
dpc-1965	77	9	were	be	AUX
dpc-1965	77	10	detected	detect	VERB
dpc-1965	77	11	between	between	ADP
dpc-1965	77	12	il-15	il-15	NOUN
dpc-1965	77	13	levels	level	NOUN
dpc-1965	77	14	and	and	CCONJ
dpc-1965	77	15	anti	anti	NOUN
dpc-1965	77	16	-	-	ADJ
dpc-1965	77	17	dsg1	dsg1	NOUN
dpc-1965	77	18	(	(	PUNCT
dpc-1965	77	19	r	r	NOUN
dpc-1965	77	20	=	=	SYM
dpc-1965	77	21	0.06	0.06	NUM
dpc-1965	77	22	,	,	PUNCT
dpc-1965	77	23	p	p	NOUN
dpc-1965	77	24	=	=	NOUN
dpc-1965	77	25	0.6	0.6	NUM
dpc-1965	77	26	)	)	PUNCT
dpc-1965	77	27	or	or	CCONJ
dpc-1965	77	28	anti	anti	ADJ
dpc-1965	77	29	-	-	ADJ
dpc-1965	77	30	dsg3	dsg3	ADJ
dpc-1965	77	31	(	(	PUNCT
dpc-1965	77	32	r	r	NOUN
dpc-1965	77	33	=	=	SYM
dpc-1965	77	34	0.006	0.006	NUM
dpc-1965	77	35	,	,	PUNCT
dpc-1965	77	36	p	p	NOUN
dpc-1965	77	37	=	=	NOUN
dpc-1965	77	38	0.9	0.9	NUM
dpc-1965	77	39	)	)	PUNCT
dpc-1965	77	40	antibodies	antibodie	VERB
dpc-1965	77	41	.	.	PUNCT
dpc-1965	78	1	serum	serum	NOUN
dpc-1965	78	2	levels	level	NOUN
dpc-1965	78	3	of	of	ADP
dpc-1965	78	4	il-15	il-15	PUNCT
dpc-1965	78	5	were	be	AUX
dpc-1965	78	6	positively	positively	ADV
dpc-1965	78	7	correlated	correlate	VERB
dpc-1965	78	8	with	with	ADP
dpc-1965	78	9	pv	pv	NOUN
dpc-1965	78	10	severity	severity	NOUN
dpc-1965	78	11	according	accord	VERB
dpc-1965	78	12	to	to	ADP
dpc-1965	78	13	total	total	ADJ
dpc-1965	78	14	absis	absis	NOUN
dpc-1965	78	15	(	(	PUNCT
dpc-1965	78	16	r	r	NOUN
dpc-1965	78	17	=	=	SYM
dpc-1965	78	18	0.5	0.5	NUM
dpc-1965	78	19	,	,	PUNCT
dpc-1965	78	20	p	p	NOUN
dpc-1965	78	21	=	=	NOUN
dpc-1965	78	22	0.04	0.04	NUM
dpc-1965	78	23	)	)	PUNCT
dpc-1965	78	24	.	.	PUNCT
dpc-1965	79	1	in	in	ADP
dpc-1965	79	2	the	the	DET
dpc-1965	79	3	patients	patient	NOUN
dpc-1965	79	4	group	group	NOUN
dpc-1965	79	5	,	,	PUNCT
dpc-1965	79	6	there	there	PRON
dpc-1965	79	7	was	be	VERB
dpc-1965	79	8	no	no	DET
dpc-1965	79	9	significant	significant	ADJ
dpc-1965	79	10	difference	difference	NOUN
dpc-1965	79	11	in	in	ADP
dpc-1965	79	12	the	the	DET
dpc-1965	79	13	mean	mean	ADJ
dpc-1965	79	14	levels	level	NOUN
dpc-1965	79	15	of	of	ADP
dpc-1965	79	16	serum	serum	NOUN
dpc-1965	79	17	il-15	il-15	PUNCT
dpc-1965	79	18	between	between	ADP
dpc-1965	79	19	men	man	NOUN
dpc-1965	79	20	and	and	CCONJ
dpc-1965	79	21	women	woman	NOUN
dpc-1965	79	22	or	or	CCONJ
dpc-1965	79	23	between	between	ADP
dpc-1965	79	24	patients	patient	NOUN
dpc-1965	79	25	with	with	ADP
dpc-1965	79	26	cutaneous	cutaneous	ADJ
dpc-1965	79	27	,	,	PUNCT
dpc-1965	79	28	mucosal	mucosal	NOUN
dpc-1965	79	29	,	,	PUNCT
dpc-1965	79	30	or	or	CCONJ
dpc-1965	79	31	mucocutaneous	mucocutaneous	ADJ
dpc-1965	79	32	forms	form	NOUN
dpc-1965	79	33	of	of	ADP
dpc-1965	79	34	the	the	DET
dpc-1965	79	35	disease	disease	NOUN
dpc-1965	79	36	(	(	PUNCT
dpc-1965	79	37	p	p	NOUN
dpc-1965	79	38	=	=	NOUN
dpc-1965	79	39	0.9	0.9	NUM
dpc-1965	79	40	and	and	CCONJ
dpc-1965	79	41	0.09	0.09	NUM
dpc-1965	79	42	,	,	PUNCT
dpc-1965	79	43	respectively	respectively	ADV
dpc-1965	79	44	)	)	PUNCT
dpc-1965	79	45	.	.	PUNCT
dpc-1965	80	1	there	there	PRON
dpc-1965	80	2	was	be	VERB
dpc-1965	80	3	a	a	DET
dpc-1965	80	4	significant	significant	ADJ
dpc-1965	80	5	correlation	correlation	NOUN
dpc-1965	80	6	between	between	ADP
dpc-1965	80	7	pemphigus	pemphigus	NOUN
dpc-1965	80	8	severity	severity	NOUN
dpc-1965	80	9	(	(	PUNCT
dpc-1965	80	10	absis	absis	NOUN
dpc-1965	80	11	score	score	NOUN
dpc-1965	80	12	)	)	PUNCT
dpc-1965	80	13	and	and	CCONJ
dpc-1965	80	14	anti	anti	ADJ
dpc-1965	80	15	dsg3	dsg3	PROPN
dpc-1965	80	16	(	(	PUNCT
dpc-1965	80	17	r	r	NOUN
dpc-1965	80	18	=	=	SYM
dpc-1965	80	19	0.3	0.3	NUM
dpc-1965	80	20	,	,	PUNCT
dpc-1965	80	21	p	p	X
dpc-1965	80	22	=	=	NOUN
dpc-1965	80	23	0.01	0.01	NUM
dpc-1965	80	24	)	)	PUNCT
dpc-1965	80	25	and	and	CCONJ
dpc-1965	80	26	anti	anti	ADJ
dpc-1965	80	27	-	-	ADJ
dpc-1965	80	28	dsg1	dsg1	ADJ
dpc-1965	80	29	levels	level	NOUN
dpc-1965	80	30	(	(	PUNCT
dpc-1965	80	31	r	r	NOUN
dpc-1965	80	32	=	=	SYM
dpc-1965	80	33	0.6	0.6	NUM
dpc-1965	80	34	,	,	PUNCT
dpc-1965	80	35	p	p	X
dpc-1965	80	36	<	<	X
dpc-1965	80	37	0.001)._enref_15	0.001)._enref_15	NUM
dpc-1965	80	38	conclusions	conclusion	NOUN
dpc-1965	80	39	in	in	ADP
dpc-1965	80	40	this	this	DET
dpc-1965	80	41	study	study	NOUN
dpc-1965	80	42	,	,	PUNCT
dpc-1965	80	43	we	we	PRON
dpc-1965	80	44	have	have	AUX
dpc-1965	80	45	evaluated	evaluate	VERB
dpc-1965	80	46	plasma	plasma	NOUN
dpc-1965	80	47	levels	level	NOUN
dpc-1965	80	48	of	of	ADP
dpc-1965	80	49	il-15	il-15	NOUN
dpc-1965	80	50	in	in	ADP
dpc-1965	80	51	patients	patient	NOUN
dpc-1965	80	52	with	with	ADP
dpc-1965	80	53	pv	pv	NOUN
dpc-1965	80	54	in	in	ADP
dpc-1965	80	55	the	the	DET
dpc-1965	80	56	active	active	ADJ
dpc-1965	80	57	phase	phase	NOUN
dpc-1965	80	58	of	of	ADP
dpc-1965	80	59	the	the	DET
dpc-1965	80	60	disease	disease	NOUN
dpc-1965	80	61	and	and	CCONJ
dpc-1965	80	62	searched	search	VERB
dpc-1965	80	63	for	for	ADP
dpc-1965	80	64	a	a	DET
dpc-1965	80	65	potential	potential	ADJ
dpc-1965	80	66	relationship	relationship	NOUN
dpc-1965	80	67	between	between	ADP
dpc-1965	80	68	levels	level	NOUN
dpc-1965	80	69	of	of	ADP
dpc-1965	80	70	il-15	il-15	NOUN
dpc-1965	80	71	and	and	CCONJ
dpc-1965	80	72	the	the	DET
dpc-1965	80	73	severity	severity	NOUN
dpc-1965	80	74	of	of	ADP
dpc-1965	80	75	the	the	DET
dpc-1965	80	76	disease	disease	NOUN
dpc-1965	80	77	.	.	PUNCT
dpc-1965	81	1	we	we	PRON
dpc-1965	81	2	have	have	AUX
dpc-1965	81	3	found	find	VERB
dpc-1965	81	4	that	that	SCONJ
dpc-1965	81	5	levels	level	NOUN
dpc-1965	81	6	of	of	ADP
dpc-1965	81	7	il-15	il-15	NOUN
dpc-1965	81	8	are	be	AUX
dpc-1965	81	9	significantly	significantly	ADV
dpc-1965	81	10	higher	high	ADJ
dpc-1965	81	11	in	in	ADP
dpc-1965	81	12	patients	patient	NOUN
dpc-1965	81	13	compared	compare	VERB
dpc-1965	81	14	to	to	ADP
dpc-1965	81	15	healthy	healthy	ADJ
dpc-1965	81	16	controls	control	NOUN
dpc-1965	81	17	.	.	PUNCT
dpc-1965	82	1	our	our	PRON
dpc-1965	82	2	study	study	NOUN
dpc-1965	82	3	group	group	NOUN
dpc-1965	82	4	results	result	NOUN
dpc-1965	82	5	were	be	AUX
dpc-1965	82	6	comparable	comparable	ADJ
dpc-1965	82	7	to	to	ADP
dpc-1965	82	8	those	those	PRON
dpc-1965	82	9	previously	previously	ADV
dpc-1965	82	10	reported	report	VERB
dpc-1965	82	11	[	[	X
dpc-1965	82	12	10,11	10,11	NOUN
dpc-1965	82	13	]	]	X
dpc-1965	82	14	.	.	PUNCT
dpc-1965	83	1	8.00	8.00	NUM
dpc-1965	83	2	6.00	6.00	NUM
dpc-1965	83	3	4.00il	4.00il	NUM
dpc-1965	83	4	1	1	NUM
dpc-1965	83	5	5	5	NUM
dpc-1965	83	6	2.00	2.00	NUM
dpc-1965	83	7	0.00	0.00	NUM
dpc-1965	83	8	patient	patient	ADJ
dpc-1965	83	9	control	control	NOUN
dpc-1965	83	10	*	*	PUNCT
dpc-1965	84	1	*	*	PUNCT
dpc-1965	84	2	*	*	PUNCT
dpc-1965	84	3	participant	participant	ADJ
dpc-1965	84	4	figure	figure	NOUN
dpc-1965	84	5	1	1	NUM
dpc-1965	84	6	.	.	PUNCT
dpc-1965	85	1	serum	serum	PROPN
dpc-1965	85	2	il-15	il-15	PUNCT
dpc-1965	85	3	concentrations	concentration	NOUN
dpc-1965	85	4	(	(	PUNCT
dpc-1965	85	5	pg	pg	NOUN
dpc-1965	85	6	/	/	SYM
dpc-1965	85	7	ml	ml	VERB
dpc-1965	85	8	)	)	PUNCT
dpc-1965	85	9	in	in	ADP
dpc-1965	85	10	patients	patient	NOUN
dpc-1965	85	11	with	with	ADP
dpc-1965	85	12	pemphigus	pemphigus	NOUN
dpc-1965	85	13	in	in	ADP
dpc-1965	85	14	comparison	comparison	NOUN
dpc-1965	85	15	to	to	ADP
dpc-1965	85	16	healthy	healthy	ADJ
dpc-1965	85	17	controls	control	NOUN
dpc-1965	85	18	.	.	PUNCT
dpc-1965	86	1	overall	overall	ADJ
dpc-1965	86	2	,	,	PUNCT
dpc-1965	86	3	il-15	il-15	ADJ
dpc-1965	86	4	levels	level	NOUN
dpc-1965	86	5	in	in	ADP
dpc-1965	86	6	the	the	DET
dpc-1965	86	7	pemphigus	pemphigus	NOUN
dpc-1965	86	8	group	group	NOUN
dpc-1965	86	9	were	be	AUX
dpc-1965	86	10	higher	high	ADJ
dpc-1965	86	11	than	than	ADP
dpc-1965	86	12	that	that	PRON
dpc-1965	86	13	of	of	ADP
dpc-1965	86	14	the	the	DET
dpc-1965	86	15	control	control	NOUN
dpc-1965	86	16	group	group	NOUN
dpc-1965	86	17	(	(	PUNCT
dpc-1965	86	18	p	p	X
dpc-1965	86	19	<	<	X
dpc-1965	86	20	0.001	0.001	NUM
dpc-1965	86	21	)	)	PUNCT
dpc-1965	86	22	.	.	PUNCT
dpc-1965	87	1	il-15	il-15	PUNCT
dpc-1965	88	1	=	=	PUNCT
dpc-1965	88	2	interleukin-15	interleukin-15	PROPN
dpc-1965	88	3	.	.	NOUN
dpc-1965	88	4	4	4	NUM
dpc-1965	88	5	original	original	ADJ
dpc-1965	88	6	article	article	NOUN
dpc-1965	88	7	|	|	ADV
dpc-1965	88	8	dermatol	dermatol	ADJ
dpc-1965	88	9	pract	pract	NOUN
dpc-1965	88	10	concept	concept	NOUN
dpc-1965	88	11	.	.	PUNCT
dpc-1965	89	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	89	2	approximately	approximately	ADV
dpc-1965	89	3	two	two	NUM
dpc-1965	89	4	decades	decade	NOUN
dpc-1965	89	5	ago	ago	ADV
dpc-1965	89	6	,	,	PUNCT
dpc-1965	89	7	d’auria	d’auria	PROPN
dpc-1965	89	8	et	et	NOUN
dpc-1965	89	9	al	al	PROPN
dpc-1965	89	10	assessed	assess	VERB
dpc-1965	89	11	the	the	DET
dpc-1965	89	12	levels	level	NOUN
dpc-1965	89	13	of	of	ADP
dpc-1965	89	14	il-15	il-15	NOUN
dpc-1965	89	15	in	in	ADP
dpc-1965	89	16	the	the	DET
dpc-1965	89	17	serum	serum	NOUN
dpc-1965	89	18	sample	sample	NOUN
dpc-1965	89	19	of	of	ADP
dpc-1965	89	20	patients	patient	NOUN
dpc-1965	89	21	affected	affect	VERB
dpc-1965	89	22	with	with	ADP
dpc-1965	89	23	three	three	NUM
dpc-1965	89	24	different	different	ADJ
dpc-1965	89	25	bullous	bullous	ADJ
dpc-1965	89	26	dermatoses	dermatosis	NOUN
dpc-1965	89	27	(	(	PUNCT
dpc-1965	89	28	5	5	NUM
dpc-1965	89	29	with	with	ADP
dpc-1965	89	30	bullous	bullous	ADJ
dpc-1965	89	31	pemphigoid	pemphigoid	NOUN
dpc-1965	89	32	,	,	PUNCT
dpc-1965	89	33	15	15	NUM
dpc-1965	89	34	with	with	ADP
dpc-1965	89	35	pv	pv	NOUN
dpc-1965	89	36	and	and	CCONJ
dpc-1965	89	37	15	15	NUM
dpc-1965	89	38	with	with	ADP
dpc-1965	89	39	pemphigus	pemphigus	PROPN
dpc-1965	89	40	erythematosus	erythematosus	PROPN
dpc-1965	89	41	)	)	PUNCT
dpc-1965	90	1	[	[	X
dpc-1965	90	2	10	10	NUM
dpc-1965	90	3	]	]	PUNCT
dpc-1965	90	4	.	.	PUNCT
dpc-1965	91	1	they	they	PRON
dpc-1965	91	2	showed	show	VERB
dpc-1965	91	3	a	a	DET
dpc-1965	91	4	higher	high	ADJ
dpc-1965	91	5	level	level	NOUN
dpc-1965	91	6	of	of	ADP
dpc-1965	91	7	il-15	il-15	NOUN
dpc-1965	91	8	serum	serum	NOUN
dpc-1965	91	9	in	in	ADP
dpc-1965	91	10	all	all	DET
dpc-1965	91	11	the	the	DET
dpc-1965	91	12	dermatosis	dermatosis	NOUN
dpc-1965	91	13	as	as	SCONJ
dpc-1965	91	14	compared	compare	VERB
dpc-1965	91	15	with	with	ADP
dpc-1965	91	16	healthy	healthy	ADJ
dpc-1965	91	17	subjects	subject	NOUN
dpc-1965	91	18	.	.	PUNCT
dpc-1965	92	1	they	they	PRON
dpc-1965	92	2	also	also	ADV
dpc-1965	92	3	showed	show	VERB
dpc-1965	92	4	a	a	DET
dpc-1965	92	5	significant	significant	ADJ
dpc-1965	92	6	correlation	correlation	NOUN
dpc-1965	92	7	between	between	ADP
dpc-1965	92	8	the	the	DET
dpc-1965	92	9	number	number	NOUN
dpc-1965	92	10	of	of	ADP
dpc-1965	92	11	lesions	lesion	NOUN
dpc-1965	92	12	and	and	CCONJ
dpc-1965	92	13	il-15	il-15	NOUN
dpc-1965	92	14	serum	serum	NOUN
dpc-1965	92	15	levels	level	NOUN
dpc-1965	92	16	[	[	X
dpc-1965	92	17	10]._enref_16	10]._enref_16	NUM
dpc-1965	92	18	additionally	additionally	ADV
dpc-1965	92	19	,	,	PUNCT
dpc-1965	92	20	ameglio	ameglio	NOUN
dpc-1965	92	21	et	et	NOUN
dpc-1965	92	22	al	al	PROPN
dpc-1965	92	23	showed	show	VERB
dpc-1965	92	24	increased	increased	ADJ
dpc-1965	92	25	levels	level	NOUN
dpc-1965	92	26	of	of	ADP
dpc-1965	92	27	interleukin	interleukin	NOUN
dpc-1965	92	28	15	15	NUM
dpc-1965	92	29	in	in	ADP
dpc-1965	92	30	the	the	DET
dpc-1965	92	31	serum	serum	NOUN
dpc-1965	92	32	of	of	ADP
dpc-1965	92	33	15	15	NUM
dpc-1965	92	34	pv	pv	NOUN
dpc-1965	92	35	patients	patient	NOUN
dpc-1965	92	36	with	with	ADP
dpc-1965	92	37	active	active	ADJ
dpc-1965	92	38	disease	disease	NOUN
dpc-1965	92	39	[	[	X
dpc-1965	92	40	11	11	NUM
dpc-1965	92	41	]	]	PUNCT
dpc-1965	92	42	.	.	PUNCT
dpc-1965	93	1	in	in	ADP
dpc-1965	93	2	contrast	contrast	NOUN
dpc-1965	93	3	,	,	PUNCT
dpc-1965	93	4	in	in	ADP
dpc-1965	93	5	a	a	DET
dpc-1965	93	6	recently	recently	ADV
dpc-1965	93	7	conducted	conduct	VERB
dpc-1965	93	8	study	study	NOUN
dpc-1965	93	9	,	,	PUNCT
dpc-1965	93	10	timoteo	timoteo	NOUN
dpc-1965	93	11	et	et	NOUN
dpc-1965	93	12	al	al	PROPN
dpc-1965	93	13	with	with	ADP
dpc-1965	93	14	the	the	DET
dpc-1965	93	15	evaluation	evaluation	NOUN
dpc-1965	93	16	of	of	ADP
dpc-1965	93	17	20	20	NUM
dpc-1965	93	18	pv	pv	NOUN
dpc-1965	93	19	patients	patient	NOUN
dpc-1965	93	20	and	and	CCONJ
dpc-1965	93	21	20	20	NUM
dpc-1965	93	22	healthy	healthy	ADJ
dpc-1965	93	23	controls	control	NOUN
dpc-1965	93	24	revealed	reveal	VERB
dpc-1965	93	25	a	a	DET
dpc-1965	93	26	significantly	significantly	ADV
dpc-1965	93	27	lower	low	ADJ
dpc-1965	93	28	serum	serum	NOUN
dpc-1965	93	29	level	level	NOUN
dpc-1965	93	30	of	of	ADP
dpc-1965	93	31	il-15	il-15	NOUN
dpc-1965	93	32	in	in	ADP
dpc-1965	93	33	patients	patient	NOUN
dpc-1965	93	34	with	with	ADP
dpc-1965	93	35	pv	pv	NOUN
dpc-1965	93	36	than	than	ADP
dpc-1965	93	37	in	in	ADP
dpc-1965	93	38	control	control	NOUN
dpc-1965	93	39	group	group	NOUN
dpc-1965	93	40	patients	patient	NOUN
dpc-1965	93	41	[	[	X
dpc-1965	93	42	12	12	NUM
dpc-1965	93	43	]	]	PUNCT
dpc-1965	93	44	.	.	PUNCT
dpc-1965	94	1	in	in	ADP
dpc-1965	94	2	their	their	PRON
dpc-1965	94	3	study	study	NOUN
dpc-1965	94	4	the	the	DET
dpc-1965	94	5	study	study	NOUN
dpc-1965	94	6	population	population	NOUN
dpc-1965	94	7	consisted	consist	VERB
dpc-1965	94	8	of	of	ADP
dpc-1965	94	9	non	non	ADJ
dpc-1965	94	10	-	-	ADJ
dpc-1965	94	11	active	active	ADJ
dpc-1965	94	12	patients	patient	NOUN
dpc-1965	94	13	under	under	ADP
dpc-1965	94	14	pharmacologic	pharmacologic	ADJ
dpc-1965	94	15	therapy	therapy	NOUN
dpc-1965	94	16	,	,	PUNCT
dpc-1965	94	17	then	then	ADV
dpc-1965	94	18	their	their	PRON
dpc-1965	94	19	results	result	NOUN
dpc-1965	94	20	can	can	AUX
dpc-1965	94	21	be	be	AUX
dpc-1965	94	22	confounded	confound	VERB
dpc-1965	94	23	by	by	ADP
dpc-1965	94	24	potential	potential	ADJ
dpc-1965	94	25	suppressive	suppressive	ADJ
dpc-1965	94	26	effects	effect	NOUN
dpc-1965	94	27	of	of	ADP
dpc-1965	94	28	immunosuppressants	immunosuppressant	NOUN
dpc-1965	94	29	on	on	ADP
dpc-1965	94	30	il-15	il-15	ADJ
dpc-1965	94	31	secretions	secretion	NOUN
dpc-1965	94	32	.	.	PUNCT
dpc-1965	95	1	il-15	il-15	PUNCT
dpc-1965	95	2	is	be	AUX
dpc-1965	95	3	assumed	assume	VERB
dpc-1965	95	4	to	to	PART
dpc-1965	95	5	be	be	AUX
dpc-1965	95	6	a	a	DET
dpc-1965	95	7	member	member	NOUN
dpc-1965	95	8	of	of	ADP
dpc-1965	95	9	the	the	DET
dpc-1965	95	10	immunoregulatory	immunoregulatory	ADJ
dpc-1965	95	11	cytokines	cytokine	NOUN
dpc-1965	95	12	family	family	NOUN
dpc-1965	95	13	which	which	PRON
dpc-1965	95	14	is	be	AUX
dpc-1965	95	15	primarily	primarily	ADV
dpc-1965	95	16	produced	produce	VERB
dpc-1965	95	17	by	by	ADP
dpc-1965	95	18	monocytes	monocyte	NOUN
dpc-1965	95	19	,	,	PUNCT
dpc-1965	95	20	macrophage	macrophage	ADJ
dpc-1965	95	21	,	,	PUNCT
dpc-1965	95	22	dendritic	dendritic	ADJ
dpc-1965	95	23	cells	cell	NOUN
dpc-1965	95	24	,	,	PUNCT
dpc-1965	95	25	fibroblast	fibroblast	ADJ
dpc-1965	95	26	,	,	PUNCT
dpc-1965	95	27	and	and	CCONJ
dpc-1965	95	28	epithelial	epithelial	ADJ
dpc-1965	95	29	cells	cell	NOUN
dpc-1965	95	30	.	.	PUNCT
dpc-1965	96	1	it	it	PRON
dpc-1965	96	2	is	be	AUX
dpc-1965	96	3	believed	believe	VERB
dpc-1965	96	4	that	that	SCONJ
dpc-1965	96	5	il-15	il-15	ADJ
dpc-1965	96	6	overexpression	overexpression	NOUN
dpc-1965	96	7	is	be	AUX
dpc-1965	96	8	associated	associate	VERB
dpc-1965	96	9	with	with	ADP
dpc-1965	96	10	the	the	DET
dpc-1965	96	11	development	development	NOUN
dpc-1965	96	12	of	of	ADP
dpc-1965	96	13	chronic	chronic	ADJ
dpc-1965	96	14	inflammatory	inflammatory	ADJ
dpc-1965	96	15	disease	disease	NOUN
dpc-1965	96	16	or	or	CCONJ
dpc-1965	96	17	autoimmune	autoimmune	ADJ
dpc-1965	96	18	disorders	disorder	NOUN
dpc-1965	96	19	.	.	PUNCT
dpc-1965	97	1	when	when	SCONJ
dpc-1965	97	2	il-15	il-15	ADV
dpc-1965	97	3	is	be	AUX
dpc-1965	97	4	overexpressed	overexpresse	VERB
dpc-1965	97	5	,	,	PUNCT
dpc-1965	97	6	autoreactive	autoreactive	ADJ
dpc-1965	97	7	t	t	PROPN
dpc-1965	97	8	-	-	PUNCT
dpc-1965	97	9	cells	cell	NOUN
dpc-1965	97	10	are	be	AUX
dpc-1965	97	11	survived	survive	VERB
dpc-1965	97	12	for	for	ADP
dpc-1965	97	13	longer	long	ADJ
dpc-1965	97	14	periods	period	NOUN
dpc-1965	97	15	of	of	ADP
dpc-1965	97	16	time	time	NOUN
dpc-1965	97	17	,	,	PUNCT
dpc-1965	97	18	that	that	PRON
dpc-1965	97	19	results	result	VERB
dpc-1965	97	20	in	in	ADP
dpc-1965	97	21	abnormal	abnormal	ADJ
dpc-1965	97	22	lymphocyte	lymphocyte	ADJ
dpc-1965	97	23	activation	activation	NOUN
dpc-1965	97	24	[	[	X
dpc-1965	97	25	14	14	NUM
dpc-1965	97	26	]	]	PUNCT
dpc-1965	97	27	.	.	PUNCT
dpc-1965	98	1	furthermore	furthermore	ADV
dpc-1965	98	2	il-15	il-15	PUNCT
dpc-1965	98	3	is	be	AUX
dpc-1965	98	4	also	also	ADV
dpc-1965	98	5	involved	involve	VERB
dpc-1965	98	6	in	in	ADP
dpc-1965	98	7	the	the	DET
dpc-1965	98	8	activation	activation	NOUN
dpc-1965	98	9	and	and	CCONJ
dpc-1965	98	10	proliferation	proliferation	NOUN
dpc-1965	98	11	of	of	ADP
dpc-1965	98	12	natural	natural	ADJ
dpc-1965	98	13	killer	killer	NOUN
dpc-1965	98	14	cells	cell	NOUN
dpc-1965	98	15	(	(	PUNCT
dpc-1965	98	16	nks	nk	NOUN
dpc-1965	98	17	)	)	PUNCT
dpc-1965	99	1	[	[	X
dpc-1965	99	2	17	17	NUM
dpc-1965	99	3	]	]	PUNCT
dpc-1965	99	4	.	.	PUNCT
dpc-1965	100	1	stern	stern	PROPN
dpc-1965	100	2	et	et	PROPN
dpc-1965	100	3	al	al	PROPN
dpc-1965	100	4	have	have	AUX
dpc-1965	100	5	suggested	suggest	VERB
dpc-1965	100	6	a	a	DET
dpc-1965	100	7	possible	possible	ADJ
dpc-1965	100	8	role	role	NOUN
dpc-1965	100	9	for	for	ADP
dpc-1965	100	10	nks	nk	NOUN
dpc-1965	100	11	in	in	ADP
dpc-1965	100	12	the	the	DET
dpc-1965	100	13	pathobiology	pathobiology	NOUN
dpc-1965	100	14	of	of	ADP
dpc-1965	100	15	pv	pv	NOUN
dpc-1965	100	16	and	and	CCONJ
dpc-1965	100	17	d’auria	d’auria	PROPN
dpc-1965	100	18	et	et	NOUN
dpc-1965	100	19	al	al	PROPN
dpc-1965	100	20	have	have	AUX
dpc-1965	100	21	shown	show	VERB
dpc-1965	100	22	that	that	SCONJ
dpc-1965	100	23	the	the	DET
dpc-1965	100	24	number	number	NOUN
dpc-1965	100	25	of	of	ADP
dpc-1965	100	26	circulating	circulate	VERB
dpc-1965	100	27	natural	natural	ADJ
dpc-1965	100	28	killer	killer	NOUN
dpc-1965	100	29	cells	cell	NOUN
dpc-1965	100	30	is	be	AUX
dpc-1965	100	31	significantly	significantly	ADV
dpc-1965	100	32	correlated	correlate	VERB
dpc-1965	100	33	with	with	ADP
dpc-1965	100	34	the	the	DET
dpc-1965	100	35	concentration	concentration	NOUN
dpc-1965	100	36	of	of	ADP
dpc-1965	100	37	il15	il15	PROPN
dpc-1965	100	38	in	in	ADP
dpc-1965	100	39	patients	patient	NOUN
dpc-1965	100	40	with	with	ADP
dpc-1965	100	41	pemphigus	pemphigus	PROPN
dpc-1965	100	42	[	[	X
dpc-1965	100	43	10,18	10,18	NOUN
dpc-1965	100	44	]	]	PUNCT
dpc-1965	100	45	.	.	PUNCT
dpc-1965	101	1	according	accord	VERB
dpc-1965	101	2	to	to	ADP
dpc-1965	101	3	the	the	DET
dpc-1965	101	4	mentioned	mention	VERB
dpc-1965	101	5	role	role	NOUN
dpc-1965	101	6	of	of	ADP
dpc-1965	101	7	il-15	il-15	NOUN
dpc-1965	101	8	in	in	ADP
dpc-1965	101	9	the	the	DET
dpc-1965	101	10	differentiation	differentiation	NOUN
dpc-1965	101	11	and	and	CCONJ
dpc-1965	101	12	development	development	NOUN
dpc-1965	101	13	of	of	ADP
dpc-1965	101	14	involved	involved	ADJ
dpc-1965	101	15	cells	cell	NOUN
dpc-1965	101	16	in	in	ADP
dpc-1965	101	17	immune	immune	ADJ
dpc-1965	101	18	responses	response	NOUN
dpc-1965	101	19	,	,	PUNCT
dpc-1965	101	20	the	the	DET
dpc-1965	101	21	role	role	NOUN
dpc-1965	101	22	of	of	ADP
dpc-1965	101	23	this	this	DET
dpc-1965	101	24	cytokine	cytokine	NOUN
dpc-1965	101	25	has	have	AUX
dpc-1965	101	26	been	be	AUX
dpc-1965	101	27	studied	study	VERB
dpc-1965	101	28	in	in	ADP
dpc-1965	101	29	a	a	DET
dpc-1965	101	30	number	number	NOUN
dpc-1965	101	31	of	of	ADP
dpc-1965	101	32	autoimmune	autoimmune	ADJ
dpc-1965	101	33	diseases	disease	NOUN
dpc-1965	101	34	.	.	PUNCT
dpc-1965	102	1	there	there	PRON
dpc-1965	102	2	are	be	VERB
dpc-1965	102	3	some	some	DET
dpc-1965	102	4	reports	report	NOUN
dpc-1965	102	5	showing	show	VERB
dpc-1965	102	6	that	that	SCONJ
dpc-1965	102	7	the	the	DET
dpc-1965	102	8	mean	mean	ADJ
dpc-1965	102	9	levels	level	NOUN
dpc-1965	102	10	of	of	ADP
dpc-1965	102	11	il-15	il-15	NOUN
dpc-1965	102	12	serum	serum	NOUN
dpc-1965	102	13	are	be	AUX
dpc-1965	102	14	significantly	significantly	ADV
dpc-1965	102	15	higher	high	ADJ
dpc-1965	102	16	in	in	ADP
dpc-1965	102	17	behcet	behcet	NOUN
dpc-1965	102	18	disease	disease	NOUN
dpc-1965	102	19	,	,	PUNCT
dpc-1965	102	20	sle	sle	PROPN
dpc-1965	102	21	and	and	CCONJ
dpc-1965	102	22	rheumatoid	rheumatoid	VERB
dpc-1965	102	23	arthritis	arthritis	NOUN
dpc-1965	102	24	[	[	X
dpc-1965	102	25	19	19	NUM
dpc-1965	102	26	]	]	PUNCT
dpc-1965	102	27	.	.	PUNCT
dpc-1965	103	1	active	active	ADJ
dpc-1965	103	2	sle	sle	PROPN
dpc-1965	103	3	patients	patient	NOUN
dpc-1965	103	4	had	have	VERB
dpc-1965	103	5	significantly	significantly	ADV
dpc-1965	103	6	higher	high	ADJ
dpc-1965	103	7	levels	level	NOUN
dpc-1965	103	8	of	of	ADP
dpc-1965	103	9	il-15	il-15	X
dpc-1965	103	10	serum	serum	NOUN
dpc-1965	103	11	compared	compare	VERB
dpc-1965	103	12	to	to	ADP
dpc-1965	103	13	healthy	healthy	ADJ
dpc-1965	103	14	controls	control	NOUN
dpc-1965	103	15	,	,	PUNCT
dpc-1965	103	16	while	while	SCONJ
dpc-1965	103	17	it	it	PRON
dpc-1965	103	18	was	be	AUX
dpc-1965	103	19	not	not	PART
dpc-1965	103	20	directly	directly	ADV
dpc-1965	103	21	associated	associate	VERB
dpc-1965	103	22	with	with	ADP
dpc-1965	103	23	disease	disease	NOUN
dpc-1965	103	24	activity	activity	NOUN
dpc-1965	104	1	[	[	X
dpc-1965	104	2	20	20	NUM
dpc-1965	104	3	]	]	PUNCT
dpc-1965	104	4	.	.	PUNCT
dpc-1965	105	1	the	the	DET
dpc-1965	105	2	levels	level	NOUN
dpc-1965	105	3	of	of	ADP
dpc-1965	105	4	il-15	il-15	NOUN
dpc-1965	105	5	in	in	ADP
dpc-1965	105	6	the	the	DET
dpc-1965	105	7	serum	serum	NOUN
dpc-1965	105	8	and	and	CCONJ
dpc-1965	105	9	synovial	synovial	ADJ
dpc-1965	105	10	fluid	fluid	NOUN
dpc-1965	105	11	of	of	ADP
dpc-1965	105	12	patients	patient	NOUN
dpc-1965	105	13	with	with	ADP
dpc-1965	105	14	rheumatoid	rheumatoid	NOUN
dpc-1965	105	15	arthritis	arthritis	NOUN
dpc-1965	105	16	,	,	PUNCT
dpc-1965	105	17	were	be	AUX
dpc-1965	105	18	much	much	ADV
dpc-1965	105	19	higher	high	ADJ
dpc-1965	105	20	compared	compare	VERB
dpc-1965	105	21	to	to	ADP
dpc-1965	105	22	the	the	DET
dpc-1965	105	23	controls	control	NOUN
dpc-1965	105	24	[	[	X
dpc-1965	105	25	21	21	NUM
dpc-1965	105	26	]	]	PUNCT
dpc-1965	105	27	.	.	PUNCT
dpc-1965	106	1	interestingly	interestingly	ADV
dpc-1965	106	2	,	,	PUNCT
dpc-1965	106	3	the	the	DET
dpc-1965	106	4	levels	level	NOUN
dpc-1965	106	5	of	of	ADP
dpc-1965	106	6	il-15	il-15	PUNCT
dpc-1965	106	7	were	be	AUX
dpc-1965	106	8	related	relate	VERB
dpc-1965	106	9	to	to	ADP
dpc-1965	106	10	the	the	DET
dpc-1965	106	11	disease	disease	NOUN
dpc-1965	106	12	severity	severity	NOUN
dpc-1965	106	13	and	and	CCONJ
dpc-1965	106	14	serum	serum	NOUN
dpc-1965	106	15	levels	level	NOUN
dpc-1965	106	16	of	of	ADP
dpc-1965	106	17	il-15	il-15	PUNCT
dpc-1965	106	18	were	be	AUX
dpc-1965	106	19	strongly	strongly	ADV
dpc-1965	106	20	correlated	correlate	VERB
dpc-1965	106	21	with	with	ADP
dpc-1965	106	22	the	the	DET
dpc-1965	106	23	levels	level	NOUN
dpc-1965	106	24	of	of	ADP
dpc-1965	106	25	rheumatoid	rheumatoid	NOUN
dpc-1965	106	26	factor	factor	NOUN
dpc-1965	106	27	and	and	CCONJ
dpc-1965	106	28	anti	anti	NOUN
dpc-1965	106	29	-	-	ADJ
dpc-1965	106	30	ccp	ccp	PROPN
dpc-1965	107	1	[	[	X
dpc-1965	107	2	21	21	NUM
dpc-1965	107	3	]	]	PUNCT
dpc-1965	107	4	.	.	PUNCT
dpc-1965	108	1	collectively	collectively	ADV
dpc-1965	108	2	these	these	DET
dpc-1965	108	3	findings	finding	NOUN
dpc-1965	108	4	indicated	indicate	VERB
dpc-1965	108	5	that	that	SCONJ
dpc-1965	108	6	il-15	il-15	NOUN
dpc-1965	108	7	is	be	AUX
dpc-1965	108	8	a	a	DET
dpc-1965	108	9	key	key	ADJ
dpc-1965	108	10	cytokine	cytokine	NOUN
dpc-1965	108	11	in	in	ADP
dpc-1965	108	12	several	several	ADJ
dpc-1965	108	13	autoimmune	autoimmune	ADJ
dpc-1965	108	14	diseases	disease	NOUN
dpc-1965	108	15	,	,	PUNCT
dpc-1965	108	16	and	and	CCONJ
dpc-1965	108	17	raises	raise	VERB
dpc-1965	108	18	the	the	DET
dpc-1965	108	19	possibility	possibility	NOUN
dpc-1965	108	20	that	that	SCONJ
dpc-1965	108	21	targeting	target	VERB
dpc-1965	108	22	il15	il15	PROPN
dpc-1965	108	23	with	with	ADP
dpc-1965	108	24	various	various	ADJ
dpc-1965	108	25	anti	anti	ADJ
dpc-1965	108	26	-	-	ADJ
dpc-1965	108	27	il15	il15	ADJ
dpc-1965	108	28	approaches	approach	NOUN
dpc-1965	108	29	table	table	NOUN
dpc-1965	108	30	1	1	NUM
dpc-1965	108	31	.	.	PUNCT
dpc-1965	108	32	baseline	baseline	PROPN
dpc-1965	108	33	demographics	demographic	NOUN
dpc-1965	108	34	and	and	CCONJ
dpc-1965	108	35	clinical	clinical	ADJ
dpc-1965	108	36	characteristics	characteristic	NOUN
dpc-1965	108	37	of	of	ADP
dpc-1965	108	38	patients	patient	NOUN
dpc-1965	108	39	with	with	ADP
dpc-1965	108	40	pemphigus	pemphigus	ADJ
dpc-1965	108	41	and	and	CCONJ
dpc-1965	108	42	healthy	healthy	ADJ
dpc-1965	108	43	controls	control	NOUN
dpc-1965	108	44	.	.	PUNCT
dpc-1965	109	1	characteristic	characteristic	ADJ
dpc-1965	109	2	pv	pv	NOUN
dpc-1965	109	3	patients	patient	NOUN
dpc-1965	109	4	(	(	PUNCT
dpc-1965	109	5	n	n	NOUN
dpc-1965	109	6	=	=	SYM
dpc-1965	109	7	53	53	NUM
dpc-1965	109	8	)	)	PUNCT
dpc-1965	109	9	healthy	healthy	ADJ
dpc-1965	109	10	controls	control	NOUN
dpc-1965	109	11	(	(	PUNCT
dpc-1965	109	12	n	n	NOUN
dpc-1965	109	13	=	=	SYM
dpc-1965	109	14	38	38	NUM
dpc-1965	109	15	)	)	PUNCT
dpc-1965	109	16	p	p	NOUN
dpc-1965	109	17	gender	gender	NOUN
dpc-1965	109	18	female	female	ADJ
dpc-1965	109	19	male	male	NOUN
dpc-1965	109	20	35	35	NUM
dpc-1965	109	21	(	(	PUNCT
dpc-1965	109	22	66.0	66.0	NUM
dpc-1965	109	23	%	%	NOUN
dpc-1965	109	24	)	)	PUNCT
dpc-1965	109	25	18	18	NUM
dpc-1965	109	26	(	(	PUNCT
dpc-1965	109	27	34.0	34.0	NUM
dpc-1965	109	28	%	%	NOUN
dpc-1965	109	29	)	)	PUNCT
dpc-1965	109	30	24	24	NUM
dpc-1965	109	31	(	(	PUNCT
dpc-1965	109	32	63.2	63.2	NUM
dpc-1965	109	33	%	%	NOUN
dpc-1965	109	34	)	)	PUNCT
dpc-1965	109	35	14	14	NUM
dpc-1965	109	36	(	(	PUNCT
dpc-1965	109	37	36.8	36.8	NUM
dpc-1965	109	38	%	%	NOUN
dpc-1965	109	39	)	)	PUNCT
dpc-1965	109	40	0.70	0.70	NUM
dpc-1965	109	41	age	age	NOUN
dpc-1965	109	42	,	,	PUNCT
dpc-1965	109	43	years	year	NOUN
dpc-1965	109	44	mean	mean	VERB
dpc-1965	109	45	±	±	NUM
dpc-1965	109	46	sd	sd	ADP
dpc-1965	109	47	median	median	PROPN
dpc-1965	109	48	(	(	PUNCT
dpc-1965	109	49	range	range	NOUN
dpc-1965	109	50	)	)	PUNCT
dpc-1965	109	51	45.62	45.62	NUM
dpc-1965	109	52	±	±	NUM
dpc-1965	109	53	12.27	12.27	NUM
dpc-1965	109	54	46	46	NUM
dpc-1965	109	55	(	(	PUNCT
dpc-1965	109	56	21	21	NUM
dpc-1965	109	57	–	–	SYM
dpc-1965	109	58	72	72	NUM
dpc-1965	109	59	)	)	PUNCT
dpc-1965	109	60	44.21	44.21	NUM
dpc-1965	109	61	±	±	NUM
dpc-1965	109	62	13.15	13.15	NUM
dpc-1965	109	63	45.50	45.50	NUM
dpc-1965	109	64	(	(	PUNCT
dpc-1965	109	65	25	25	NUM
dpc-1965	109	66	–	–	SYM
dpc-1965	109	67	73	73	NUM
dpc-1965	109	68	)	)	PUNCT
dpc-1965	109	69	0.60	0.60	NUM
dpc-1965	109	70	time	time	NOUN
dpc-1965	109	71	until	until	ADP
dpc-1965	109	72	diagnosis	diagnosis	NOUN
dpc-1965	109	73	or	or	CCONJ
dpc-1965	109	74	exacerbation	exacerbation	NOUN
dpc-1965	109	75	,	,	PUNCT
dpc-1965	109	76	month	month	NOUN
dpc-1965	109	77	mean	mean	VERB
dpc-1965	109	78	±	±	PROPN
dpc-1965	109	79	sd	sd	ADP
dpc-1965	109	80	2.6	2.6	NUM
dpc-1965	109	81	±2.3	±2.3	NOUN
dpc-1965	109	82	—	—	PUNCT
dpc-1965	109	83	type	type	NOUN
dpc-1965	109	84	of	of	ADP
dpc-1965	109	85	pemphigus	pemphigus	NOUN
dpc-1965	109	86	involvement	involvement	NOUN
dpc-1965	109	87	mucosal	mucosal	NOUN
dpc-1965	109	88	cutaneous	cutaneous	ADJ
dpc-1965	109	89	mucocutaneous	mucocutaneous	ADJ
dpc-1965	109	90	18	18	NUM
dpc-1965	109	91	(	(	PUNCT
dpc-1965	109	92	34	34	NUM
dpc-1965	109	93	%	%	NOUN
dpc-1965	109	94	)	)	PUNCT
dpc-1965	109	95	7	7	NUM
dpc-1965	109	96	(	(	PUNCT
dpc-1965	109	97	13.2	13.2	NUM
dpc-1965	109	98	%	%	NOUN
dpc-1965	109	99	)	)	PUNCT
dpc-1965	109	100	28	28	NUM
dpc-1965	109	101	(	(	PUNCT
dpc-1965	109	102	52.8	52.8	NUM
dpc-1965	109	103	%	%	NOUN
dpc-1965	109	104	)	)	PUNCT
dpc-1965	109	105	—	—	PUNCT
dpc-1965	109	106	absis	absis	NOUN
dpc-1965	109	107	,	,	PUNCT
dpc-1965	109	108	mean	mean	VERB
dpc-1965	109	109	±	±	NUM
dpc-1965	109	110	sd	sd	NOUN
dpc-1965	109	111	;	;	PUNCT
dpc-1965	109	112	total	total	ADJ
dpc-1965	109	113	score	score	NOUN
dpc-1965	109	114	a	a	DET
dpc-1965	109	115	36.88	36.88	NUM
dpc-1965	109	116	±	±	NUM
dpc-1965	109	117	24.92	24.92	NUM
dpc-1965	109	118	—	—	PUNCT
dpc-1965	109	119	anti	anti	ADJ
dpc-1965	109	120	-	-	ADJ
dpc-1965	109	121	dsg1	dsg1	ADJ
dpc-1965	109	122	antibody	antibody	NOUN
dpc-1965	109	123	(	(	PUNCT
dpc-1965	109	124	ru	ru	NOUN
dpc-1965	109	125	/	/	SYM
dpc-1965	109	126	ml	ml	NOUN
dpc-1965	109	127	)	)	PUNCT
dpc-1965	109	128	mean	mean	VERB
dpc-1965	109	129	±sd	±sd	PROPN
dpc-1965	109	130	238.68	238.68	NUM
dpc-1965	109	131	±	±	NUM
dpc-1965	109	132	47.70	47.70	NUM
dpc-1965	109	133	—	—	PUNCT
dpc-1965	109	134	anti	anti	ADJ
dpc-1965	109	135	-	-	ADJ
dpc-1965	109	136	dsg3	dsg3	ADJ
dpc-1965	109	137	antibody	antibody	NOUN
dpc-1965	109	138	(	(	PUNCT
dpc-1965	109	139	ru	ru	NOUN
dpc-1965	109	140	/	/	SYM
dpc-1965	109	141	ml	ml	NOUN
dpc-1965	109	142	)	)	PUNCT
dpc-1965	109	143	mean	mean	VERB
dpc-1965	109	144	±sd	±sd	PRON
dpc-1965	109	145	729.63	729.63	NUM
dpc-1965	109	146	±	±	NUM
dpc-1965	109	147	99.05	99.05	NUM
dpc-1965	109	148	—	—	PUNCT
dpc-1965	109	149	il-15	il-15	NOUN
dpc-1965	109	150	(	(	PUNCT
dpc-1965	109	151	pg	pg	NOUN
dpc-1965	109	152	/	/	SYM
dpc-1965	109	153	ml	ml	NOUN
dpc-1965	109	154	)	)	PUNCT
dpc-1965	110	1	mean	mean	VERB
dpc-1965	110	2	±	±	NUM
dpc-1965	110	3	sd	sd	ADP
dpc-1965	110	4	3.71	3.71	NUM
dpc-1965	110	5	±	±	NUM
dpc-1965	110	6	1.5	1.5	NUM
dpc-1965	110	7	0.79	0.79	NUM
dpc-1965	110	8	±	±	NUM
dpc-1965	110	9	1.03	1.03	NUM
dpc-1965	110	10	<	<	NOUN
dpc-1965	110	11	0.001	0.001	NUM
dpc-1965	110	12	absis	absis	NOUN
dpc-1965	110	13	=	=	NOUN
dpc-1965	110	14	autoimmune	autoimmune	ADJ
dpc-1965	110	15	bullous	bullous	ADJ
dpc-1965	110	16	skin	skin	NOUN
dpc-1965	110	17	disorder	disorder	NOUN
dpc-1965	110	18	intensity	intensity	NOUN
dpc-1965	110	19	score	score	NOUN
dpc-1965	110	20	;	;	PUNCT
dpc-1965	110	21	dsg	dsg	PROPN
dpc-1965	110	22	=	=	SYM
dpc-1965	110	23	desmoglein	desmoglein	PROPN
dpc-1965	110	24	;	;	PUNCT
dpc-1965	110	25	il-15	il-15	NOUN
dpc-1965	110	26	=	=	PUNCT
dpc-1965	110	27	interleukin-15	interleukin-15	PROPN
dpc-1965	110	28	;	;	PUNCT
dpc-1965	110	29	;	;	PUNCT
dpc-1965	110	30	sd	sd	NOUN
dpc-1965	110	31	=	=	SYM
dpc-1965	110	32	standard	standard	ADJ
dpc-1965	110	33	deviation	deviation	NOUN
dpc-1965	110	34	.	.	PUNCT
dpc-1965	111	1	values	value	NOUN
dpc-1965	111	2	are	be	AUX
dpc-1965	111	3	reported	report	VERB
dpc-1965	111	4	as	as	ADP
dpc-1965	111	5	numbers	number	NOUN
dpc-1965	111	6	(	(	PUNCT
dpc-1965	111	7	%	%	INTJ
dpc-1965	111	8	)	)	PUNCT
dpc-1965	111	9	unless	unless	SCONJ
dpc-1965	111	10	otherwise	otherwise	ADV
dpc-1965	111	11	specified	specify	VERB
dpc-1965	111	12	.	.	PUNCT
dpc-1965	112	1	atotal	atotal	ADJ
dpc-1965	112	2	score	score	NOUN
dpc-1965	112	3	is	be	AUX
dpc-1965	112	4	sum	sum	NOUN
dpc-1965	112	5	of	of	ADP
dpc-1965	112	6	objective	objective	ADJ
dpc-1965	112	7	and	and	CCONJ
dpc-1965	112	8	subjective	subjective	ADJ
dpc-1965	112	9	scores	score	NOUN
dpc-1965	112	10	.	.	PUNCT
dpc-1965	113	1	original	original	ADJ
dpc-1965	113	2	article	article	NOUN
dpc-1965	113	3	|	|	ADV
dpc-1965	113	4	dermatol	dermatol	ADJ
dpc-1965	113	5	pract	pract	NOUN
dpc-1965	113	6	concept	concept	NOUN
dpc-1965	113	7	.	.	PUNCT
dpc-1965	114	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	114	2	5	5	NUM
dpc-1965	114	3	may	may	AUX
dpc-1965	114	4	provide	provide	VERB
dpc-1965	114	5	a	a	DET
dpc-1965	114	6	new	new	ADJ
dpc-1965	114	7	insight	insight	NOUN
dpc-1965	114	8	for	for	ADP
dpc-1965	114	9	the	the	DET
dpc-1965	114	10	treatment	treatment	NOUN
dpc-1965	114	11	of	of	ADP
dpc-1965	114	12	such	such	ADJ
dpc-1965	114	13	disorders	disorder	NOUN
dpc-1965	114	14	[	[	X
dpc-1965	114	15	19	19	NUM
dpc-1965	114	16	]	]	PUNCT
dpc-1965	114	17	.	.	PUNCT
dpc-1965	115	1	for	for	ADP
dpc-1965	115	2	instance	instance	NOUN
dpc-1965	115	3	,	,	PUNCT
dpc-1965	115	4	in	in	ADP
dpc-1965	115	5	an	an	DET
dpc-1965	115	6	animal	animal	NOUN
dpc-1965	115	7	model	model	NOUN
dpc-1965	115	8	of	of	ADP
dpc-1965	115	9	human	human	ADJ
dpc-1965	115	10	psoriasis	psoriasis	NOUN
dpc-1965	115	11	(	(	PUNCT
dpc-1965	115	12	xenograft	xenograft	NOUN
dpc-1965	115	13	mouse	mouse	PROPN
dpc-1965	115	14	)	)	PUNCT
dpc-1965	115	15	,	,	PUNCT
dpc-1965	115	16	the	the	DET
dpc-1965	115	17	il-15	il-15	ADJ
dpc-1965	115	18	blockade	blockade	NOUN
dpc-1965	115	19	led	lead	VERB
dpc-1965	115	20	to	to	ADP
dpc-1965	115	21	the	the	DET
dpc-1965	115	22	psoriasis	psoriasis	NOUN
dpc-1965	115	23	resolution	resolution	NOUN
dpc-1965	115	24	[	[	X
dpc-1965	115	25	22	22	NUM
dpc-1965	115	26	]	]	PUNCT
dpc-1965	115	27	.	.	PUNCT
dpc-1965	116	1	in	in	ADP
dpc-1965	116	2	rat	rat	NOUN
dpc-1965	116	3	models	model	NOUN
dpc-1965	116	4	of	of	ADP
dpc-1965	116	5	induced	induce	VERB
dpc-1965	116	6	arthritis	arthritis	NOUN
dpc-1965	116	7	,	,	PUNCT
dpc-1965	116	8	weekly	weekly	ADJ
dpc-1965	116	9	administration	administration	NOUN
dpc-1965	116	10	of	of	ADP
dpc-1965	116	11	small	small	ADJ
dpc-1965	116	12	interfering	interfere	VERB
dpc-1965	116	13	rna	rna	NOUN
dpc-1965	116	14	targeting	targeting	NOUN
dpc-1965	116	15	il-15	il-15	PUNCT
dpc-1965	116	16	reduces	reduce	VERB
dpc-1965	116	17	the	the	DET
dpc-1965	116	18	expression	expression	NOUN
dpc-1965	116	19	of	of	ADP
dpc-1965	116	20	proinflammatory	proinflammatory	ADJ
dpc-1965	116	21	mediators	mediator	NOUN
dpc-1965	116	22	in	in	ADP
dpc-1965	116	23	the	the	DET
dpc-1965	116	24	inflamed	inflame	VERB
dpc-1965	116	25	joints	joint	NOUN
dpc-1965	116	26	,	,	PUNCT
dpc-1965	116	27	alleviates	alleviate	VERB
dpc-1965	116	28	disease	disease	NOUN
dpc-1965	116	29	progression	progression	NOUN
dpc-1965	116	30	and	and	CCONJ
dpc-1965	116	31	significantly	significantly	ADV
dpc-1965	116	32	inhibits	inhibit	VERB
dpc-1965	116	33	the	the	DET
dpc-1965	116	34	clinical	clinical	ADJ
dpc-1965	116	35	,	,	PUNCT
dpc-1965	116	36	radiologic	radiologic	ADJ
dpc-1965	116	37	and	and	CCONJ
dpc-1965	116	38	histologic	histologic	ADJ
dpc-1965	116	39	features	feature	NOUN
dpc-1965	116	40	of	of	ADP
dpc-1965	116	41	rheumatoid	rheumatoid	NOUN
dpc-1965	116	42	arthritis	arthritis	NOUN
dpc-1965	116	43	[	[	X
dpc-1965	116	44	19	19	NUM
dpc-1965	116	45	]	]	PUNCT
dpc-1965	116	46	.	.	PUNCT
dpc-1965	117	1	in	in	ADP
dpc-1965	117	2	the	the	DET
dpc-1965	117	3	case	case	NOUN
dpc-1965	117	4	of	of	ADP
dpc-1965	117	5	pemphigus	pemphigus	PROPN
dpc-1965	117	6	,	,	PUNCT
dpc-1965	117	7	corticosteroid	corticosteroid	ADJ
dpc-1965	117	8	medications	medication	NOUN
dpc-1965	117	9	that	that	PRON
dpc-1965	117	10	usually	usually	ADV
dpc-1965	117	11	used	use	VERB
dpc-1965	117	12	to	to	PART
dpc-1965	117	13	suppress	suppress	VERB
dpc-1965	117	14	auto	auto	NOUN
dpc-1965	117	15	-	-	PUNCT
dpc-1965	117	16	antibodies	antibody	NOUN
dpc-1965	117	17	,	,	PUNCT
dpc-1965	117	18	include	include	VERB
dpc-1965	117	19	delayed	delay	VERB
dpc-1965	117	20	and	and	CCONJ
dpc-1965	117	21	serious	serious	ADJ
dpc-1965	117	22	side	side	NOUN
dpc-1965	117	23	effects	effect	NOUN
dpc-1965	117	24	[	[	X
dpc-1965	117	25	23	23	NUM
dpc-1965	117	26	]	]	PUNCT
dpc-1965	117	27	.	.	PUNCT
dpc-1965	118	1	targeting	target	VERB
dpc-1965	118	2	b	b	NOUN
dpc-1965	118	3	-	-	NOUN
dpc-1965	118	4	cell	cell	NOUN
dpc-1965	118	5	by	by	ADP
dpc-1965	118	6	the	the	DET
dpc-1965	118	7	anti	anti	ADJ
dpc-1965	118	8	-	-	ADJ
dpc-1965	118	9	cd20	cd20	ADJ
dpc-1965	118	10	molecule	molecule	NOUN
dpc-1965	118	11	(	(	PUNCT
dpc-1965	118	12	rituximab	rituximab	NOUN
dpc-1965	118	13	)	)	PUNCT
dpc-1965	118	14	is	be	AUX
dpc-1965	118	15	currently	currently	ADV
dpc-1965	118	16	the	the	DET
dpc-1965	118	17	best	well	ADV
dpc-1965	118	18	available	available	ADJ
dpc-1965	118	19	agent	agent	NOUN
dpc-1965	118	20	for	for	ADP
dpc-1965	118	21	the	the	DET
dpc-1965	118	22	treatment	treatment	NOUN
dpc-1965	118	23	of	of	ADP
dpc-1965	118	24	pemphigus	pemphigus	NOUN
dpc-1965	118	25	patients	patient	NOUN
dpc-1965	118	26	not	not	PART
dpc-1965	118	27	responding	respond	VERB
dpc-1965	118	28	to	to	ADP
dpc-1965	118	29	conventional	conventional	ADJ
dpc-1965	118	30	treatments	treatment	NOUN
dpc-1965	118	31	[	[	X
dpc-1965	118	32	24	24	NUM
dpc-1965	118	33	]	]	PUNCT
dpc-1965	118	34	.	.	PUNCT
dpc-1965	119	1	this	this	DET
dpc-1965	119	2	drug	drug	NOUN
dpc-1965	119	3	eliminates	eliminate	VERB
dpc-1965	119	4	peripheral	peripheral	ADJ
dpc-1965	119	5	b	b	NOUN
dpc-1965	119	6	-	-	PUNCT
dpc-1965	119	7	cells	cell	NOUN
dpc-1965	119	8	.	.	PUNCT
dpc-1965	120	1	b	b	X
dpc-1965	120	2	-	-	PUNCT
dpc-1965	120	3	cell	cell	NOUN
dpc-1965	120	4	depletion	depletion	NOUN
dpc-1965	120	5	,	,	PUNCT
dpc-1965	120	6	may	may	AUX
dpc-1965	120	7	not	not	PART
dpc-1965	120	8	be	be	AUX
dpc-1965	120	9	desirable	desirable	ADJ
dpc-1965	120	10	because	because	SCONJ
dpc-1965	120	11	b	b	X
dpc-1965	120	12	-	-	PUNCT
dpc-1965	120	13	cells	cell	NOUN
dpc-1965	120	14	are	be	AUX
dpc-1965	120	15	essential	essential	ADJ
dpc-1965	120	16	for	for	ADP
dpc-1965	120	17	antibody	antibody	NOUN
dpc-1965	120	18	production	production	NOUN
dpc-1965	120	19	,	,	PUNCT
dpc-1965	120	20	activation	activation	NOUN
dpc-1965	120	21	of	of	ADP
dpc-1965	120	22	t	t	PROPN
dpc-1965	120	23	-	-	PUNCT
dpc-1965	120	24	cells	cell	NOUN
dpc-1965	120	25	and	and	CCONJ
dpc-1965	120	26	complements	complement	NOUN
dpc-1965	120	27	.	.	PUNCT
dpc-1965	121	1	therefore	therefore	ADV
dpc-1965	121	2	,	,	PUNCT
dpc-1965	121	3	interrupting	interrupt	VERB
dpc-1965	121	4	the	the	DET
dpc-1965	121	5	homing	homing	NOUN
dpc-1965	121	6	of	of	ADP
dpc-1965	121	7	b	b	NOUN
dpc-1965	121	8	-	-	PUNCT
dpc-1965	121	9	cells	cell	NOUN
dpc-1965	121	10	by	by	ADP
dpc-1965	121	11	blocking	block	VERB
dpc-1965	121	12	the	the	DET
dpc-1965	121	13	il-15	il-15	ADJ
dpc-1965	121	14	pathway	pathway	NOUN
dpc-1965	121	15	might	might	AUX
dpc-1965	121	16	be	be	AUX
dpc-1965	121	17	a	a	DET
dpc-1965	121	18	suitable	suitable	ADJ
dpc-1965	121	19	alternative	alternative	NOUN
dpc-1965	121	20	to	to	PART
dpc-1965	121	21	reduce	reduce	VERB
dpc-1965	121	22	excessive	excessive	ADJ
dpc-1965	121	23	inflammation	inflammation	NOUN
dpc-1965	121	24	[	[	X
dpc-1965	121	25	14	14	NUM
dpc-1965	121	26	]	]	PUNCT
dpc-1965	121	27	.	.	PUNCT
dpc-1965	122	1	torn	tear	VERB
dpc-1965	122	2	et	et	PROPN
dpc-1965	122	3	al	al	PROPN
dpc-1965	122	4	showed	show	VERB
dpc-1965	122	5	that	that	SCONJ
dpc-1965	122	6	in	in	ADP
dpc-1965	122	7	patients	patient	NOUN
dpc-1965	122	8	with	with	ADP
dpc-1965	122	9	ra	ra	PROPN
dpc-1965	122	10	,	,	PUNCT
dpc-1965	122	11	the	the	DET
dpc-1965	122	12	treatment	treatment	NOUN
dpc-1965	122	13	with	with	ADP
dpc-1965	122	14	rituximab	rituximab	NOUN
dpc-1965	122	15	significantly	significantly	ADV
dpc-1965	122	16	decreased	decrease	VERB
dpc-1965	122	17	il-15	il-15	NOUN
dpc-1965	122	18	serum	serum	NOUN
dpc-1965	122	19	levels	level	NOUN
dpc-1965	122	20	as	as	ADV
dpc-1965	122	21	well	well	ADV
dpc-1965	122	22	as	as	ADP
dpc-1965	122	23	il-15	il-15	ADJ
dpc-1965	122	24	cellular	cellular	ADJ
dpc-1965	122	25	levels	level	NOUN
dpc-1965	122	26	.	.	PUNCT
dpc-1965	123	1	they	they	PRON
dpc-1965	123	2	concluded	conclude	VERB
dpc-1965	123	3	that	that	SCONJ
dpc-1965	123	4	sustained	sustain	VERB
dpc-1965	123	5	clinical	clinical	ADJ
dpc-1965	123	6	improvement	improvement	NOUN
dpc-1965	123	7	following	follow	VERB
dpc-1965	123	8	rituximab	rituximab	NOUN
dpc-1965	123	9	treatment	treatment	NOUN
dpc-1965	123	10	was	be	AUX
dpc-1965	123	11	related	relate	VERB
dpc-1965	123	12	to	to	ADP
dpc-1965	123	13	il-15	il-15	PUNCT
dpc-1965	123	14	and	and	CCONJ
dpc-1965	123	15	the	the	DET
dpc-1965	123	16	mechanisms	mechanism	NOUN
dpc-1965	123	17	by	by	ADP
dpc-1965	123	18	which	which	PRON
dpc-1965	123	19	il-15	il-15	NOUN
dpc-1965	123	20	exerts	exert	VERB
dpc-1965	123	21	influence	influence	NOUN
dpc-1965	123	22	on	on	ADP
dpc-1965	123	23	t	t	NOUN
dpc-1965	123	24	-	-	PUNCT
dpc-1965	123	25	cells	cell	NOUN
dpc-1965	123	26	[	[	X
dpc-1965	123	27	25	25	NUM
dpc-1965	123	28	]	]	PUNCT
dpc-1965	123	29	.	.	PUNCT
dpc-1965	124	1	based	base	VERB
dpc-1965	124	2	on	on	ADP
dpc-1965	124	3	our	our	PRON
dpc-1965	124	4	findings	finding	NOUN
dpc-1965	124	5	,	,	PUNCT
dpc-1965	124	6	the	the	DET
dpc-1965	124	7	elevated	elevated	ADJ
dpc-1965	124	8	levels	level	NOUN
dpc-1965	124	9	of	of	ADP
dpc-1965	124	10	il-15	il-15	NOUN
dpc-1965	124	11	in	in	ADP
dpc-1965	124	12	sera	sera	NOUN
dpc-1965	124	13	of	of	ADP
dpc-1965	124	14	patients	patient	NOUN
dpc-1965	124	15	with	with	ADP
dpc-1965	124	16	pemphigus	pemphigus	PROPN
dpc-1965	124	17	suggest	suggest	VERB
dpc-1965	124	18	that	that	SCONJ
dpc-1965	124	19	this	this	DET
dpc-1965	124	20	cytokine	cytokine	NOUN
dpc-1965	124	21	may	may	AUX
dpc-1965	124	22	actually	actually	ADV
dpc-1965	124	23	be	be	AUX
dpc-1965	124	24	involved	involve	VERB
dpc-1965	124	25	in	in	ADP
dpc-1965	124	26	pathogenesis	pathogenesis	NOUN
dpc-1965	124	27	of	of	ADP
dpc-1965	124	28	pemphigus	pemphigus	PROPN
dpc-1965	124	29	.	.	PUNCT
dpc-1965	125	1	the	the	DET
dpc-1965	125	2	generalizability	generalizability	NOUN
dpc-1965	125	3	of	of	ADP
dpc-1965	125	4	these	these	DET
dpc-1965	125	5	results	result	NOUN
dpc-1965	125	6	is	be	AUX
dpc-1965	125	7	subject	subject	ADJ
dpc-1965	125	8	to	to	ADP
dpc-1965	125	9	certain	certain	ADJ
dpc-1965	125	10	limitations	limitation	NOUN
dpc-1965	125	11	.	.	PUNCT
dpc-1965	126	1	for	for	ADP
dpc-1965	126	2	instance	instance	NOUN
dpc-1965	126	3	,	,	PUNCT
dpc-1965	126	4	in	in	ADP
dpc-1965	126	5	our	our	PRON
dpc-1965	126	6	study	study	NOUN
dpc-1965	126	7	,	,	PUNCT
dpc-1965	126	8	we	we	PRON
dpc-1965	126	9	did	do	AUX
dpc-1965	126	10	not	not	PART
dpc-1965	126	11	analyze	analyze	VERB
dpc-1965	126	12	the	the	DET
dpc-1965	126	13	serum	serum	NOUN
dpc-1965	126	14	level	level	NOUN
dpc-1965	126	15	of	of	ADP
dpc-1965	126	16	il-15	il-15	NOUN
dpc-1965	126	17	after	after	ADP
dpc-1965	126	18	treatment	treatment	NOUN
dpc-1965	126	19	of	of	ADP
dpc-1965	126	20	patients	patient	NOUN
dpc-1965	126	21	with	with	ADP
dpc-1965	126	22	steroid	steroid	PROPN
dpc-1965	126	23	pulse	pulse	NOUN
dpc-1965	126	24	or	or	CCONJ
dpc-1965	126	25	rituximab	rituximab	VERB
dpc-1965	126	26	,	,	PUNCT
dpc-1965	126	27	and	and	CCONJ
dpc-1965	126	28	we	we	PRON
dpc-1965	126	29	intend	intend	VERB
dpc-1965	126	30	to	to	PART
dpc-1965	126	31	address	address	VERB
dpc-1965	126	32	it	it	PRON
dpc-1965	126	33	in	in	ADP
dpc-1965	126	34	future	future	ADJ
dpc-1965	126	35	work	work	NOUN
dpc-1965	126	36	.	.	PUNCT
dpc-1965	127	1	in	in	ADP
dpc-1965	127	2	our	our	PRON
dpc-1965	127	3	study	study	NOUN
dpc-1965	127	4	,	,	PUNCT
dpc-1965	127	5	although	although	SCONJ
dpc-1965	127	6	we	we	PRON
dpc-1965	127	7	showed	show	VERB
dpc-1965	127	8	there	there	PRON
dpc-1965	127	9	is	be	VERB
dpc-1965	127	10	a	a	DET
dpc-1965	127	11	positive	positive	ADJ
dpc-1965	127	12	correlation	correlation	NOUN
dpc-1965	127	13	between	between	ADP
dpc-1965	127	14	serum	serum	NOUN
dpc-1965	127	15	il15	il15	PROPN
dpc-1965	127	16	levels	level	NOUN
dpc-1965	127	17	and	and	CCONJ
dpc-1965	127	18	disease	disease	NOUN
dpc-1965	127	19	severity	severity	NOUN
dpc-1965	127	20	we	we	PRON
dpc-1965	127	21	did	do	AUX
dpc-1965	127	22	not	not	PART
dpc-1965	127	23	find	find	VERB
dpc-1965	127	24	a	a	DET
dpc-1965	127	25	direct	direct	ADJ
dpc-1965	127	26	association	association	NOUN
dpc-1965	127	27	between	between	ADP
dpc-1965	127	28	il-15	il-15	NOUN
dpc-1965	127	29	serum	serum	NOUN
dpc-1965	127	30	levels	level	NOUN
dpc-1965	127	31	and	and	CCONJ
dpc-1965	127	32	anti	anti	ADJ
dpc-1965	127	33	-	-	ADJ
dpc-1965	127	34	dsg	dsg	ADJ
dpc-1965	127	35	levels	level	NOUN
dpc-1965	127	36	.	.	PUNCT
dpc-1965	128	1	it	it	PRON
dpc-1965	128	2	might	might	AUX
dpc-1965	128	3	be	be	AUX
dpc-1965	128	4	due	due	ADJ
dpc-1965	128	5	to	to	ADP
dpc-1965	128	6	different	different	ADJ
dpc-1965	128	7	mechanisms	mechanism	NOUN
dpc-1965	128	8	regarding	regard	VERB
dpc-1965	128	9	pemphigus	pemphigus	NOUN
dpc-1965	128	10	pathogenesis	pathogenesis	NOUN
dpc-1965	128	11	and	and	CCONJ
dpc-1965	128	12	autoantibody	autoantibody	ADJ
dpc-1965	128	13	production	production	NOUN
dpc-1965	128	14	.	.	PUNCT
dpc-1965	129	1	it	it	PRON
dpc-1965	129	2	could	could	AUX
dpc-1965	129	3	be	be	AUX
dpc-1965	129	4	speculated	speculate	VERB
dpc-1965	129	5	that	that	SCONJ
dpc-1965	129	6	il‐15	il‐15	PROPN
dpc-1965	129	7	might	might	AUX
dpc-1965	129	8	rather	rather	ADV
dpc-1965	129	9	be	be	AUX
dpc-1965	129	10	involved	involve	VERB
dpc-1965	129	11	in	in	ADP
dpc-1965	129	12	tuning	tune	VERB
dpc-1965	129	13	the	the	DET
dpc-1965	129	14	immune	immune	ADJ
dpc-1965	129	15	system	system	NOUN
dpc-1965	129	16	towards	towards	ADP
dpc-1965	129	17	autoimmunity	autoimmunity	NOUN
dpc-1965	129	18	not	not	PART
dpc-1965	129	19	to	to	PART
dpc-1965	129	20	directly	directly	ADV
dpc-1965	129	21	exert	exert	VERB
dpc-1965	129	22	its	its	PRON
dpc-1965	129	23	influence	influence	NOUN
dpc-1965	129	24	on	on	ADP
dpc-1965	129	25	antibody	antibody	NOUN
dpc-1965	129	26	production	production	NOUN
dpc-1965	129	27	.	.	PUNCT
dpc-1965	130	1	taken	take	VERB
dpc-1965	130	2	together	together	ADV
dpc-1965	130	3	our	our	PRON
dpc-1965	130	4	findings	finding	NOUN
dpc-1965	130	5	suggest	suggest	VERB
dpc-1965	130	6	that	that	SCONJ
dpc-1965	130	7	levels	level	NOUN
dpc-1965	130	8	of	of	ADP
dpc-1965	130	9	il‐15	il‐15	PROPN
dpc-1965	130	10	in	in	ADP
dpc-1965	130	11	the	the	DET
dpc-1965	130	12	sera	sera	NOUN
dpc-1965	130	13	of	of	ADP
dpc-1965	130	14	patients	patient	NOUN
dpc-1965	130	15	with	with	ADP
dpc-1965	130	16	pemphigus	pemphigus	PROPN
dpc-1965	130	17	are	be	AUX
dpc-1965	130	18	high	high	ADJ
dpc-1965	130	19	,	,	PUNCT
dpc-1965	130	20	which	which	PRON
dpc-1965	130	21	suggests	suggest	VERB
dpc-1965	130	22	that	that	SCONJ
dpc-1965	130	23	this	this	DET
dpc-1965	130	24	cytokine	cytokine	NOUN
dpc-1965	130	25	may	may	AUX
dpc-1965	130	26	have	have	VERB
dpc-1965	130	27	a	a	DET
dpc-1965	130	28	role	role	NOUN
dpc-1965	130	29	in	in	ADP
dpc-1965	130	30	the	the	DET
dpc-1965	130	31	pathogenesis	pathogenesis	NOUN
dpc-1965	130	32	of	of	ADP
dpc-1965	130	33	pemphigus	pemphigus	PROPN
dpc-1965	130	34	.	.	PUNCT
dpc-1965	131	1	whether	whether	SCONJ
dpc-1965	131	2	the	the	DET
dpc-1965	131	3	higher	high	ADJ
dpc-1965	131	4	level	level	NOUN
dpc-1965	131	5	of	of	ADP
dpc-1965	131	6	il-15	il-15	NOUN
dpc-1965	131	7	is	be	AUX
dpc-1965	131	8	the	the	DET
dpc-1965	131	9	cause	cause	NOUN
dpc-1965	131	10	or	or	CCONJ
dpc-1965	131	11	result	result	NOUN
dpc-1965	131	12	of	of	ADP
dpc-1965	131	13	autoimmune	autoimmune	ADJ
dpc-1965	131	14	diseases	disease	NOUN
dpc-1965	131	15	remains	remain	VERB
dpc-1965	131	16	to	to	PART
dpc-1965	131	17	be	be	AUX
dpc-1965	131	18	determined	determine	VERB
dpc-1965	131	19	in	in	ADP
dpc-1965	131	20	future	future	ADJ
dpc-1965	131	21	studies	study	NOUN
dpc-1965	131	22	.	.	PUNCT
dpc-1965	132	1	understanding	understand	VERB
dpc-1965	132	2	the	the	DET
dpc-1965	132	3	role	role	NOUN
dpc-1965	132	4	of	of	ADP
dpc-1965	132	5	il-15	il-15	NOUN
dpc-1965	132	6	in	in	ADV
dpc-1965	132	7	pv	pv	NOUN
dpc-1965	132	8	provides	provide	VERB
dpc-1965	132	9	a	a	DET
dpc-1965	132	10	scientific	scientific	ADJ
dpc-1965	132	11	basis	basis	NOUN
dpc-1965	132	12	for	for	ADP
dpc-1965	132	13	the	the	DET
dpc-1965	132	14	development	development	NOUN
dpc-1965	132	15	of	of	ADP
dpc-1965	132	16	novel	novel	ADJ
dpc-1965	132	17	therapeutic	therapeutic	ADJ
dpc-1965	132	18	options	option	NOUN
dpc-1965	132	19	for	for	ADP
dpc-1965	132	20	this	this	DET
dpc-1965	132	21	autoimmune	autoimmune	ADJ
dpc-1965	132	22	disease	disease	NOUN
dpc-1965	132	23	.	.	PUNCT
dpc-1965	133	1	anti	anti	ADJ
dpc-1965	133	2	-	-	ADJ
dpc-1965	133	3	cytokine	cytokine	ADJ
dpc-1965	133	4	therapy	therapy	NOUN
dpc-1965	133	5	is	be	AUX
dpc-1965	133	6	an	an	DET
dpc-1965	133	7	emerging	emerge	VERB
dpc-1965	133	8	treatment	treatment	NOUN
dpc-1965	133	9	and	and	CCONJ
dpc-1965	133	10	considered	consider	VERB
dpc-1965	133	11	to	to	PART
dpc-1965	133	12	be	be	AUX
dpc-1965	133	13	a	a	DET
dpc-1965	133	14	promising	promising	ADJ
dpc-1965	133	15	therapy	therapy	NOUN
dpc-1965	133	16	in	in	ADP
dpc-1965	133	17	autoimmune	autoimmune	ADJ
dpc-1965	133	18	diseases	disease	NOUN
dpc-1965	133	19	;	;	PUNCT
dpc-1965	133	20	while	while	SCONJ
dpc-1965	133	21	there	there	PRON
dpc-1965	133	22	is	be	VERB
dpc-1965	133	23	a	a	DET
dpc-1965	133	24	need	need	NOUN
dpc-1965	133	25	for	for	ADP
dpc-1965	133	26	further	further	ADJ
dpc-1965	133	27	clarification	clarification	NOUN
dpc-1965	133	28	to	to	PART
dpc-1965	133	29	establish	establish	VERB
dpc-1965	133	30	whether	whether	SCONJ
dpc-1965	133	31	inhibition	inhibition	NOUN
dpc-1965	133	32	of	of	ADP
dpc-1965	133	33	il-15	il-15	NOUN
dpc-1965	133	34	action	action	NOUN
dpc-1965	133	35	might	might	AUX
dpc-1965	133	36	prove	prove	VERB
dpc-1965	133	37	valuable	valuable	ADJ
dpc-1965	133	38	in	in	ADP
dpc-1965	133	39	the	the	DET
dpc-1965	133	40	treatment	treatment	NOUN
dpc-1965	133	41	of	of	ADP
dpc-1965	133	42	pv	pv	NOUN
dpc-1965	133	43	.	.	PUNCT
dpc-1965	134	1	references	reference	NOUN
dpc-1965	134	2	1	1	NUM
dpc-1965	134	3	.	.	PUNCT
dpc-1965	134	4	schmidt	schmidt	PROPN
dpc-1965	134	5	e	e	PROPN
dpc-1965	134	6	,	,	PUNCT
dpc-1965	134	7	kasperkiewicz	kasperkiewicz	PROPN
dpc-1965	134	8	m	m	PROPN
dpc-1965	134	9	,	,	PUNCT
dpc-1965	134	10	joly	joly	PROPN
dpc-1965	134	11	p.	p.	PROPN
dpc-1965	134	12	pemphigus	pemphigus	PROPN
dpc-1965	134	13	.	.	PUNCT
dpc-1965	135	1	lancet	lancet	PROPN
dpc-1965	135	2	.	.	PUNCT
dpc-1965	136	1	2019;394(10201):882	2019;394(10201):882	NUM
dpc-1965	136	2	-	-	SYM
dpc-1965	136	3	894	894	NUM
dpc-1965	136	4	.	.	PUNCT
dpc-1965	136	5	doi	doi	NOUN
dpc-1965	136	6	:	:	PUNCT
dpc-1965	136	7	10.1016	10.1016	NUM
dpc-1965	136	8	/	/	SYM
dpc-1965	136	9	s0140	s0140	PROPN
dpc-1965	136	10	-	-	PUNCT
dpc-1965	136	11	6736(19)31778	6736(19)31778	NUM
dpc-1965	136	12	-	-	SYM
dpc-1965	136	13	7	7	NUM
dpc-1965	136	14	.	.	PUNCT
dpc-1965	137	1	pmid	pmid	NOUN
dpc-1965	137	2	:	:	PUNCT
dpc-1965	137	3	31498102	31498102	NUM
dpc-1965	137	4	.	.	PUNCT
dpc-1965	138	1	2	2	X
dpc-1965	138	2	.	.	X
dpc-1965	138	3	murrell	murrell	PROPN
dpc-1965	138	4	df	df	PROPN
dpc-1965	138	5	,	,	PUNCT
dpc-1965	138	6	peña	peña	PROPN
dpc-1965	138	7	s	s	PROPN
dpc-1965	138	8	,	,	PUNCT
dpc-1965	138	9	joly	joly	PROPN
dpc-1965	138	10	p	p	PROPN
dpc-1965	138	11	,	,	PUNCT
dpc-1965	138	12	et	et	PROPN
dpc-1965	138	13	al	al	PROPN
dpc-1965	138	14	.	.	PUNCT
dpc-1965	138	15	diagnosis	diagnosis	NOUN
dpc-1965	138	16	and	and	CCONJ
dpc-1965	138	17	management	management	NOUN
dpc-1965	138	18	of	of	ADP
dpc-1965	138	19	pemphigus	pemphigus	NOUN
dpc-1965	138	20	:	:	PUNCT
dpc-1965	138	21	recommendations	recommendation	NOUN
dpc-1965	138	22	by	by	ADP
dpc-1965	138	23	an	an	DET
dpc-1965	138	24	international	international	ADJ
dpc-1965	138	25	panel	panel	NOUN
dpc-1965	138	26	of	of	ADP
dpc-1965	138	27	experts	expert	NOUN
dpc-1965	138	28	.	.	PUNCT
dpc-1965	139	1	j	j	PROPN
dpc-1965	139	2	am	be	AUX
dpc-1965	139	3	acad	acad	ADJ
dpc-1965	139	4	dermatol	dermatol	NOUN
dpc-1965	139	5	.	.	PUNCT
dpc-1965	140	1	2018;82(3):575	2018;82(3):575	NUM
dpc-1965	140	2	-	-	PUNCT
dpc-1965	140	3	585.e1	585.e1	PROPN
dpc-1965	140	4	.	.	PUNCT
dpc-1965	141	1	doi	doi	NOUN
dpc-1965	141	2	:	:	PUNCT
dpc-1965	141	3	10.1016	10.1016	NUM
dpc-1965	141	4	/	/	SYM
dpc-1965	141	5	j.jaad.2018.02.021	j.jaad.2018.02.021	PROPN
dpc-1965	141	6	.	.	PUNCT
dpc-1965	142	1	pmid	pmid	NOUN
dpc-1965	142	2	:	:	PUNCT
dpc-1965	142	3	29438767	29438767	NUM
dpc-1965	142	4	.	.	PUNCT
dpc-1965	143	1	pmcid	pmcid	ADJ
dpc-1965	143	2	:	:	PUNCT
dpc-1965	143	3	pmc7313440	pmc7313440	ADJ
dpc-1965	143	4	.	.	PUNCT
dpc-1965	144	1	3	3	X
dpc-1965	144	2	.	.	X
dpc-1965	144	3	ketabi	ketabi	PROPN
dpc-1965	144	4	y	y	PROPN
dpc-1965	144	5	,	,	PUNCT
dpc-1965	144	6	nasiri	nasiri	ADV
dpc-1965	144	7	s	s	PRON
dpc-1965	144	8	,	,	PUNCT
dpc-1965	144	9	kheirodin	kheirodin	VERB
dpc-1965	144	10	m	m	PRON
dpc-1965	144	11	,	,	PUNCT
dpc-1965	144	12	tavakolpour	tavakolpour	PROPN
dpc-1965	144	13	s	s	NOUN
dpc-1965	144	14	,	,	PUNCT
dpc-1965	144	15	mozafari	mozafari	PROPN
dpc-1965	144	16	n.	n.	VERB
dpc-1965	144	17	the	the	DET
dpc-1965	144	18	elevated	elevated	ADJ
dpc-1965	144	19	level	level	NOUN
dpc-1965	144	20	of	of	ADP
dpc-1965	144	21	osteopontin	osteopontin	NOUN
dpc-1965	144	22	in	in	ADP
dpc-1965	144	23	patients	patient	NOUN
dpc-1965	144	24	with	with	ADP
dpc-1965	144	25	pemphigus	pemphigus	NOUN
dpc-1965	144	26	vulgaris	vulgaris	NOUN
dpc-1965	144	27	:	:	PUNCT
dpc-1965	144	28	a	a	DET
dpc-1965	144	29	cytokine	cytokine	NOUN
dpc-1965	144	30	-	-	PUNCT
dpc-1965	144	31	like	like	ADJ
dpc-1965	144	32	protein	protein	NOUN
dpc-1965	144	33	with	with	ADP
dpc-1965	144	34	a	a	DET
dpc-1965	144	35	therapeutic	therapeutic	ADJ
dpc-1965	144	36	potential	potential	NOUN
dpc-1965	144	37	.	.	PUNCT
dpc-1965	145	1	dermatol	dermatol	NOUN
dpc-1965	145	2	ther	ther	ADV
dpc-1965	145	3	.	.	PUNCT
dpc-1965	146	1	jul	jul	PROPN
dpc-1965	146	2	2019;32(4):e12973	2019;32(4):e12973	PROPN
dpc-1965	146	3	.	.	PUNCT
dpc-1965	147	1	doi	doi	NOUN
dpc-1965	147	2	:	:	PUNCT
dpc-1965	147	3	10.1111/	10.1111/	NUM
dpc-1965	147	4	dth.12973	dth.12973	NOUN
dpc-1965	147	5	.	.	PUNCT
dpc-1965	148	1	pmid	pmid	NOUN
dpc-1965	148	2	:	:	PUNCT
dpc-1965	148	3	31136685	31136685	NUM
dpc-1965	148	4	.	.	PUNCT
dpc-1965	149	1	4	4	X
dpc-1965	149	2	.	.	X
dpc-1965	149	3	tavakolpour	tavakolpour	NUM
dpc-1965	149	4	s.	s.	PROPN
dpc-1965	149	5	interleukin	interleukin	PROPN
dpc-1965	149	6	21	21	NUM
dpc-1965	149	7	as	as	ADP
dpc-1965	149	8	a	a	DET
dpc-1965	149	9	new	new	ADJ
dpc-1965	149	10	possible	possible	ADJ
dpc-1965	149	11	player	player	NOUN
dpc-1965	149	12	in	in	ADP
dpc-1965	149	13	pemphigus	pemphigus	PROPN
dpc-1965	149	14	:	:	PUNCT
dpc-1965	149	15	is	be	AUX
dpc-1965	149	16	it	it	PRON
dpc-1965	149	17	a	a	DET
dpc-1965	149	18	suitable	suitable	ADJ
dpc-1965	149	19	target	target	NOUN
dpc-1965	149	20	?	?	PUNCT
dpc-1965	150	1	int	int	NOUN
dpc-1965	150	2	immunopharmacol	immunopharmacol	PROPN
dpc-1965	150	3	.	.	PUNCT
dpc-1965	151	1	2016;34:139145	2016;34:139145	X
dpc-1965	151	2	.	.	PUNCT
dpc-1965	151	3	doi	doi	NOUN
dpc-1965	151	4	:	:	PUNCT
dpc-1965	151	5	10.1016	10.1016	NUM
dpc-1965	151	6	/	/	SYM
dpc-1965	151	7	j.intimp.2016.02.020	j.intimp.2016.02.020	PROPN
dpc-1965	151	8	.	.	PUNCT
dpc-1965	152	1	pmid	pmid	NOUN
dpc-1965	152	2	:	:	PUNCT
dpc-1965	152	3	26945832	26945832	NUM
dpc-1965	152	4	.	.	X
dpc-1965	153	1	5	5	X
dpc-1965	153	2	.	.	X
dpc-1965	153	3	tavakolpour	tavakolpour	NUM
dpc-1965	153	4	s	s	PROPN
dpc-1965	153	5	,	,	PUNCT
dpc-1965	153	6	tavakolpour	tavakolpour	PRON
dpc-1965	153	7	v.	v.	ADP
dpc-1965	153	8	interleukin	interleukin	NOUN
dpc-1965	153	9	4	4	NUM
dpc-1965	153	10	inhibition	inhibition	NOUN
dpc-1965	153	11	as	as	ADP
dpc-1965	153	12	a	a	DET
dpc-1965	153	13	potential	potential	ADJ
dpc-1965	153	14	therapeutic	therapeutic	ADJ
dpc-1965	153	15	in	in	ADP
dpc-1965	153	16	pemphigus	pemphigus	PROPN
dpc-1965	153	17	.	.	PUNCT
dpc-1965	153	18	cytokine	cytokine	VERB
dpc-1965	153	19	.	.	PUNCT
dpc-1965	154	1	2016;77:189	2016;77:189	PROPN
dpc-1965	154	2	-	-	PUNCT
dpc-1965	154	3	195	195	NUM
dpc-1965	154	4	.	.	PUNCT
dpc-1965	154	5	doi	doi	NOUN
dpc-1965	154	6	:	:	PUNCT
dpc-1965	154	7	10.1016	10.1016	NUM
dpc-1965	154	8	/	/	SYM
dpc-1965	154	9	j.cyto.2015.09.017	j.cyto.2015.09.017	X
dpc-1965	154	10	.	.	PUNCT
dpc-1965	155	1	pmid	pmid	NOUN
dpc-1965	155	2	:	:	PUNCT
dpc-1965	155	3	26440137	26440137	NUM
dpc-1965	155	4	.	.	PUNCT
dpc-1965	156	1	6	6	NUM
dpc-1965	156	2	.	.	X
dpc-1965	156	3	tavakolpour	tavakolpour	NUM
dpc-1965	156	4	s.	s.	PROPN
dpc-1965	156	5	dupilumab	dupilumab	PROPN
dpc-1965	156	6	:	:	PUNCT
dpc-1965	156	7	a	a	DET
dpc-1965	156	8	revolutionary	revolutionary	ADJ
dpc-1965	156	9	emerging	emerge	VERB
dpc-1965	156	10	drug	drug	NOUN
dpc-1965	156	11	in	in	ADP
dpc-1965	156	12	atopic	atopic	NOUN
dpc-1965	156	13	dermatitis	dermatitis	NOUN
dpc-1965	156	14	and	and	CCONJ
dpc-1965	156	15	its	its	PRON
dpc-1965	156	16	possible	possible	ADJ
dpc-1965	156	17	role	role	NOUN
dpc-1965	156	18	in	in	ADP
dpc-1965	156	19	pemphigus	pemphigus	PROPN
dpc-1965	156	20	.	.	PUNCT
dpc-1965	157	1	dermatol	dermatol	NOUN
dpc-1965	157	2	ther	ther	ADV
dpc-1965	157	3	.	.	PUNCT
dpc-1965	158	1	2016;29(5):299	2016;29(5):299	NUM
dpc-1965	158	2	.	.	PUNCT
dpc-1965	159	1	doi	doi	NOUN
dpc-1965	159	2	:	:	PUNCT
dpc-1965	159	3	10.1111	10.1111	NUM
dpc-1965	159	4	/	/	SYM
dpc-1965	159	5	dth.12327	dth.12327	PROPN
dpc-1965	159	6	.	.	PUNCT
dpc-1965	160	1	pmid	pmid	NOUN
dpc-1965	160	2	:	:	PUNCT
dpc-1965	160	3	26800435	26800435	NUM
dpc-1965	160	4	.	.	PUNCT
dpc-1965	161	1	7	7	X
dpc-1965	161	2	.	.	X
dpc-1965	161	3	russo	russo	PROPN
dpc-1965	161	4	r	r	PROPN
dpc-1965	161	5	,	,	PUNCT
dpc-1965	161	6	cozzani	cozzani	ADJ
dpc-1965	161	7	e	e	NOUN
dpc-1965	161	8	,	,	PUNCT
dpc-1965	161	9	gasparini	gasparini	VERB
dpc-1965	161	10	g	g	NOUN
dpc-1965	161	11	,	,	PUNCT
dpc-1965	161	12	parodi	parodi	NOUN
dpc-1965	161	13	a.	a.	NOUN
dpc-1965	161	14	targeting	target	VERB
dpc-1965	161	15	interleukin	interleukin	NOUN
dpc-1965	161	16	4	4	NUM
dpc-1965	161	17	receptor	receptor	NOUN
dpc-1965	161	18	α	α	NOUN
dpc-1965	161	19	:	:	PUNCT
dpc-1965	161	20	a	a	DET
dpc-1965	161	21	new	new	ADJ
dpc-1965	161	22	approach	approach	NOUN
dpc-1965	161	23	to	to	ADP
dpc-1965	161	24	the	the	DET
dpc-1965	161	25	treatment	treatment	NOUN
dpc-1965	161	26	of	of	ADP
dpc-1965	161	27	cutaneous	cutaneous	ADJ
dpc-1965	161	28	autoimmune	autoimmune	ADJ
dpc-1965	161	29	bullous	bullous	ADJ
dpc-1965	161	30	diseases	disease	NOUN
dpc-1965	161	31	?	?	PUNCT
dpc-1965	162	1	dermatol	dermatol	NOUN
dpc-1965	162	2	ther	ther	ADV
dpc-1965	162	3	.	.	PUNCT
dpc-1965	163	1	2020;33(1):e13190	2020;33(1):e13190	NUM
dpc-1965	163	2	.	.	PUNCT
dpc-1965	163	3	doi	doi	NOUN
dpc-1965	163	4	:	:	PUNCT
dpc-1965	163	5	10.1111	10.1111	NUM
dpc-1965	163	6	/	/	SYM
dpc-1965	163	7	dth.13190	dth.13190	PROPN
dpc-1965	163	8	.	.	PUNCT
dpc-1965	164	1	pmid	pmid	NOUN
dpc-1965	164	2	:	:	PUNCT
dpc-1965	164	3	31863534	31863534	NUM
dpc-1965	164	4	;	;	PUNCT
dpc-1965	164	5	pmcid	pmcid	ADJ
dpc-1965	164	6	:	:	PUNCT
dpc-1965	164	7	pmc7154653	pmc7154653	ADJ
dpc-1965	164	8	.	.	PUNCT
dpc-1965	165	1	8	8	X
dpc-1965	165	2	.	.	X
dpc-1965	166	1	tavakolpour	tavakolpour	NUM
dpc-1965	166	2	s	s	PROPN
dpc-1965	166	3	,	,	PUNCT
dpc-1965	166	4	kheiry	kheiry	PROPN
dpc-1965	166	5	f	f	PROPN
dpc-1965	166	6	,	,	PUNCT
dpc-1965	166	7	mirsafaei	mirsafaei	ADJ
dpc-1965	166	8	hs	hs	PROPN
dpc-1965	166	9	,	,	PUNCT
dpc-1965	166	10	akhlaghdoust	akhlaghdoust	PROPN
dpc-1965	166	11	m.	m.	NOUN
dpc-1965	166	12	the	the	DET
dpc-1965	166	13	possible	possible	ADJ
dpc-1965	166	14	role	role	NOUN
dpc-1965	166	15	of	of	ADP
dpc-1965	166	16	interleukin-35	interleukin-35	PROPN
dpc-1965	166	17	and	and	CCONJ
dpc-1965	166	18	its	its	PRON
dpc-1965	166	19	therapeutic	therapeutic	ADJ
dpc-1965	166	20	potential	potential	NOUN
dpc-1965	166	21	in	in	ADP
dpc-1965	166	22	pemphigus	pemphigus	PROPN
dpc-1965	166	23	.	.	PUNCT
dpc-1965	167	1	int	int	PROPN
dpc-1965	167	2	immunopharmacol	immunopharmacol	PROPN
dpc-1965	167	3	.	.	PUNCT
dpc-1965	168	1	2017;42:11	2017;42:11	NUM
dpc-1965	168	2	-	-	SYM
dpc-1965	168	3	17	17	NUM
dpc-1965	168	4	.	.	PUNCT
dpc-1965	169	1	doi	doi	NOUN
dpc-1965	169	2	:	:	PUNCT
dpc-1965	169	3	10.1016	10.1016	NUM
dpc-1965	169	4	/	/	SYM
dpc-1965	169	5	j.intimp.2016.11.005	j.intimp.2016.11.005	PROPN
dpc-1965	169	6	.	.	PUNCT
dpc-1965	170	1	pmid	pmid	NOUN
dpc-1965	170	2	:	:	PUNCT
dpc-1965	170	3	27855302	27855302	NUM
dpc-1965	170	4	9	9	NUM
dpc-1965	170	5	.	.	PUNCT
dpc-1965	171	1	liu	liu	PROPN
dpc-1965	171	2	m	m	PROPN
dpc-1965	171	3	,	,	PUNCT
dpc-1965	171	4	li	li	PROPN
dpc-1965	171	5	s	s	PROPN
dpc-1965	171	6	,	,	PUNCT
dpc-1965	171	7	li	li	PROPN
dpc-1965	171	8	mo	mo	PROPN
dpc-1965	171	9	.	.	PUNCT
dpc-1965	172	1	tgf‐β	tgf‐β	NOUN
dpc-1965	172	2	control	control	NOUN
dpc-1965	172	3	of	of	ADP
dpc-1965	172	4	adaptive	adaptive	ADJ
dpc-1965	172	5	immune	immune	ADJ
dpc-1965	172	6	tolerance	tolerance	NOUN
dpc-1965	172	7	:	:	PUNCT
dpc-1965	172	8	a	a	DET
dpc-1965	172	9	break	break	NOUN
dpc-1965	172	10	from	from	ADP
dpc-1965	172	11	treg	treg	PROPN
dpc-1965	172	12	cells	cell	NOUN
dpc-1965	172	13	.	.	PUNCT
dpc-1965	173	1	bioessays	bioessay	NOUN
dpc-1965	173	2	.	.	PUNCT
dpc-1965	174	1	2018;40(11):1800063	2018;40(11):1800063	X
dpc-1965	174	2	.	.	PUNCT
dpc-1965	174	3	doi	doi	NOUN
dpc-1965	174	4	:	:	PUNCT
dpc-1965	174	5	10.1002	10.1002	NUM
dpc-1965	174	6	/	/	SYM
dpc-1965	174	7	bies.201800063	bies.201800063	PROPN
dpc-1965	174	8	.	.	PUNCT
dpc-1965	175	1	pmid	pmid	NOUN
dpc-1965	175	2	:	:	PUNCT
dpc-1965	175	3	30159904	30159904	NUM
dpc-1965	175	4	.	.	PUNCT
dpc-1965	176	1	pmcid	pmcid	NOUN
dpc-1965	176	2	:	:	PUNCT
dpc-1965	176	3	pmc6300063	pmc6300063	NOUN
dpc-1965	176	4	.	.	PUNCT
dpc-1965	177	1	10	10	NUM
dpc-1965	177	2	.	.	PUNCT
dpc-1965	178	1	d’auria	d’auria	PROPN
dpc-1965	178	2	l	l	NOUN
dpc-1965	178	3	,	,	PUNCT
dpc-1965	178	4	bonifati	bonifati	PROPN
dpc-1965	178	5	c	c	NOUN
dpc-1965	178	6	,	,	PUNCT
dpc-1965	178	7	cordiali	cordiali	ADJ
dpc-1965	178	8	-	-	PROPN
dpc-1965	178	9	fei	fei	PROPN
dpc-1965	178	10	p	p	NOUN
dpc-1965	178	11	,	,	PUNCT
dpc-1965	178	12	et	et	PROPN
dpc-1965	178	13	al	al	PROPN
dpc-1965	178	14	.	.	PROPN
dpc-1965	178	15	increased	increase	VERB
dpc-1965	178	16	serum	serum	PROPN
dpc-1965	178	17	interleukin-15	interleukin-15	PROPN
dpc-1965	178	18	levels	level	NOUN
dpc-1965	178	19	in	in	ADP
dpc-1965	178	20	bullous	bullous	ADJ
dpc-1965	178	21	skin	skin	NOUN
dpc-1965	178	22	diseases	disease	NOUN
dpc-1965	178	23	:	:	PUNCT
dpc-1965	178	24	correlation	correlation	NOUN
dpc-1965	178	25	with	with	ADP
dpc-1965	178	26	disease	disease	NOUN
dpc-1965	178	27	intensity	intensity	NOUN
dpc-1965	178	28	.	.	PUNCT
dpc-1965	179	1	arch	arch	ADJ
dpc-1965	179	2	dermatol	dermatol	NOUN
dpc-1965	179	3	res	re	NOUN
dpc-1965	179	4	.	.	PUNCT
dpc-1965	180	1	1999;291(6):354	1999;291(6):354	PROPN
dpc-1965	180	2	-	-	SYM
dpc-1965	180	3	356	356	NUM
dpc-1965	180	4	.	.	PUNCT
dpc-1965	181	1	doi	doi	NOUN
dpc-1965	181	2	:	:	PUNCT
dpc-1965	181	3	10.1007	10.1007	NUM
dpc-1965	181	4	/	/	SYM
dpc-1965	181	5	s004030050421	s004030050421	PROPN
dpc-1965	181	6	.	.	PUNCT
dpc-1965	182	1	pmid	pmid	NOUN
dpc-1965	182	2	:	:	PUNCT
dpc-1965	182	3	10421062	10421062	NUM
dpc-1965	182	4	..	..	PUNCT
dpc-1965	183	1	11	11	NUM
dpc-1965	183	2	.	.	PUNCT
dpc-1965	184	1	ameglio	ameglio	PROPN
dpc-1965	184	2	f	f	NOUN
dpc-1965	184	3	,	,	PUNCT
dpc-1965	184	4	d’auria	d’auria	PROPN
dpc-1965	184	5	l	l	NOUN
dpc-1965	184	6	,	,	PUNCT
dpc-1965	184	7	cordiali	cordiali	ADJ
dpc-1965	184	8	-	-	PROPN
dpc-1965	184	9	fei	fei	PROPN
dpc-1965	184	10	p	p	NOUN
dpc-1965	184	11	,	,	PUNCT
dpc-1965	184	12	et	et	PROPN
dpc-1965	184	13	al	al	PROPN
dpc-1965	184	14	.	.	PUNCT
dpc-1965	185	1	anti	anti	ADJ
dpc-1965	185	2	-	-	ADJ
dpc-1965	185	3	intercellular	intercellular	ADJ
dpc-1965	185	4	substance	substance	NOUN
dpc-1965	185	5	antibody	antibody	NOUN
dpc-1965	185	6	log	log	NOUN
dpc-1965	185	7	titres	titre	NOUN
dpc-1965	185	8	are	be	AUX
dpc-1965	185	9	correlated	correlate	VERB
dpc-1965	185	10	with	with	ADP
dpc-1965	185	11	serum	serum	NOUN
dpc-1965	185	12	concentrations	concentration	NOUN
dpc-1965	185	13	of	of	ADP
dpc-1965	185	14	interleukin-6	interleukin-6	NUM
dpc-1965	185	15	,	,	PUNCT
dpc-1965	185	16	interleukin-15	interleukin-15	PROPN
dpc-1965	185	17	and	and	CCONJ
dpc-1965	185	18	tumor	tumor	NOUN
dpc-1965	185	19	necrosis	necrosis	NOUN
dpc-1965	185	20	factor	factor	NOUN
dpc-1965	185	21	-	-	PUNCT
dpc-1965	185	22	alpha	alpha	NOUN
dpc-1965	185	23	in	in	ADP
dpc-1965	185	24	patients	patient	NOUN
dpc-1965	185	25	with	with	ADP
dpc-1965	185	26	pemphigus	pemphigus	NOUN
dpc-1965	185	27	vulgaris	vulgaris	NOUN
dpc-1965	185	28	relationships	relationship	NOUN
dpc-1965	185	29	with	with	ADP
dpc-1965	185	30	peripheral	peripheral	ADJ
dpc-1965	185	31	blood	blood	NOUN
dpc-1965	185	32	neutrophil	neutrophil	ADJ
dpc-1965	185	33	counts	count	NOUN
dpc-1965	185	34	,	,	PUNCT
dpc-1965	185	35	disease	disease	NOUN
dpc-1965	185	36	severity	severity	NOUN
dpc-1965	185	37	and	and	CCONJ
dpc-1965	185	38	duration	duration	NOUN
dpc-1965	185	39	and	and	CCONJ
dpc-1965	185	40	patients	patient	NOUN
dpc-1965	185	41	’	'	PUNCT
dpc-1965	185	42	age	age	NOUN
dpc-1965	185	43	.	.	PUNCT
dpc-1965	186	1	j	j	PROPN
dpc-1965	186	2	biol	biol	PROPN
dpc-1965	186	3	regul	regul	PROPN
dpc-1965	186	4	homeost	homeost	ADJ
dpc-1965	186	5	agents	agent	NOUN
dpc-1965	186	6	.	.	PUNCT
dpc-1965	187	1	1999;13(4):220224	1999;13(4):220224	NUM
dpc-1965	187	2	.	.	PUNCT
dpc-1965	188	1	pmid	pmid	NOUN
dpc-1965	188	2	:	:	PUNCT
dpc-1965	188	3	10703946	10703946	NUM
dpc-1965	188	4	..	..	PUNCT
dpc-1965	189	1	12	12	NUM
dpc-1965	189	2	.	.	PUNCT
dpc-1965	189	3	timoteo	timoteo	PROPN
dpc-1965	189	4	rp	rp	PROPN
dpc-1965	189	5	,	,	PUNCT
dpc-1965	189	6	da	da	PROPN
dpc-1965	189	7	silva	silva	PROPN
dpc-1965	189	8	mv	mv	PROPN
dpc-1965	189	9	,	,	PUNCT
dpc-1965	189	10	miguel	miguel	PROPN
dpc-1965	189	11	cb	cb	PROPN
dpc-1965	189	12	,	,	PUNCT
dpc-1965	189	13	et	et	PROPN
dpc-1965	189	14	al	al	PROPN
dpc-1965	189	15	.	.	PUNCT
dpc-1965	190	1	th1	th1	PROPN
dpc-1965	190	2	/	/	SYM
dpc-1965	190	3	th17	th17	PROPN
dpc-1965	190	4	-	-	PUNCT
dpc-1965	190	5	related	relate	VERB
dpc-1965	190	6	cytokines	cytokine	NOUN
dpc-1965	190	7	and	and	CCONJ
dpc-1965	190	8	chemokines	chemokine	NOUN
dpc-1965	190	9	and	and	CCONJ
dpc-1965	190	10	their	their	PRON
dpc-1965	190	11	implications	implication	NOUN
dpc-1965	190	12	in	in	ADP
dpc-1965	190	13	the	the	DET
dpc-1965	190	14	pathogenesis	pathogenesis	NOUN
dpc-1965	190	15	of	of	ADP
dpc-1965	190	16	pemphigus	pemphigus	NOUN
dpc-1965	190	17	vulgaris	vulgaris	NOUN
dpc-1965	190	18	.	.	PUNCT
dpc-1965	191	1	mediators	mediator	NOUN
dpc-1965	191	2	inflamm	inflamm	NOUN
dpc-1965	191	3	.	.	PUNCT
dpc-1965	192	1	2017;2017:7151285	2017;2017:7151285	NUM
dpc-1965	192	2	.	.	PUNCT
dpc-1965	193	1	doi	doi	NOUN
dpc-1965	193	2	:	:	PUNCT
dpc-1965	193	3	10.1155/2017/7151285	10.1155/2017/7151285	NUM
dpc-1965	193	4	.	.	PUNCT
dpc-1965	194	1	pmid	pmid	NOUN
dpc-1965	194	2	:	:	PUNCT
dpc-1965	194	3	28321152	28321152	NUM
dpc-1965	194	4	.	.	PUNCT
dpc-1965	195	1	pmcid	pmcid	NOUN
dpc-1965	195	2	:	:	PUNCT
dpc-1965	195	3	pmc5340942	pmc5340942	NOUN
dpc-1965	195	4	.	.	PUNCT
dpc-1965	196	1	13	13	NUM
dpc-1965	196	2	.	.	X
dpc-1965	197	1	sisto	sisto	PROPN
dpc-1965	197	2	m	m	PROPN
dpc-1965	197	3	,	,	PUNCT
dpc-1965	197	4	lorusso	lorusso	PROPN
dpc-1965	197	5	l	l	PROPN
dpc-1965	197	6	,	,	PUNCT
dpc-1965	197	7	lisi	lisi	PROPN
dpc-1965	197	8	s.	s.	PROPN
dpc-1965	197	9	interleukin-15	interleukin-15	PROPN
dpc-1965	197	10	as	as	ADP
dpc-1965	197	11	a	a	DET
dpc-1965	197	12	potential	potential	ADJ
dpc-1965	197	13	new	new	ADJ
dpc-1965	197	14	target	target	NOUN
dpc-1965	197	15	in	in	ADP
dpc-1965	197	16	sjögren	sjögren	PROPN
dpc-1965	197	17	’s	’s	PART
dpc-1965	197	18	syndrome	syndrome	NOUN
dpc-1965	197	19	-	-	PUNCT
dpc-1965	197	20	associated	associate	VERB
dpc-1965	197	21	inflammation	inflammation	NOUN
dpc-1965	197	22	.	.	PUNCT
dpc-1965	198	1	pathology	pathology	NOUN
dpc-1965	198	2	.	.	PUNCT
dpc-1965	199	1	oct	oct	PROPN
dpc-1965	199	2	2016;48(6):602	2016;48(6):602	PROPN
dpc-1965	199	3	-	-	PUNCT
dpc-1965	199	4	607	607	NUM
dpc-1965	199	5	.	.	PUNCT
dpc-1965	200	1	doi	doi	NOUN
dpc-1965	200	2	:	:	PUNCT
dpc-1965	200	3	10.1016	10.1016	NUM
dpc-1965	200	4	/	/	SYM
dpc-1965	200	5	j.pathol.2016.06.001	j.pathol.2016.06.001	PROPN
dpc-1965	200	6	.	.	PUNCT
dpc-1965	201	1	pmid	pmid	NOUN
dpc-1965	201	2	:	:	PUNCT
dpc-1965	201	3	27567226	27567226	NUM
dpc-1965	201	4	.	.	PUNCT
dpc-1965	202	1	6	6	NUM
dpc-1965	202	2	original	original	ADJ
dpc-1965	202	3	article	article	NOUN
dpc-1965	202	4	|	|	ADV
dpc-1965	202	5	dermatol	dermatol	ADJ
dpc-1965	202	6	pract	pract	NOUN
dpc-1965	202	7	concept	concept	NOUN
dpc-1965	202	8	.	.	PUNCT
dpc-1965	203	1	2022;12(3):e2022118	2022;12(3):e2022118	NUM
dpc-1965	203	2	14	14	NUM
dpc-1965	203	3	.	.	PUNCT
dpc-1965	204	1	patidar	patidar	PROPN
dpc-1965	204	2	m	m	PROPN
dpc-1965	204	3	,	,	PUNCT
dpc-1965	204	4	yadav	yadav	PROPN
dpc-1965	204	5	n	n	CCONJ
dpc-1965	204	6	,	,	PUNCT
dpc-1965	204	7	dalai	dalai	PROPN
dpc-1965	204	8	sk	sk	PROPN
dpc-1965	204	9	.	.	PUNCT
dpc-1965	204	10	interleukin	interleukin	PROPN
dpc-1965	204	11	15	15	NUM
dpc-1965	204	12	:	:	PUNCT
dpc-1965	204	13	a	a	DET
dpc-1965	204	14	key	key	ADJ
dpc-1965	204	15	cytokine	cytokine	NOUN
dpc-1965	204	16	for	for	ADP
dpc-1965	204	17	immunotherapy	immunotherapy	NOUN
dpc-1965	204	18	.	.	PUNCT
dpc-1965	205	1	cytokine	cytokine	ADJ
dpc-1965	205	2	growth	growth	NOUN
dpc-1965	205	3	factor	factor	NOUN
dpc-1965	205	4	rev	rev	VERB
dpc-1965	205	5	.	.	PROPN
dpc-1965	205	6	2016;31:49	2016;31:49	NUM
dpc-1965	205	7	-	-	SYM
dpc-1965	205	8	59	59	NUM
dpc-1965	205	9	.	.	PUNCT
dpc-1965	206	1	doi	doi	NOUN
dpc-1965	206	2	:	:	PUNCT
dpc-1965	206	3	10.1016	10.1016	NUM
dpc-1965	206	4	/	/	SYM
dpc-1965	206	5	j.cytogfr.2016.06.001	j.cytogfr.2016.06.001	PROPN
dpc-1965	206	6	.	.	PUNCT
dpc-1965	207	1	pmid	pmid	NOUN
dpc-1965	207	2	:	:	PUNCT
dpc-1965	207	3	27325459	27325459	NUM
dpc-1965	207	4	.	.	PUNCT
dpc-1965	208	1	15	15	NUM
dpc-1965	208	2	.	.	PUNCT
dpc-1965	209	1	carroll	carroll	PROPN
dpc-1965	209	2	h	h	PROPN
dpc-1965	209	3	,	,	PUNCT
dpc-1965	209	4	paunović	paunović	ADJ
dpc-1965	209	5	v	v	NOUN
dpc-1965	209	6	,	,	PUNCT
dpc-1965	209	7	gadina	gadina	PROPN
dpc-1965	209	8	m.	m.	NOUN
dpc-1965	209	9	signalling	signalling	NOUN
dpc-1965	209	10	,	,	PUNCT
dpc-1965	209	11	inflammation	inflammation	NOUN
dpc-1965	209	12	and	and	CCONJ
dpc-1965	209	13	arthritis	arthritis	NOUN
dpc-1965	209	14	:	:	PUNCT
dpc-1965	209	15	crossed	cross	VERB
dpc-1965	209	16	signals	signal	NOUN
dpc-1965	209	17	:	:	PUNCT
dpc-1965	209	18	the	the	DET
dpc-1965	209	19	role	role	NOUN
dpc-1965	209	20	of	of	ADP
dpc-1965	209	21	interleukin-15	interleukin-15	PROPN
dpc-1965	209	22	and-18	and-18	NOUN
dpc-1965	209	23	in	in	ADP
dpc-1965	209	24	autoimmunity	autoimmunity	NOUN
dpc-1965	209	25	.	.	PUNCT
dpc-1965	210	1	rheumatology	rheumatology	NOUN
dpc-1965	210	2	(	(	PUNCT
dpc-1965	210	3	oxford	oxford	PROPN
dpc-1965	210	4	)	)	PUNCT
dpc-1965	210	5	.	.	PUNCT
dpc-1965	211	1	2008;47(9):1269	2008;47(9):1269	NUM
dpc-1965	211	2	-	-	SYM
dpc-1965	211	3	1277	1277	NUM
dpc-1965	211	4	.	.	PUNCT
dpc-1965	212	1	doi	doi	NOUN
dpc-1965	212	2	:	:	PUNCT
dpc-1965	212	3	10.1093	10.1093	NUM
dpc-1965	212	4	/	/	SYM
dpc-1965	212	5	rheumatology	rheumatology	NOUN
dpc-1965	212	6	/	/	SYM
dpc-1965	212	7	ken257	ken257	PROPN
dpc-1965	212	8	.	.	PUNCT
dpc-1965	213	1	pmid	pmid	NOUN
dpc-1965	213	2	:	:	PUNCT
dpc-1965	213	3	18621751	18621751	NUM
dpc-1965	213	4	.	.	PUNCT
dpc-1965	214	1	16	16	NUM
dpc-1965	214	2	.	.	PUNCT
dpc-1965	215	1	pfütze	pfütze	PROPN
dpc-1965	215	2	m	m	PROPN
dpc-1965	215	3	,	,	PUNCT
dpc-1965	215	4	niedermeier	niedermeier	PROPN
dpc-1965	215	5	a	a	PRON
dpc-1965	215	6	,	,	PUNCT
dpc-1965	215	7	hertl	hertl	NOUN
dpc-1965	215	8	m	m	PROPN
dpc-1965	215	9	,	,	PUNCT
dpc-1965	215	10	eming	eme	VERB
dpc-1965	215	11	r.	r.	NOUN
dpc-1965	215	12	introducing	introduce	VERB
dpc-1965	215	13	a	a	DET
dpc-1965	215	14	novel	novel	ADJ
dpc-1965	215	15	autoimmune	autoimmune	ADJ
dpc-1965	215	16	bullous	bullous	ADJ
dpc-1965	215	17	skin	skin	NOUN
dpc-1965	215	18	disorder	disorder	NOUN
dpc-1965	215	19	intensity	intensity	NOUN
dpc-1965	215	20	score	score	NOUN
dpc-1965	215	21	(	(	PUNCT
dpc-1965	215	22	absis	absis	NOUN
dpc-1965	215	23	)	)	PUNCT
dpc-1965	215	24	in	in	ADP
dpc-1965	215	25	pemphigus	pemphigus	PROPN
dpc-1965	215	26	.	.	PUNCT
dpc-1965	216	1	eur	eur	PROPN
dpc-1965	216	2	j	j	PROPN
dpc-1965	216	3	dermatol	dermatol	NOUN
dpc-1965	216	4	.	.	PUNCT
dpc-1965	217	1	2007;17(1):4	2007;17(1):4	NUM
dpc-1965	217	2	-	-	SYM
dpc-1965	217	3	11	11	NUM
dpc-1965	217	4	.	.	PUNCT
dpc-1965	218	1	doi	doi	NOUN
dpc-1965	218	2	:	:	PUNCT
dpc-1965	218	3	10.1684/	10.1684/	NUM
dpc-1965	218	4	ejd.2007.0090	ejd.2007.0090	PROPN
dpc-1965	218	5	.	.	PUNCT
dpc-1965	219	1	pmid	pmid	NOUN
dpc-1965	219	2	:	:	PUNCT
dpc-1965	219	3	17324820	17324820	NUM
dpc-1965	219	4	.	.	PUNCT
dpc-1965	220	1	17	17	NUM
dpc-1965	220	2	.	.	PUNCT
dpc-1965	221	1	marçais	marçais	PROPN
dpc-1965	221	2	a	a	X
dpc-1965	221	3	,	,	PUNCT
dpc-1965	221	4	cherfils	cherfil	NOUN
dpc-1965	221	5	-	-	PUNCT
dpc-1965	221	6	vicini	vicini	NUM
dpc-1965	221	7	j	j	PROPN
dpc-1965	221	8	,	,	PUNCT
dpc-1965	221	9	viant	viant	PROPN
dpc-1965	221	10	c	c	PROPN
dpc-1965	221	11	,	,	PUNCT
dpc-1965	221	12	et	et	PROPN
dpc-1965	221	13	al	al	PROPN
dpc-1965	221	14	.	.	PUNCT
dpc-1965	222	1	the	the	DET
dpc-1965	222	2	metabolic	metabolic	PROPN
dpc-1965	222	3	checkpoint	checkpoint	NOUN
dpc-1965	222	4	kinase	kinase	PROPN
dpc-1965	222	5	mtor	mtor	PROPN
dpc-1965	222	6	is	be	AUX
dpc-1965	222	7	essential	essential	ADJ
dpc-1965	222	8	for	for	ADP
dpc-1965	222	9	il-15	il-15	NOUN
dpc-1965	222	10	signaling	signal	VERB
dpc-1965	222	11	during	during	ADP
dpc-1965	222	12	the	the	DET
dpc-1965	222	13	development	development	NOUN
dpc-1965	222	14	and	and	CCONJ
dpc-1965	222	15	activation	activation	NOUN
dpc-1965	222	16	of	of	ADP
dpc-1965	222	17	nk	nk	PROPN
dpc-1965	222	18	cells	cell	NOUN
dpc-1965	222	19	.	.	PUNCT
dpc-1965	223	1	nat	nat	PROPN
dpc-1965	223	2	immunol	immunol	NOUN
dpc-1965	223	3	.	.	PUNCT
dpc-1965	224	1	2014;15(8):749	2014;15(8):749	NUM
dpc-1965	224	2	-	-	PUNCT
dpc-1965	224	3	757	757	PROPN
dpc-1965	224	4	.	.	PUNCT
dpc-1965	225	1	doi	doi	NOUN
dpc-1965	225	2	:	:	PUNCT
dpc-1965	225	3	10.1038	10.1038	NUM
dpc-1965	225	4	/	/	SYM
dpc-1965	225	5	ni.2936	ni.2936	PROPN
dpc-1965	225	6	.	.	PUNCT
dpc-1965	226	1	pmid	pmid	NOUN
dpc-1965	226	2	:	:	PUNCT
dpc-1965	226	3	24973821	24973821	NUM
dpc-1965	226	4	.	.	PUNCT
dpc-1965	227	1	pmcid	pmcid	NOUN
dpc-1965	227	2	:	:	PUNCT
dpc-1965	227	3	pmc4110708	pmc4110708	ADJ
dpc-1965	227	4	.	.	PUNCT
dpc-1965	228	1	18	18	NUM
dpc-1965	228	2	.	.	PUNCT
dpc-1965	228	3	stern	stern	PROPN
dpc-1965	228	4	j	j	PROPN
dpc-1965	228	5	,	,	PUNCT
dpc-1965	228	6	keskin	keskin	PROPN
dpc-1965	228	7	d	d	PROPN
dpc-1965	228	8	,	,	PUNCT
dpc-1965	228	9	barteneva	barteneva	PROPN
dpc-1965	228	10	n	n	CCONJ
dpc-1965	228	11	,	,	PUNCT
dpc-1965	228	12	zuniga	zuniga	PROPN
dpc-1965	228	13	j	j	PROPN
dpc-1965	228	14	,	,	PUNCT
dpc-1965	228	15	yunis	yunis	PROPN
dpc-1965	228	16	e	e	PROPN
dpc-1965	228	17	,	,	PUNCT
dpc-1965	228	18	ahmed	ahmed	PROPN
dpc-1965	228	19	a.	a.	PROPN
dpc-1965	228	20	possible	possible	ADJ
dpc-1965	228	21	role	role	NOUN
dpc-1965	228	22	of	of	ADP
dpc-1965	228	23	natural	natural	ADJ
dpc-1965	228	24	killer	killer	NOUN
dpc-1965	228	25	cells	cell	NOUN
dpc-1965	228	26	in	in	ADP
dpc-1965	228	27	pemphigus	pemphigus	PROPN
dpc-1965	228	28	vulgaris−	vulgaris−	VERB
dpc-1965	228	29	preliminary	preliminary	ADJ
dpc-1965	228	30	observations	observation	NOUN
dpc-1965	228	31	.	.	PUNCT
dpc-1965	229	1	clin	clin	PROPN
dpc-1965	229	2	exp	exp	NOUN
dpc-1965	229	3	immunol	immunol	NOUN
dpc-1965	229	4	.	.	PUNCT
dpc-1965	230	1	2008;152(3):472	2008;152(3):472	PROPN
dpc-1965	230	2	-	-	SYM
dpc-1965	230	3	481	481	NUM
dpc-1965	230	4	.	.	PUNCT
dpc-1965	230	5	doi	doi	NOUN
dpc-1965	230	6	:	:	PUNCT
dpc-1965	230	7	10.1111	10.1111	NUM
dpc-1965	230	8	/	/	SYM
dpc-1965	230	9	j.1365	j.1365	NOUN
dpc-1965	230	10	-	-	PUNCT
dpc-1965	230	11	2249.2008.03638.x	2249.2008.03638.x	NUM
dpc-1965	230	12	.	.	PUNCT
dpc-1965	231	1	pmid	pmid	NOUN
dpc-1965	231	2	:	:	PUNCT
dpc-1965	231	3	18373702	18373702	NUM
dpc-1965	231	4	;	;	PUNCT
dpc-1965	231	5	pmcid	pmcid	ADJ
dpc-1965	231	6	:	:	PUNCT
dpc-1965	231	7	pmc2453198	pmc2453198	NOUN
dpc-1965	231	8	.	.	PUNCT
dpc-1965	232	1	19	19	NUM
dpc-1965	232	2	.	.	X
dpc-1965	233	1	yang	yang	PROPN
dpc-1965	233	2	x	x	PROPN
dpc-1965	233	3	-	-	PROPN
dpc-1965	233	4	k	k	PROPN
dpc-1965	233	5	,	,	PUNCT
dpc-1965	233	6	xu	xu	PROPN
dpc-1965	233	7	w	w	PROPN
dpc-1965	233	8	-	-	PROPN
dpc-1965	233	9	d	d	PROPN
dpc-1965	233	10	,	,	PUNCT
dpc-1965	233	11	leng	leng	PROPN
dpc-1965	233	12	r	r	PROPN
dpc-1965	233	13	-	-	PUNCT
dpc-1965	233	14	x	x	NOUN
dpc-1965	233	15	,	,	PUNCT
dpc-1965	233	16	et	et	PROPN
dpc-1965	233	17	al	al	PROPN
dpc-1965	233	18	.	.	PUNCT
dpc-1965	234	1	therapeutic	therapeutic	ADJ
dpc-1965	234	2	potential	potential	NOUN
dpc-1965	234	3	of	of	ADP
dpc-1965	234	4	il-15	il-15	NOUN
dpc-1965	234	5	in	in	ADP
dpc-1965	234	6	rheumatoid	rheumatoid	NOUN
dpc-1965	234	7	arthritis	arthritis	NOUN
dpc-1965	234	8	.	.	PUNCT
dpc-1965	235	1	hum	hum	PROPN
dpc-1965	235	2	immunol	immunol	NOUN
dpc-1965	235	3	.	.	PUNCT
dpc-1965	236	1	2015;76(11):812818	2015;76(11):812818	X
dpc-1965	236	2	.	.	X
dpc-1965	236	3	doi	doi	PROPN
dpc-1965	236	4	:	:	PUNCT
dpc-1965	236	5	10.1016	10.1016	NUM
dpc-1965	236	6	/	/	SYM
dpc-1965	236	7	j.humimm.2015.09.041	j.humimm.2015.09.041	PROPN
dpc-1965	236	8	.	.	PUNCT
dpc-1965	237	1	pmid	pmid	NOUN
dpc-1965	237	2	:	:	PUNCT
dpc-1965	237	3	26429323	26429323	NUM
dpc-1965	237	4	.	.	PUNCT
dpc-1965	238	1	20	20	NUM
dpc-1965	238	2	.	.	X
dpc-1965	239	1	aringer	aringer	PROPN
dpc-1965	239	2	m	m	PROPN
dpc-1965	239	3	,	,	PUNCT
dpc-1965	239	4	stummvoll	stummvoll	NOUN
dpc-1965	239	5	g	g	NOUN
dpc-1965	239	6	,	,	PUNCT
dpc-1965	239	7	steiner	steiner	PROPN
dpc-1965	239	8	g	g	PROPN
dpc-1965	239	9	,	,	PUNCT
dpc-1965	239	10	et	et	PROPN
dpc-1965	239	11	al	al	PROPN
dpc-1965	239	12	.	.	PROPN
dpc-1965	239	13	serum	serum	PROPN
dpc-1965	239	14	interleukin‐15	interleukin‐15	PROPN
dpc-1965	239	15	is	be	AUX
dpc-1965	239	16	elevated	elevate	VERB
dpc-1965	239	17	in	in	ADP
dpc-1965	239	18	systemic	systemic	ADJ
dpc-1965	239	19	lupus	lupus	PROPN
dpc-1965	239	20	erythematosus	erythematosus	PROPN
dpc-1965	239	21	.	.	PUNCT
dpc-1965	240	1	rheumatology	rheumatology	NOUN
dpc-1965	240	2	(	(	PUNCT
dpc-1965	240	3	oxford	oxford	PROPN
dpc-1965	240	4	)	)	PUNCT
dpc-1965	240	5	.	.	PUNCT
dpc-1965	241	1	2001;40(8):876	2001;40(8):876	NUM
dpc-1965	241	2	-	-	SYM
dpc-1965	241	3	881	881	NUM
dpc-1965	241	4	.	.	PUNCT
dpc-1965	241	5	doi	doi	NOUN
dpc-1965	241	6	:	:	PUNCT
dpc-1965	241	7	10.1093/	10.1093/	NUM
dpc-1965	241	8	rheumatology/40.8.876	rheumatology/40.8.876	NOUN
dpc-1965	241	9	.	.	PUNCT
dpc-1965	242	1	pmid	pmid	NOUN
dpc-1965	242	2	:	:	PUNCT
dpc-1965	242	3	11511756	11511756	NUM
dpc-1965	242	4	.	.	PUNCT
dpc-1965	243	1	21	21	NUM
dpc-1965	243	2	.	.	PUNCT
dpc-1965	243	3	pavkova	pavkova	VERB
dpc-1965	243	4	goldbergova	goldbergova	PROPN
dpc-1965	243	5	m	m	PROPN
dpc-1965	243	6	,	,	PUNCT
dpc-1965	243	7	pavek	pavek	NOUN
dpc-1965	243	8	n	n	CCONJ
dpc-1965	243	9	,	,	PUNCT
dpc-1965	243	10	lipkova	lipkova	PROPN
dpc-1965	243	11	j	j	PROPN
dpc-1965	243	12	,	,	PUNCT
dpc-1965	243	13	et	et	PROPN
dpc-1965	243	14	al	al	PROPN
dpc-1965	243	15	.	.	PUNCT
dpc-1965	244	1	circulating	circulate	VERB
dpc-1965	244	2	cytokine	cytokine	NOUN
dpc-1965	244	3	pattern	pattern	NOUN
dpc-1965	244	4	and	and	CCONJ
dpc-1965	244	5	factors	factor	NOUN
dpc-1965	244	6	describing	describe	VERB
dpc-1965	244	7	rheumatoid	rheumatoid	NOUN
dpc-1965	244	8	arthritis	arthritis	NOUN
dpc-1965	244	9	:	:	PUNCT
dpc-1965	244	10	il-15	il-15	NOUN
dpc-1965	244	11	as	as	ADP
dpc-1965	244	12	one	one	NUM
dpc-1965	244	13	of	of	ADP
dpc-1965	244	14	the	the	DET
dpc-1965	244	15	biomarkers	biomarker	NOUN
dpc-1965	244	16	for	for	ADP
dpc-1965	244	17	ra	ra	PROPN
dpc-1965	244	18	?	?	PUNCT
dpc-1965	244	19	biomarkers	biomarker	NOUN
dpc-1965	244	20	.	.	PUNCT
dpc-1965	245	1	2012;17(7):655	2012;17(7):655	PROPN
dpc-1965	245	2	-	-	PUNCT
dpc-1965	245	3	662	662	NUM
dpc-1965	245	4	.	.	PUNCT
dpc-1965	246	1	doi	doi	NOUN
dpc-1965	246	2	:	:	PUNCT
dpc-1965	246	3	10.3109/1354750x.2012.719036	10.3109/1354750x.2012.719036	NOUN
dpc-1965	246	4	.	.	PUNCT
dpc-1965	247	1	pmid	pmid	NOUN
dpc-1965	247	2	:	:	PUNCT
dpc-1965	247	3	22998011	22998011	NUM
dpc-1965	247	4	.	.	PUNCT
dpc-1965	248	1	22	22	NUM
dpc-1965	248	2	.	.	PUNCT
dpc-1965	249	1	villadsen	villadsen	PROPN
dpc-1965	249	2	ls	ls	PROPN
dpc-1965	249	3	,	,	PUNCT
dpc-1965	249	4	schuurman	schuurman	PROPN
dpc-1965	249	5	j	j	PROPN
dpc-1965	249	6	,	,	PUNCT
dpc-1965	249	7	beurskens	beurskens	PROPN
dpc-1965	249	8	f	f	PROPN
dpc-1965	249	9	,	,	PUNCT
dpc-1965	249	10	et	et	PROPN
dpc-1965	249	11	al	al	PROPN
dpc-1965	249	12	.	.	PUNCT
dpc-1965	249	13	resolution	resolution	NOUN
dpc-1965	249	14	of	of	ADP
dpc-1965	249	15	psoriasis	psoriasis	NOUN
dpc-1965	249	16	upon	upon	SCONJ
dpc-1965	249	17	blockade	blockade	NOUN
dpc-1965	249	18	of	of	ADP
dpc-1965	249	19	il-15	il-15	NOUN
dpc-1965	249	20	biological	biological	ADJ
dpc-1965	249	21	activity	activity	NOUN
dpc-1965	249	22	in	in	ADP
dpc-1965	249	23	a	a	DET
dpc-1965	249	24	xenograft	xenograft	NOUN
dpc-1965	249	25	mouse	mouse	NOUN
dpc-1965	249	26	model	model	NOUN
dpc-1965	249	27	.	.	PUNCT
dpc-1965	250	1	the	the	DET
dpc-1965	250	2	journal	journal	NOUN
dpc-1965	250	3	of	of	ADP
dpc-1965	250	4	clinical	clinical	ADJ
dpc-1965	250	5	investigation	investigation	NOUN
dpc-1965	250	6	.	.	PUNCT
dpc-1965	251	1	2003;112(10):1571	2003;112(10):1571	NUM
dpc-1965	251	2	-	-	SYM
dpc-1965	251	3	1580	1580	NUM
dpc-1965	251	4	.	.	PUNCT
dpc-1965	252	1	doi	doi	NOUN
dpc-1965	252	2	:	:	PUNCT
dpc-1965	252	3	10.1172	10.1172	NUM
dpc-1965	252	4	/	/	SYM
dpc-1965	252	5	jci18986	jci18986	NOUN
dpc-1965	252	6	.	.	PUNCT
dpc-1965	253	1	pmid	pmid	NOUN
dpc-1965	253	2	:	:	PUNCT
dpc-1965	253	3	14617758	14617758	NUM
dpc-1965	253	4	.	.	PUNCT
dpc-1965	254	1	pmcid	pmcid	NOUN
dpc-1965	254	2	:	:	PUNCT
dpc-1965	254	3	pmc259129	pmc259129	PROPN
dpc-1965	254	4	.	.	PUNCT
dpc-1965	255	1	23	23	NUM
dpc-1965	255	2	.	.	PUNCT
dpc-1965	256	1	gheisari	gheisari	PROPN
dpc-1965	256	2	m	m	PROPN
dpc-1965	256	3	,	,	PUNCT
dpc-1965	256	4	faraji	faraji	PROPN
dpc-1965	256	5	z	z	PROPN
dpc-1965	256	6	,	,	PUNCT
dpc-1965	256	7	dadras	dadras	PROPN
dpc-1965	256	8	ms	ms	PROPN
dpc-1965	256	9	,	,	PUNCT
dpc-1965	256	10	et	et	PROPN
dpc-1965	256	11	al	al	PROPN
dpc-1965	256	12	.	.	PROPN
dpc-1965	256	13	methylprednisolone	methylprednisolone	PROPN
dpc-1965	256	14	pulse	pulse	NOUN
dpc-1965	256	15	therapy	therapy	NOUN
dpc-1965	256	16	plus	plus	CCONJ
dpc-1965	256	17	adjuvant	adjuvant	NOUN
dpc-1965	256	18	therapy	therapy	NOUN
dpc-1965	256	19	for	for	ADP
dpc-1965	256	20	pemphigus	pemphigus	NOUN
dpc-1965	256	21	vulgaris	vulgaris	NOUN
dpc-1965	256	22	;	;	PUNCT
dpc-1965	256	23	an	an	DET
dpc-1965	256	24	analysis	analysis	NOUN
dpc-1965	256	25	of	of	ADP
dpc-1965	256	26	ten	ten	NUM
dpc-1965	256	27	years	year	NOUN
dpc-1965	256	28	’	'	PUNCT
dpc-1965	256	29	experience	experience	NOUN
dpc-1965	256	30	on	on	ADP
dpc-1965	256	31	312	312	NUM
dpc-1965	256	32	patients	patient	NOUN
dpc-1965	256	33	.	.	PUNCT
dpc-1965	257	1	dermatol	dermatol	NOUN
dpc-1965	257	2	ther	ther	ADV
dpc-1965	257	3	.	.	PUNCT
dpc-1965	258	1	2019;32(5):e13057	2019;32(5):e13057	X
dpc-1965	258	2	.	.	X
dpc-1965	258	3	doi	doi	NOUN
dpc-1965	258	4	:	:	PUNCT
dpc-1965	258	5	10.1111	10.1111	NUM
dpc-1965	258	6	/	/	SYM
dpc-1965	258	7	dth.13057	dth.13057	NOUN
dpc-1965	258	8	.	.	PUNCT
dpc-1965	259	1	pmid	pmid	NOUN
dpc-1965	259	2	:	:	PUNCT
dpc-1965	259	3	31400243	31400243	NUM
dpc-1965	259	4	.	.	PUNCT
dpc-1965	260	1	24	24	NUM
dpc-1965	260	2	.	.	PUNCT
dpc-1965	261	1	wang	wang	PROPN
dpc-1965	261	2	h	h	PROPN
dpc-1965	261	3	-	-	PUNCT
dpc-1965	261	4	h	h	PROPN
dpc-1965	261	5	,	,	PUNCT
dpc-1965	261	6	liu	liu	PROPN
dpc-1965	261	7	c	c	PROPN
dpc-1965	261	8	-	-	PUNCT
dpc-1965	261	9	w	w	PROPN
dpc-1965	261	10	,	,	PUNCT
dpc-1965	261	11	li	li	PROPN
dpc-1965	261	12	y	y	PROPN
dpc-1965	261	13	-	-	PUNCT
dpc-1965	261	14	c	c	PROPN
dpc-1965	261	15	,	,	PUNCT
dpc-1965	261	16	huang	huang	PROPN
dpc-1965	261	17	y	y	PROPN
dpc-1965	261	18	-	-	PUNCT
dpc-1965	261	19	c.	c.	PROPN
dpc-1965	261	20	efficacy	efficacy	NOUN
dpc-1965	261	21	of	of	ADP
dpc-1965	261	22	rituximab	rituximab	NOUN
dpc-1965	261	23	for	for	ADP
dpc-1965	261	24	pemphigus	pemphigus	NOUN
dpc-1965	261	25	:	:	PUNCT
dpc-1965	261	26	a	a	DET
dpc-1965	261	27	systematic	systematic	ADJ
dpc-1965	261	28	review	review	NOUN
dpc-1965	261	29	and	and	CCONJ
dpc-1965	261	30	meta	meta	ADJ
dpc-1965	261	31	-	-	PUNCT
dpc-1965	261	32	analysis	analysis	NOUN
dpc-1965	261	33	of	of	ADP
dpc-1965	261	34	different	different	ADJ
dpc-1965	261	35	regimens	regimen	NOUN
dpc-1965	261	36	.	.	PUNCT
dpc-1965	262	1	acta	acta	PROPN
dpc-1965	262	2	derm	derm	PROPN
dpc-1965	262	3	venereol	venereol	NOUN
dpc-1965	262	4	.	.	PUNCT
dpc-1965	263	1	2015;95(8):928	2015;95(8):928	NOUN
dpc-1965	263	2	-	-	SYM
dpc-1965	263	3	932	932	NUM
dpc-1965	263	4	.	.	PUNCT
dpc-1965	264	1	doi	doi	NOUN
dpc-1965	264	2	:	:	PUNCT
dpc-1965	264	3	10.2340/00015555	10.2340/00015555	NUM
dpc-1965	264	4	-	-	SYM
dpc-1965	264	5	2116	2116	NUM
dpc-1965	264	6	.	.	PUNCT
dpc-1965	265	1	pmid	pmid	NOUN
dpc-1965	265	2	:	:	PUNCT
dpc-1965	265	3	25881672	25881672	NUM
dpc-1965	265	4	.	.	PUNCT
dpc-1965	266	1	25	25	NUM
dpc-1965	266	2	.	.	X
dpc-1965	266	3	díaz‐torné	díaz‐torné	NOUN
dpc-1965	266	4	c	c	X
dpc-1965	266	5	,	,	PUNCT
dpc-1965	266	6	ortiz	ortiz	PROPN
dpc-1965	266	7	de	de	PROPN
dpc-1965	266	8	juana	juana	PROPN
dpc-1965	266	9	ma	ma	PROPN
dpc-1965	266	10	,	,	PUNCT
dpc-1965	266	11	geli	geli	ADJ
dpc-1965	266	12	c	c	X
dpc-1965	266	13	,	,	PUNCT
dpc-1965	266	14	et	et	PROPN
dpc-1965	266	15	al	al	PROPN
dpc-1965	266	16	.	.	PROPN
dpc-1965	266	17	rituximab‐induced	rituximab‐induce	VERB
dpc-1965	266	18	interleukin‐15	interleukin‐15	PROPN
dpc-1965	266	19	reduction	reduction	NOUN
dpc-1965	266	20	associated	associate	VERB
dpc-1965	266	21	with	with	ADP
dpc-1965	266	22	clinical	clinical	ADJ
dpc-1965	266	23	improvement	improvement	NOUN
dpc-1965	266	24	in	in	ADP
dpc-1965	266	25	rheumatoid	rheumatoid	NOUN
dpc-1965	266	26	arthritis	arthritis	NOUN
dpc-1965	266	27	.	.	PUNCT
dpc-1965	267	1	immunology	immunology	NOUN
dpc-1965	267	2	.	.	PUNCT
dpc-1965	268	1	2014;142(3):354	2014;142(3):354	NOUN
dpc-1965	268	2	-	-	SYM
dpc-1965	268	3	362	362	NUM
dpc-1965	268	4	.	.	PUNCT
dpc-1965	269	1	doi	doi	NOUN
dpc-1965	269	2	:	:	PUNCT
dpc-1965	269	3	10.1111	10.1111	NUM
dpc-1965	269	4	/	/	SYM
dpc-1965	269	5	imm.12212	imm.12212	NUM
dpc-1965	269	6	.	.	PUNCT
dpc-1965	270	1	pmid	pmid	NOUN
dpc-1965	270	2	:	:	PUNCT
dpc-1965	270	3	24219764	24219764	NUM
dpc-1965	270	4	.	.	PUNCT
dpc-1965	271	1	pmcid	pmcid	ADJ
dpc-1965	271	2	:	:	PUNCT
dpc-1965	271	3	pmc4080951	pmc4080951	NOUN
dpc-1965	271	4	.	.	PUNCT